Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (32021)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Jun 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol 2014; 5(3): 412-424 [PMID: 25114856 DOI: 10.5306/wjco.v5.i3.412] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2824/full/v5/i3/412.htm |
| Number | Citing Articles |
| 1 |
Ekaterina V. Gubarkova, Vadim V. Elagin, Varvara V. Dudenkova, Sergey S. Kuznetsov, Maria M. Karabut, Arseny L. Potapov, Dmitry A. Vorontsov, Alexey Y. Vorontsov, Marina A. Sirotkina, Elena V. Zagaynova, Natalia D. Gladkova. Multiphoton tomography in differentiation of morphological and molecular subtypes of breast cancer: A quantitative analysis. Journal of Biophotonics 2021; 14(5) doi: 10.1002/jbio.202000471
|
| 2 |
Byungkyu Park, Jinho Im, Kyungsook Han. Comparative Analysis of Gene Correlation Networks of Breast Cancer Patients Based on Mutations in TP53. Biomolecules 2022; 12(7): 979 doi: 10.3390/biom12070979
|
| 3 |
Qi Li, Hengchen Liu, Yun Jin, Yuanquan Yu, Yihang Wang, Di Wu, Yinghao Guo, Longfu Xi, Dan Ye, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes. Computers in Biology and Medicine 2023; 165: 107370 doi: 10.1016/j.compbiomed.2023.107370
|
| 4 |
Alkistis Papatheodoridi, Eleni Papamattheou, Spyridon Marinopoulos, Ioannis Ntanasis-Stathopoulos, Constantine Dimitrakakis, Aris Giannos, Maria Kaparelou, Michalis Liontos, Meletios-Athanasios Dimopoulos, Flora Zagouri. Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature. Medical Sciences 2023; 11(2): 35 doi: 10.3390/medsci11020035
|
| 5 |
Asaad Azarnezhad, Parvin Mehdipour. Cancer Genetics and Psychotherapy. 2017; : 79 doi: 10.1007/978-3-319-64550-6_5
|
| 6 |
梦琳 曹. Research Progress of Multimodal Imaging in Evaluating Postoperative Recurrence of Breast Cancer. Advances in Clinical Medicine 2022; 12(09): 8088 doi: 10.12677/ACM.2022.1291165
|
| 7 |
Pavel Sokolov, Galina Nifontova, Pavel Samokhvalov, Alexander Karaulov, Alyona Sukhanova, Igor Nabiev. Nontoxic Fluorescent Nanoprobes for Multiplexed Detection and 3D Imaging of Tumor Markers in Breast Cancer. Pharmaceutics 2023; 15(3): 946 doi: 10.3390/pharmaceutics15030946
|
| 8 |
Amal Tazzite, Hassan Jouhadi, Abdellatif Benider, Sellama Nadifi. BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer. Current Drug Targets 2020; 21(10): 962 doi: 10.2174/1389450121666200203162541
|
| 9 |
Yousra Ahmed ZeinElAbdeen, Amna AbdAlSeed, Rana A. Youness. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 2022; 27(1): 79 doi: 10.1007/s10911-022-09511-z
|
| 10 |
Nahaa M. Alotaibi, Modhi O. Alotaibi, Nawaf Alshammari, Mohd Adnan, Mitesh Patel. Network Pharmacology Combined with Molecular Docking, Molecular Dynamics, and In Vitro Experimental Validation Reveals the Therapeutic Potential of Thymus vulgaris L. Essential Oil (Thyme Oil) against Human Breast Cancer. ACS Omega 2023; 8(50): 48344 doi: 10.1021/acsomega.3c07782
|
| 11 |
Molham Sakkal, Abdallah Abou Hajal. Machine learning predictions of tumor progression: How reliable are we?. Computers in Biology and Medicine 2025; 191: 110156 doi: 10.1016/j.compbiomed.2025.110156
|
| 12 |
Neelakshi Mungra, Fleury A. N. Biteghe, Zaria Malindi, Allan M. Huysamen, Maryam Karaan, Natasha S. Hardcastle, Rubina Bunjun, Shivan Chetty, Krupa Naran, Dirk Lang, Wolfgang Richter, Roger Hunter, Stefan Barth. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12203 doi: 10.1007/s00432-023-05031-3
|
| 13 |
Azadeh Hekmat, Luciano Saso, Viney Lather, Deepti Pandita, Irena Kostova, Ali Akbar Saboury. Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment. Pharmaceutics 2022; 14(12): 2640 doi: 10.3390/pharmaceutics14122640
|
| 14 |
Sarah M. Bernhardt, Pallave Dasari, David Walsh, Amanda R. Townsend, Timothy J. Price, Wendy V. Ingman. Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00241
|
| 15 |
Diksha Nagpal, Ravinder Verma, Vineet Mittal, Philippe Jeandet, Deepak Kaushik. Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities. Journal of Drug Delivery Science and Technology 2023; 89: 105049 doi: 10.1016/j.jddst.2023.105049
|
| 16 |
Xueqian Yang, Xiangnan Zheng, Cheng Liu, Jiaqing Zheng, Xu Dong, Wengang Ren, Tao Zhang, Hongxiang Lou, Peihong Fan. Design, synthesis, and biological evaluation of novel PROTACs compounds with good ERα degradation ability. Bioorganic & Medicinal Chemistry 2025; 122: 118111 doi: 10.1016/j.bmc.2025.118111
|
| 17 |
Tong Xu, Yanyu Jiang, Shuying Yuan, Li Zhang, Xihui Chen, Weili Zhao, Lili Cai, Biying Xiao, Lijun Jia. Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.899402
|
| 18 |
Toshihiko Takeiwa, Kazuhiro Ikeda, Takashi Suzuki, Wataru Sato, Kaori Iino, Yuichi Mitobe, Hidetaka Kawabata, Kuniko Horie, Satoshi Inoue. PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13601-7
|
| 19 |
Negin Soghli, Hassan Yousefi, Tohid Naderi, Aysan Fallah, Amin Moshksar, Farzaneh Darbeheshti, Cecilia Vittori, Mahsa Rostamian Delavar, Ali Zare, Habib Sadeghi Rad, Abtin Kazemi, Amirreza Bitaraf, Bashdar Mahmud Hussen, Mohammad Taheri, Elena Jamali. NRF2 signaling pathway: A comprehensive prognostic and gene expression profile analysis in breast cancer. Pathology - Research and Practice 2023; 243: 154341 doi: 10.1016/j.prp.2023.154341
|
| 20 |
Kaiming Zhang, Liqin Ping, Tian Du, Gehao Liang, Yun Huang, Zhiling Li, Rong Deng, Jun Tang. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.678877
|
| 21 |
Martin Nzegwu, Joseph Uzoigwe, Babatunde Omotowo, Anthony Ugochukwu, Benjamin Ozumba, Emmanuel Sule, Emmanuel Ezeome, Daniel Olusina, Okechukwu Okafor, Victor Nzegwu, Christie Nzegwu, Chidi Eluke, Francis I Ukekwe. Predictive and prognostic relevance of immunohistochemical testing of estrogen and progesterone receptors in breast cancer in South East Nigeria: A review of 417 cases. Rare Tumors 2021; 13 doi: 10.1177/20363613211006338
|
| 22 |
Murugesan Palaniappan. Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer. Biomedicines 2024; 12(12): 2700 doi: 10.3390/biomedicines12122700
|
| 23 |
Michael Abiodun Adeyanju. MOLECULAR SUBTYPES OF BREAST CANCER. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2022; : 15 doi: 10.36106/ijsr/1634010
|
| 24 |
Gunjan Vasant Bonde, Sarita Kumari Yadav, Sheetal Chauhan, Pooja Mittal, Gufran Ajmal, Sathish Thokala, Brahmeshwar Mishra. Lapatinib nano-delivery systems: a promising future for breast cancer treatment. Expert Opinion on Drug Delivery 2018; 15(5): 495 doi: 10.1080/17425247.2018.1449832
|
| 25 |
John P. Micha, Mark A. Rettenmaier, Randy D. Bohart, Bram H. Goldstein. Prolonged endocrine therapy in the management of hormone receptor‐positive early‐stage breast cancer: What is the appropriate duration?. Journal of Obstetrics and Gynaecology Research 2023; 49(4): 1079 doi: 10.1111/jog.15553
|
| 26 |
Anshu Soni, Vishakha Jaiswal. Polymeric Micelles in Targeted Breast Cancer Therapy：Recent Advances and Future Trends. Nano Biomedicine and Engineering 2025; 17(2): 212 doi: 10.26599/NBE.2025.9290122
|
| 27 |
F. O. Andrade, L. Hilakivi-Clarke. Nutrition and Cancer Prevention. 2019; : 368 doi: 10.1039/9781788016506-00368
|
| 28 |
Kazuki Nishimoto, Nobuyuki Okahashi, Masaharu Maruyama, Yoshihiro Izumi, Kohta Nakatani, Yuki Ito, Junko Iida, Takeshi Bamba, Fumio Matsuda. Lipidome and metabolome analyses reveal metabolic alterations associated with MCF-7 apoptosis upon 4-hydroxytamoxifen treatment. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45764-2
|
| 29 |
Jonathan Barra, Isaiah Crosbourne, Cassandra L. Roberge, Ramon Bossardi-Ramos, Janine S. A. Warren, Kailie Matteson, Ling Wang, Frances Jourd’heuil, Sergey M. Borisov, Erin Bresnahan, Jose Javier Bravo-Cordero, Ruslan I. Dmitriev, David Jourd’heuil, Alejandro P. Adam, John M. Lamar, David T. Corr, Margarida M. Barroso. DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth. Oncogene 2024; 43(9): 650 doi: 10.1038/s41388-023-02933-x
|
| 30 |
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. International Journal of Molecular Sciences 2022; 23(3): 1234 doi: 10.3390/ijms23031234
|
| 31 |
Shujun Huang, Pingzhao Hu, Ted M. Lakowski. Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer. The Pharmacogenomics Journal 2023; 23(4): 61 doi: 10.1038/s41397-022-00297-1
|
| 32 |
Lukasz Turczyk, Kamila Kitowska, Magdalena Mieszkowska, Kamil Mieczkowski, Dominika Czaplinska, Dominika Piasecka, Radzisław Kordek, Andrzej C. Skladanowski, Piotr Potemski, Hanna M. Romanska, Rafal Sadej. FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells. Neoplasia 2017; 19(10): 791 doi: 10.1016/j.neo.2017.07.006
|
| 33 |
Raghuveer Kavarthapu, Rajakumar Anbazhagan, Maria L. Dufau. Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer. Cancers 2021; 13(18): 4685 doi: 10.3390/cancers13184685
|
| 34 |
Ruobing Huang, Yinyu Ye, Ao Chang, Han Huang, Zijie Zheng, Long Tan, Guoxue Tang, Man Luo, Xiuwen Yi, Pan Liu, Jiayi Wu, Baoming Luo, Dong Ni. Subtyping breast lesions via collective intelligence based long-tailed recognition in ultrasound. Medical Image Analysis 2025; 102: 103548 doi: 10.1016/j.media.2025.103548
|
| 35 |
Nabeelah Pooloo, Anisah Wahed Ghoorah, Zahra Mungloo-Dilmohamud, Shakuntala Baichoo. Soft Computing and Its Engineering Applications. Communications in Computer and Information Science 2025; 2430: 348 doi: 10.1007/978-3-031-88039-1_27
|
| 36 |
Marco Palma. Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges. Vaccines 2025; 13(4): 344 doi: 10.3390/vaccines13040344
|
| 37 |
Youssef El-Ahmad, Michel Tabart, Frank Halley, Victor Certal, Fabienne Thompson, Bruno Filoche-Rommé, Florence Gruss-Leleu, Claire Muller, Maurice Brollo, Laurence Fabien, Véronique Loyau, Luc Bertin, Patrick Richepin, Fabienne Pilorge, Pascal Desmazeau, Chrystelle Girardet, Sylvie Beccari, Audrey Louboutin, Gilles Lebourg, Jacques Le-Roux, Corinne Terrier, François Vallée, Valérie Steier, Magali Mathieu, Alexey Rak, Pierre-Yves Abecassis, Pascale Vicat, Tsiala Benard, Monsif Bouaboula, Fangxian Sun, Maysoun Shomali, Andrew Hebert, Mikhail Levit, Hong Cheng, Albane Courjaud, Celine Ginesty, Christelle Perrault, Carlos Garcia-Echeverria, Gary McCort, Laurent Schio. Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer. Journal of Medicinal Chemistry 2020; 63(2): 512 doi: 10.1021/acs.jmedchem.9b01293
|
| 38 |
McCabe Michelle, Dineo Disenyane, Benny Mosoane, Aristotelis Chatziioannou, Rodney Hull, Zodwa Dlamini. Overcoming Breast Cancer Therapy Resistance. 2024; : 25 doi: 10.1007/978-3-031-52860-6_2
|
| 39 |
Geovanni Dantas Cassali, Karen Yumi Ribeiro Nakagaki, Marisa Salvi, Marina Possa dos Reys, Marcos André Nino Rocha, Cecilia Bonolo de Campos, Enio Ferreira, Angelica Cavalheiro Bertagnolli Rodrigues, Diego Carlos dos Reis, Karine Araujo Damasceno, Alessandra Estrela-Lima. Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer. Veterinary Sciences 2025; 12(2): 189 doi: 10.3390/vetsci12020189
|
| 40 |
Yongnan Chen, Songsong Liu, Lazaros G. Papageorgiou, Konstantinos Theofilatos, Sophia Tsoka. Optimisation Models for Pathway Activity Inference in Cancer. Cancers 2023; 15(6): 1787 doi: 10.3390/cancers15061787
|
| 41 |
Alejandrina Muñoz-Palomeque, Miguel Angel Guerrero-Ramirez, Lidia Ariadna Rubio-Chavez, Roberto Carlos Rosales-Gomez, Maria Guadalupe Lopez-Cardona, Victor Hugo Barajas-Avila, Alfredo Delgadillo-Barrera, Juan Carlos Canton-Romero, Hector Montoya-Fuentes, Teresa Arcelia Garcia-Cobian, Susan Andrea Gutierrez-Rubio. Association ofRETNandCAP1SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women. Genetic Testing and Molecular Biomarkers 2018; 22(4): 209 doi: 10.1089/gtmb.2017.0212
|
| 42 |
Yunlong Lu, Chao Liu, Xin Wang, Lijuan Liu, Zhihao Zhao, Zhenlin Liang, Yuanhao Liu, Zhenfan Wen, Qianming Du, Wukun Liu. Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer. European Journal of Medicinal Chemistry 2023; 253: 115324 doi: 10.1016/j.ejmech.2023.115324
|
| 43 |
Jong-Ho Cheun, Jiyoung Won, Ji Gwang Jung, Hong-Kyu Kim, Wonshik Han, Han-Byoel Lee. Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery. Journal of Breast Cancer 2021; 24(3): 301 doi: 10.4048/jbc.2021.24.e33
|
| 44 |
Tetta Takahashi, Nahoko Tomonobu, Rie Kinoshita, Ken-ichi Yamamoto, Hitoshi Murata, Ni Luh Gede Yoni Komalasari, Youyi Chen, Fan Jiang, Yuma Gohara, Toshiki Ochi, I Made Winarsa Ruma, I Wayan Sumardika, Jin Zhou, Tomoko Honjo, Yoshihiko Sakaguchi, Akira Yamauchi, Futoshi Kuribayashi, Eisaku Kondo, Yusuke Inoue, Junichiro Futami, Shinichi Toyooka, Yoshito Zamami, Masakiyo Sakaguchi. Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1371342
|
| 45 |
Hannah Romano, Katie Lin, Silvia Vivarelli, Luca Falzone, Massimo Libra, Benjamin Bonavida. Overcoming Cancers Resistant to HER-2 Antibodies. 2024; : 19 doi: 10.1016/B978-0-12-816408-2.00013-0
|
| 46 |
Jamshid Motalebzadeh, Elaheh Eskandari. Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model. Breast Cancer 2022; 29(6): 1050 doi: 10.1007/s12282-022-01385-7
|
| 47 |
Max Denis, Adriana Gregory, Mahdi Bayat, Robert T. Fazzio, Dana H. Whaley, Karthik Ghosh, Sejal Shah, Mostafa Fatemi, Azra Alizad, Aamir Ahmad. Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes. PLOS ONE 2016; 11(10): e0165003 doi: 10.1371/journal.pone.0165003
|
| 48 |
Christopher M. Franke, Vivian W. Gu, Benjamin G. Grimm, Victoria C. Cassady, Jeffrey R. White, Ronald J. Weigel, Mikhail V. Kulak. TFAP2C regulates carbonic anhydrase XII in human breast cancer. Oncogene 2020; 39(6): 1290 doi: 10.1038/s41388-019-1062-5
|
| 49 |
Wenqi Lu, Ayat G Lashen, Noorul Wahab, Islam M Miligy, Mostafa Jahanifar, Michael Toss, Simon Graham, Mohsin Bilal, Abhir Bhalerao, Nehal M Atallah, Shorouk Makhlouf, Asmaa Y Ibrahim, David Snead, Fayyaz Minhas, Shan E Ahmed Raza, Emad Rakha, Nasir Rajpoot. AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer. The Journal of Pathology: Clinical Research 2024; 10(1) doi: 10.1002/cjp2.346
|
| 50 |
Kamendra Kumar, Bo-Hyun Moon, Kamal Datta, Albert J. Fornace, Shubhankar Suman. Simulated galactic cosmic radiation (GCR)-induced expression of Spp1 coincide with mammary ductal cell proliferation and preneoplastic changes in Apc mouse. Life Sciences in Space Research 2023; 36: 116 doi: 10.1016/j.lssr.2022.09.006
|
| 51 |
Antonella Cardone, Dany Bell, Conchi Biurrun, Francesco Cognetti, Fatima Cardoso, Ana Ramirez Piris, Csaba Degi, Michael Patrick Lux, Richard Simcock, Johanna Wassermann, Rosanna D'Antona, Isabel T. Rubio. Awareness of genomic testing among patients with breast cancer in Europe. The Breast 2025; 81: 104436 doi: 10.1016/j.breast.2025.104436
|
| 52 |
Dony Ruswendro, Salman Ardi Syamsu, Rudy Thabry, Arifin Seweng, Andi Nilawati Usman, Andi Nilawati Usman. Association between molecular subtype of local advanced breast cancer with Ca 15-3 level. Breast Disease 2021; 40(s1): S119 doi: 10.3233/BD-219018
|
| 53 |
Hui Shen, Shankar Bhamidi, Yufeng Liu. Statistical Significance of Clustering with Multidimensional Scaling. Journal of Computational and Graphical Statistics 2024; 33(1): 219 doi: 10.1080/10618600.2023.2219708
|
| 54 |
Kanu Obioha, Ikwo Jonathan Kudamnya, Emem Imo Akpanudo, Emmanuel Kunle Abudu, Oluwasayo Omolara Abudu, Adekunbiola Fehintola Banjo. Prevalence of basal-like phenotype in triple-negative invasive breast carcinomas and a review of the literature. Adesh University Journal of Medical Sciences & Research 2024; 5: 60 doi: 10.25259/AUJMSR_18_2023
|
| 55 |
Özlem YERSAL, Mehmet YİĞİT, Nezih MEYDAN, Sabri BARUTCA. Retrospective evaluation of breast cancer patients with five or more axillary lymph node involvement achieving 5-year overall survival. The European Research Journal 2019; 5(2): 268 doi: 10.18621/eurj.368447
|
| 56 |
Sebastian Rubino, Daniel E. Oliver, Nam D. Tran, Michael A. Vogelbaum, Peter A. Forsyth, Hsiang-Hsuan Michael Yu, Kamran Ahmed, Arnold B. Etame. Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854402
|
| 57 |
Ali Mehdi, Mikhael Attias, Ani Arakelian, Ciriaco A. Piccirillo, Moshe Szyf, Shafaat A. Rabbani. Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone. Cancers 2022; 15(1): 48 doi: 10.3390/cancers15010048
|
| 58 |
Elaheh Eskandari, Jamshid Motalebzadeh. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer. Cancer Genetics 2019; 239: 62 doi: 10.1016/j.cancergen.2019.09.004
|
| 59 |
Min Huang, Amin Haiderali, Grace E. Fox, Andrew Frederickson, Javier Cortes, Peter A. Fasching, Joyce O’Shaughnessy. Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review. PharmacoEconomics 2022; 40(5): 519 doi: 10.1007/s40273-021-01121-7
|
| 60 |
Israa Shihab, Amal Bouzid, Burcu Yener, Alaa Altaie, Poorna Manasa Bhamidimarri, Mouza Al Ameri, Riyad Bendardaf, Mawieh Hamad, Rifat Hamoudi. Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells. F1000Research 2023; 12: 1117 doi: 10.12688/f1000research.130316.1
|
| 61 |
Reham I El-Mahdy, Madeha M. Zakhary, Doaa W. Maximous, Abeer A Mokhtar, Mahmoud I. El Dosoky. Circulating osteocyte‐related biomarkers (vitamin D, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: Their impact in disease progression and outcome. The Journal of Steroid Biochemistry and Molecular Biology 2020; 204: 105773 doi: 10.1016/j.jsbmb.2020.105773
|
| 62 |
Toshihiko Takeiwa, Kazuhiro Ikeda, Kuniko Horie, Satoshi Inoue.
Role of RNA binding proteins of the
Drosophila
behavior and human splicing (DBHS) family in health and cancer
. RNA Biology 2024; 21(1): 459 doi: 10.1080/15476286.2024.2332855
|
| 63 |
Xiaoyan Wu, Xunxi Lu, Wenchuan Zhang, Xiaorong Zhong, Hong Bu, Zhang Zhang. Development and validation of a 10-gene signature for predicting recurrence risk in HR+/HER2- early breast cancer undergoing chemo-endocrine therapy. The Breast 2025; 82: 104484 doi: 10.1016/j.breast.2025.104484
|
| 64 |
Anna A. Marusiak, Monika K. Prelowska, Dawid Mehlich, Michal Lazniewski, Klaudia Kaminska, Adam Gorczynski, Aleksandra Korwat, Olga Sokolowska, Hanna Kedzierska, Jakub Golab, Wojciech Biernat, Dariusz Plewczynski, John Brognard, Dominika Nowis. Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene 2019; 38(15): 2860 doi: 10.1038/s41388-018-0618-0
|
| 65 |
|
| 66 |
Merle M. van Leeuwen, Shannon Doyle, Alexandra W. van den Belt–Dusebout, Stevie van der Mierden, Claudette E. Loo, Ritse M. Mann, Jonas Teuwen, Jelle Wesseling. Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis. Insights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01529-z
|
| 67 |
Yanrong Zhou, Qianpeng Wang, Qi Ying, Xiaomei Zhang, Ting Ye, Kan Chen, Gongchu Li. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells. Marine Drugs 2023; 21(2): 77 doi: 10.3390/md21020077
|
| 68 |
Kamal Basri Siregar, Muhammad Al Anas. Unveiling bone metastasis: Exploring histological subtypes of breast cancer in Indonesia's tertiary referral hospital. Cancer Treatment and Research Communications 2023; 37: 100764 doi: 10.1016/j.ctarc.2023.100764
|
| 69 |
Afshin Arti, Jaleh Varshosaz. Cancer Metastasis - Mechanism, Diagnosis, Prognosis and Targeted Therapy [Working Title]. 2025; doi: 10.5772/intechopen.1010559
|
| 70 |
Zilungile Mkhize-Kwitshana, Pragalathan Naidoo, Zamathombeni Duma, Kamal S. Saini, Zodwa Dlamini. Overcoming Breast Cancer Therapy Resistance. 2024; : 235 doi: 10.1007/978-3-031-52860-6_10
|
| 71 |
Patumrat Sripan, Hutcha Sriplung, Donsuk Pongnikorn, Surichai Bilheem, Shama Virani, Narate Waisri, Chirapong Hanpragopsuk, Puttachart Maneesai, Panrada Tansiri, Imjai Chitapanarux. Clinical subtypes of breast cancer in Thai women: a population-based study of Chiang Mai province. Asian Biomedicine 2019; 13(1): 11 doi: 10.1515/abm-2019-0034
|
| 72 |
Anna Morra, Maria Escala-Garcia, Jonathan Beesley, Renske Keeman, Sander Canisius, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Paul L. Auer, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Stig E. Bojesen, Manjeet K. Bolla, Hermann Brenner, Thomas Brüning, Saundra S. Buys, Bette Caan, Daniele Campa, Federico Canzian, Jose E. Castelao, Jenny Chang-Claude, Stephen J. Chanock, Ting-Yuan David Cheng, Christine L. Clarke, Anne-Lise Børresen-Dale, Kristine K. Sahlberg, Lars Ottestad, Rolf Kåresen, Ellen Schlichting, Marit Muri Holmen, Toril Sauer, Vilde Haakensen, Olav Engebråten, Bjørn Naume, Alexander Fosså, Cecile E. Kiserud, Kristin V. Reinertsen, Åslaug Helland, Margit Riis, Jürgen Geisler, Grethe I. Grenaker Alnæs, Sarah V. Colonna, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Joe Dennis, Thilo Dörk, Laure Dossus, Alison M. Dunning, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Henrik Flyger, Lin Fritschi, Manuela Gago-Dominguez, José A. García-Sáenz, Graham G. Giles, Mervi Grip, Pascal Guénel, Melanie Gündert, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Steven N. Hart, Jaana M. Hartikainen, Arndt Hartmann, Wei He, Maartje J. Hooning, Reiner Hoppe, John L. Hopper, Anthony Howell, David J. Hunter, Christine Clarke, Deborah Marsh, Rodney Scott, Robert Baxter, Desmond Yip, Jane Carpenter, Alison Davis, Nirmala Pathmanathan, Peter Simpson, J. Dinny Graham, Mythily Sachchithananthan, Agnes Jager, Anna Jakubowska, Wolfgang Janni, Esther M. John, Audrey Y. Jung, Rudolf Kaaks, Machteld Keupers, Cari M. Kitahara, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Allison W. Kurian, James V. Lacey, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Martha Linet, Robert N. Luben, Jan Lubiński, Michael Lush, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, John W. M. Martens, Maria Elena Martinez, Dimitrios Mavroudis, Kyriaki Michailidou, Roger L. Milne, Anna Marie Mulligan, Taru A. Muranen, Heli Nevanlinna, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Andrew F. Olshan, Håkan Olsson, Nick Orr, Tjoung-Won Park-Simon, Alpa V. Patel, Bernard Peissel, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Karolina Prajzendanc, Ross Prentice, Nadege Presneau, Brigitte Rack, Gad Rennert, Hedy S. Rennert, Valerie Rhenius, Atocha Romero, Rebecca Roylance, Matthias Ruebner, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Andreas Schneeweiss, Christopher Scott, Mitul Shah, Snezhana Smichkoska, Melissa C. Southey, Jennifer Stone, Harald Surowy, Anthony J. Swerdlow, Rulla M. Tamimi, William J. Tapper, Lauren R. Teras, Mary Beth Terry, Rob A. E. M. Tollenaar, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Qin Wang, Amber N. Hurson, Robert Winqvist, Alicja Wolk, Argyrios Ziogas, Hiltrud Brauch, Montserrat García-Closas, Paul D. P. Pharoah, Douglas F. Easton, Georgia Chenevix-Trench, Marjanka K. Schmidt. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research 2021; 23(1) doi: 10.1186/s13058-021-01450-7
|
| 73 |
Shristi Bhattarai, Manali Rupji, Hsueh-ping Chao, Qi Xu, Geetanjali Saini, Padmashree Rida, Mohammed A. Aleskandarany, Andrew R. Green, Ian O. Ellis, Emiel A. Janssen, Kristin Jonsdottir, Emad Rakha, Jeanne Kowalski, Ritu Aneja. Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00097-z
|
| 74 |
Viney Kumar, Swati Haldar, Saakshi Saini, Souvik Ghosh, Poonam Dhankhar, Partha Roy. Pterostilbene–isothiocyanate reduces miR-21 level by impeding Dicer-mediated processing of pre-miR-21 in 5-fluorouracil and tamoxifen-resistant human breast cancer cell lines. 3 Biotech 2023; 13(6) doi: 10.1007/s13205-023-03582-3
|
| 75 |
Souham Meshoul, Ali Batouche, Hadil Shaiba, Shiekhah AlBinali. Explainable Multi-Class Classification Based on Integrative Feature Selection for Breast Cancer Subtyping. Mathematics 2022; 10(22): 4271 doi: 10.3390/math10224271
|
| 76 |
Ayad Ahmad Mohammed. The clinical behavior of different molecular subtypes of breast cancer. Cancer Treatment and Research Communications 2021; 29: 100469 doi: 10.1016/j.ctarc.2021.100469
|
| 77 |
Marilyn S. Criollo-Mendoza, José Basilio Heredia, Laura A. Contreras-Angulo, Israel García-Aguiar, Erick Paul Gutiérrez-Grijalva. Apoptotic Potential of Polyphenol Extract of Mexican Oregano Lippia graveolens Kunth on Breast Cancer Cells MDA-MB-231. Applied Sciences 2025; 15(12): 6393 doi: 10.3390/app15126393
|
| 78 |
Lokesh Dalasanur Nagaprashantha, Ramesh Adhikari, Jyotsana Singhal, Shireen Chikara, Sanjay Awasthi, David Horne, Sharad S. Singhal. Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer. International Journal of Cancer 2018; 142(4): 658 doi: 10.1002/ijc.31085
|
| 79 |
Anna J. Wiecek, Stephen J. Cutty, Daniel Kornai, Mario Parreno-Centeno, Lucie E. Gourmet, Guidantonio Malagoli Tagliazucchi, Daniel H. Jacobson, Ping Zhang, Lingyun Xiong, Gareth L. Bond, Alexis R. Barr, Maria Secrier. Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer. Genome Biology 2023; 24(1) doi: 10.1186/s13059-023-02963-4
|
| 80 |
Majid Sharifi, Qian Bai, Mohammad Mahdi Nejadi Babadaei, Farhan Chowdhury, Mahbub Hassan, Akbar Taghizadeh, Hossein Derakhshankhah, Suliman Khan, Anwarul Hasan, Mojtaba Falahati. 3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy. Journal of Controlled Release 2021; 333: 91 doi: 10.1016/j.jconrel.2021.03.026
|
| 81 |
Roya Gasimli, Cagla Kayabasi, Besra Ozmen Yelken, Aycan Asik, Fatma Sogutlu, Caglar Celebi, Sunde Yilmaz Susluer, Serra Kamer, Cigir Biray Avci, Ayfer Haydaroglu, Cumhur Gunduz. The effects of PKI-402 on breast tumor models’ radiosensitivity via dual inhibition of PI3K/mTOR. International Journal of Radiation Biology 2023; 99(12): 1961 doi: 10.1080/09553002.2023.2232019
|
| 82 |
Venkata Subramanian Krishnaraju, Harmandeep Singh, Lance T. Hall, Amol M. Takalkar, Bhagwant Rai Mittal. Molecular Imaging and Therapy. 2023; : 105 doi: 10.36255/molecular-imaging-of-breast-cancer
|
| 83 |
Prarambh S. R. Dwivedi, C. S. Shastry. The cytotoxic potential of sinapic acid on luminal A breast cancer; a computational and experimental pharmacology approach. Journal of Biomolecular Structure and Dynamics 2024; 42(23): 13216 doi: 10.1080/07391102.2023.2274980
|
| 84 |
Teddy Agung Saputra, Indra Indra, Salman Ardi Syamsu, Elridho Sampepajung, Berti Julian Nelwan, Firdaus Hamid, Muhammad Faruk. Vascular endothelial growth factor-A expression is significantly correlated with HER2 expression in late-stage breast cancer patients. Breast Disease 2023; 41(1): 433 doi: 10.3233/BD-229006
|
| 85 |
Ala'a El-Nabawy, Nahla Belal, Nashwa El-Bendary. Breast Cancer Subtype Classification using Clinical and Gene Expression Integration. 2017 27th International Conference on Computer Theory and Applications (ICCTA) 2017; : 105 doi: 10.1109/ICCTA43079.2017.9497184
|
| 86 |
Yuqi Lin, Wen Zhang, Huanshen Cao, Gaoyang Li, Wei Du. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data. Genes 2020; 11(8): 888 doi: 10.3390/genes11080888
|
| 87 |
Amjad Z. Alrosan, Isra Dmour, Aseel O. Rataan, Ghaith B. Heilat, Khaled Alrosan. Comparative pharmacological analysis of fam-trastuzumab deruxtecan-nxki and sacituzumab govitecan-hziy: Two recently developed chemotherapies in the crucial battle against breast cancer. Toxicology Reports 2025; 14: 102054 doi: 10.1016/j.toxrep.2025.102054
|
| 88 |
Jiayi Weng, Xiaoqiang Xiang, Lingwen Ding, Andrea Li-Ann Wong, Qi Zeng, Gautam Sethi, Lingzhi Wang, Soo Chin Lee, Boon Cher Goh. Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?. Seminars in Cancer Biology 2021; 74: 105 doi: 10.1016/j.semcancer.2021.05.011
|
| 89 |
Mohammad Aghebati, Reza Hossieni, Afsaneh Sadat Makeh, Alireza Shirzadi, Mohammad Esmaeil Akbari. Ki-67 and 21-gene recurrence score assay in decision making for adjuvant chemotherapy in breast cancer patients. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02233-8
|
| 90 |
Connor O’Brien, Chun Keat Khor, Sina Ardalan, Anna Ignaszak. Multiplex electrochemical sensing platforms for the detection of breast cancer biomarkers. Frontiers in Medical Technology 2024; 6 doi: 10.3389/fmedt.2024.1360510
|
| 91 |
Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping. Computers in Biology and Medicine 2022; 148: 105832 doi: 10.1016/j.compbiomed.2022.105832
|
| 92 |
Claudia Cava, Antonio Colaprico, Gloria Bertoli, Gianluca Bontempi, Giancarlo Mauri, Isabella Castiglioni. How interacting pathways are regulated by miRNAs in breast cancer subtypes. BMC Bioinformatics 2016; 17(S12) doi: 10.1186/s12859-016-1196-1
|
| 93 |
Valeria Consoli, Valeria Sorrenti, Maria Gulisano, Mariarita Spampinato, Luca Vanella. Navigating heme pathways: the breach of heme oxygenase and hemin in breast cancer. Molecular and Cellular Biochemistry 2025; 480(3): 1495 doi: 10.1007/s11010-024-05119-5
|
| 94 |
Vidya Sankarapandian, Ramya Lakshmi Rajendran, Conrad Ondieki Miruka, Poornima Sivamani, Balu Alagar Venmathi Maran, Rajapandiyan Krishnamoorthy, Prakash Gangadaran, Byeong-Cheol Ahn. A review on tyrosine kinase inhibitors for targeted breast cancer therapy. Pathology - Research and Practice 2024; 263: 155607 doi: 10.1016/j.prp.2024.155607
|
| 95 |
Michael J. Fox, Peter Gibbs, Martin D. Pickles. Minkowski functionals: An MRI texture analysis tool for determination of the aggressiveness of breast cancer. Journal of Magnetic Resonance Imaging 2016; 43(4): 903 doi: 10.1002/jmri.25057
|
| 96 |
Yiran Huang, Pingfan Zeng, Cheng Zhong. Classifying breast cancer subtypes on multi-omics data via sparse canonical correlation analysis and deep learning. BMC Bioinformatics 2024; 25(1) doi: 10.1186/s12859-024-05749-y
|
| 97 |
Gilbert Lazarus, Jessica Audrey, Anthony William Brian Iskandar. Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review. Oncology Reviews 2019; 13(2) doi: 10.4081/oncol.2019.425
|
| 98 |
Suman Kumar Samanta, Paramita Choudhury, Raghuram Kandimalla, Farrukh Aqil, Disha N. Moholkar, Ramesh C. Gupta, Momita Das, Bhaskarjyoti Gogoi, Neelutpal Gogoi, Partha Pratim Sarma, Rajlakshmi Devi, Narayan C. Talukdar. Mahanine mediated therapeutic inhibition of estrogen receptor-α and CDK4/6 expression, decipher the chemoprevention-signaling cascade in preclinical model of breast cancer. Journal of Ethnopharmacology 2024; 319: 117235 doi: 10.1016/j.jep.2023.117235
|
| 99 |
Jason N. Abrams. Design, Synthesis, and In Vitro Mitotic Evaluation of 3‐Amino‐Isoquinolinones as Anticancer Agents. ChemistrySelect 2022; 7(42) doi: 10.1002/slct.202202861
|
| 100 |
Swapnil Kumar, Vaibhav Vindal. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues. Functional & Integrative Genomics 2023; 23(4) doi: 10.1007/s10142-023-01251-5
|
| 101 |
Katia Cortese, Silvia Marconi, Carolina D'Alesio, Daniela Calzia, Isabella Panfoli, Sara Tavella, Cinzia Aiello, Francesca Pedrelli, Angela Bisio, Patrizio Castagnola. The novel diterpene 7β-acetoxy-20-hydroxy-19,20-epoxyroyleanone from Salvia corrugata shows complex cytotoxic activities against human breast epithelial cells. Life Sciences 2019; 232: 116610 doi: 10.1016/j.lfs.2019.116610
|
| 102 |
Alessia Vignoli, Elena Muraro, Gianmaria Miolo, Leonardo Tenori, Paola Turano, Emanuela Di Gregorio, Agostino Steffan, Claudio Luchinat, Giuseppe Corona. Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy. Cancers 2020; 12(2): 314 doi: 10.3390/cancers12020314
|
| 103 |
Silvia Cascianelli, Ivan Molineris, Claudio Isella, Marco Masseroli, Enzo Medico. Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70832-2
|
| 104 |
SP Somashekhar, Richa Jaiswal, Rohit Kumar, BC Ashok, Susmita Rakshit, Amit Rauthan, Poonam Patil, Nitin Yashas, HK Karthik, Archa Prasad, Herra Islam, KR Ashwin. An Overview of the Impact of Body Mass Index on Pathological Complete Response Following Neoadjuvant Chemotherapy in Operable Breast Cancer in a Tertiary Care Centre in South India. European Journal of Breast Health 2022; 18(3): 271 doi: 10.4274/ejbh.galenos.2022.2022-2-5
|
| 105 |
Martin Pesta, Vlastimil Kulda, Andrea Narsanska, Jakub Fichtl, Ondrej Topolcan. May CTC technologies promote better cancer management?. EPMA Journal 2015; 6(1) doi: 10.1186/s13167-014-0023-x
|
| 106 |
Meron Yohannes, Zelalem Desalegn, Marcus Bauer, Kathrin Stückrath, Endale Anberbir, Yonas Bekuretsion, Mathewos Assefa, Tariku Wakuma, Yasin Worku, Pablo S. C. Santos, Lesley Taylor, Adamu Adissie, Claudia Wickenhauser, Chiara Massa, Martina Vetter, Eva Johanna Kantelhardt, Barbara Seliger, Tamrat Abebe. Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients. Breast Cancer Research 2024; 26(1) doi: 10.1186/s13058-024-01916-4
|
| 107 |
Gauri alias Pooja M. Naik, Omkar D. Paradkar, Aarti M. Naik, Shamali S. Rane, Deepashree D. Dalvi, Saili S. Gad, Trupti S. Morajkar, Mohini T. Tawade. Recent Developments in Coumarin Derivatives for Breast Cancer Therapy. International Journal of Advanced Research in Science, Communication and Technology 2020; : 287 doi: 10.48175/IJARSCT-704
|
| 108 |
Minghai You, Jianling Chen, Shaobing Wang, Shiqing Dong, Yuhua Wang, Shusen Xie, Zhengchao Wang, Hongqin Yang. Use of quantitative optical imaging to examine the role of cholesterol-rich lipid raft microdomains in the migration of breast cancer cells. Laser Physics 2018; 28(4): 045601 doi: 10.1088/1555-6611/aaa11b
|
| 109 |
Vincenza Frisardi, Simone Canovi, Salvatore Vaccaro, Raffaele Frazzi. The Significance of Microenvironmental and Circulating Lactate in Breast Cancer. International Journal of Molecular Sciences 2023; 24(20): 15369 doi: 10.3390/ijms242015369
|
| 110 |
Liangrui Pan, Pengfei Rong, Dazheng Liu, Pinle Qin, Xiangxiang Zeng, Shaoliang Peng. PACS: Prediction and analysis of cancer subtypes from multi-omics data based on a multi-head attention mechanism model. 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2023; : 904 doi: 10.1109/BIBM58861.2023.10386066
|
| 111 |
Siti Norbaini Sabtu, S.F. Abdul Sani, D.A. Bradley, L.M. Looi, Z. Osman. A review of the applications of Raman spectroscopy for breast cancer tissue diagnostic and their histopathological classification of epithelial to mesenchymal transition. Journal of Raman Spectroscopy 2020; 51(3): 380 doi: 10.1002/jrs.5774
|
| 112 |
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, Raoni Pais Siqueira, Helen Soares Valença Ferreira, Ademar Alves Da Silva Filho, Thaise Gonçalves Araújo. Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. Pharmaceuticals 2023; 16(10): 1466 doi: 10.3390/ph16101466
|
| 113 |
Guillermo Prado-Vázquez, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, Jorge M. Arevalillo, Andrea Zapater-Moros, María Ferrer-Gómez, Mariana Díaz-Almirón, Rocío López-Vacas, Hilario Navarro, Paloma Maín, Jaime Feliú, Pilar Zamora, Enrique Espinosa, Juan Ángel Fresno Vara. A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-38364-y
|
| 114 |
Stamatia Rontogianni, Eleni Synadaki, Bohui Li, Marte C. Liefaard, Esther H. Lips, Jelle Wesseling, Wei Wu, Maarten Altelaar. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping. Communications Biology 2019; 2(1) doi: 10.1038/s42003-019-0570-8
|
| 115 |
Bora Lim, David A. Potter, Mohamad A. Salkeni, Paula Silverman, Tufia C. Haddad, Frederic Forget, Ahmad Awada, Jean-Luc Canon, Michael Danso, Alain Lortholary, Hugues Bourgeois, Elizabeth Tan-Chiu, Sylvie Vincent, Brittany Bahamon, Kevin J. Galinsky, Chirag Patel, Rachel Neuwirth, E. Jane Leonard, Jennifer R. Diamond. Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer. Clinical Cancer Research 2021; 27(12): 3329 doi: 10.1158/1078-0432.CCR-20-4131
|
| 116 |
Li Zhou, Wei Zhou, Hongwei Zhang, Yan Hu, Lei Yu, Yufei Zhang, Yanli Zhang, Shuang Wang, Peng Wang, Wei Xia. Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α. International Journal of Molecular Medicine 2017; 40(3): 755 doi: 10.3892/ijmm.2017.3060
|
| 117 |
Kimia Karami, Khatereh Anbari. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. Current Cancer Therapy Reviews 2021; 17(3): 207 doi: 10.2174/1573394717999210120195208
|
| 118 |
Simone U. Dalm, Marleen Melis, Jasper Emmering, Dik J. Kwekkeboom, Marion de Jong. Breast cancer imaging using radiolabelled somatostatin analogues. Nuclear Medicine and Biology 2016; 43(9): 559 doi: 10.1016/j.nucmedbio.2016.05.012
|
| 119 |
Natsumi Kuwabara, Hiroko Kawashima. Does residual ultrasound transmission gel affect the diagnostic ability of mammography?. Radiological Physics and Technology 2022; 15(3): 245 doi: 10.1007/s12194-022-00662-6
|
| 120 |
Matteo Brindisi, Luca Frattaruolo, Vincenzo Sicari, Monica Rosa Loizzo, Gianni Bedini, Vittoria Rago, Rosa Tundis, Anna Rita Cappello. Santolina pinnata Viv. Exerts Promising Antitumor Activity against Breast Cancer Cells and Anti-Inflammatory Effects in LPS-Stimulated RAW 264.7 Cells. International Journal of Molecular Sciences 2022; 23(21): 12885 doi: 10.3390/ijms232112885
|
| 121 |
Marika Musielak, Agnieszka Boś-Liedke, Oliwia Piwocka, Katarzyna Kowalska, Roksana Markiewicz, Barbara Szymkowiak, Paweł Bakun, Wiktoria M. Suchorska. The Role of Functionalization and Size of Gold Nanoparticles in the Response of MCF-7 Breast Cancer Cells to Ionizing Radiation Comparing 2D and 3D In Vitro Models. Pharmaceutics 2023; 15(3): 862 doi: 10.3390/pharmaceutics15030862
|
| 122 |
Kanwalat Chalertpet, Thanawitch Sangkheereeput, Prakaithip Somjit, Wichanee Bankeeree, Pattamawadee Yanatatsaneejit. Effect of Smilax spp. and Phellinus linteus combination on cytotoxicity and cell proliferation of breast cancer cells. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04003-x
|
| 123 |
Ayat G. Lashen, Michael S. Toss, Catrin S. Rutland, Andrew R. Green, Nigel P. Mongan, Emad Rakha. Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer. Pathobiology 2024; : 1 doi: 10.1159/000540790
|
| 124 |
Fatma Senel. The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features. Indian Journal of Pathology and Microbiology 2021; 64(4): 671 doi: 10.4103/IJPM.IJPM_606_20
|
| 125 |
Fernanda Malhão, Ana Catarina Macedo, Carla Costa, Eduardo Rocha, Alice Abreu Ramos. Fucoxanthin Holds Potential to Become a Drug Adjuvant in Breast Cancer Treatment: Evidence from 2D and 3D Cell Cultures. Molecules 2021; 26(14): 4288 doi: 10.3390/molecules26144288
|
| 126 |
Colin L. Hisey, Anastasiia Artuyants, George Guo, Vanessa Chang, Gabrielle Reshef, Martin Middleditch, Bincy Jacob, Lawrence W. Chamley, Cherie Blenkiron. Investigating the consistency of extracellular vesicle production from breast cancer subtypes using CELLine adherent bioreactors. Journal of Extracellular Biology 2022; 1(9) doi: 10.1002/jex2.60
|
| 127 |
Lin-xi Zhou, Hong Zheng, Yuan Tian, Ke-fei Luo, Shu-juan Ma, Zi-wei Wu, Peng Tang, Jun Jiang, Ming-hao Wang. SNCA inhibits epithelial–mesenchymal transition and correlates to favorable prognosis of breast cancer. Carcinogenesis 2022; 43(11): 1071 doi: 10.1093/carcin/bgac078
|
| 128 |
Natalia Hermán-Sánchez, Miguel E. G-García, Juan M. Jiménez-Vacas, Elena M. Yubero-Serrano, Laura M. López-Sánchez, Sara Romero-Martín, Jose L. Raya-Povedano, Marina Álvarez-Benito, Justo P. Castaño, Raúl M. Luque, Manuel D. Gahete. The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. Cellular and Molecular Life Sciences 2024; 82(1) doi: 10.1007/s00018-024-05515-6
|
| 129 |
Sherry Aristyani, Saraswati Subagjo, Tintrim Rahayu, Sutiman B. Sumitro, M. Yusuf, D. Siswanto, M. Nishizawa, N. Athiroh Abdoes Sjakoer, C. Retnaningdyah, S. Rahayu, A. Rosyidah, R. Mastuti, S.P. Sakti. Integrated bioinformatic approach of Balur therapy for breast cancer subtypes. BIO Web of Conferences 2025; 154: 02008 doi: 10.1051/bioconf/202515402008
|
| 130 |
Jie Ma, Hongtao Wang, Zhengwei Gui, Yuanrong Yang. Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1490073
|
| 131 |
Han-Tsang Wu, Yi-En Liu, Kai-Wen Hsu, Yu-Fen Wang, Ya-Chi Chan, Yeh Chen, Dar-Ren Chen. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway. The American Journal of Chinese Medicine 2020; 48(05): 1221 doi: 10.1142/S0192415X20500603
|
| 132 |
Begoña Alday-Parejo, François Richard, Janine Wörthmüller, Tilman Rau, José A. Galván, Christine Desmedt, Albert Santamaria-Martinez, Curzio Rüegg. MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer. Cancers 2020; 12(1): 223 doi: 10.3390/cancers12010223
|
| 133 |
Tian Wang, Fulin Zhang, Fulan Sun. ORY‐1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptor. Drug Development Research 2022; 83(1): 208 doi: 10.1002/ddr.21860
|
| 134 |
Min Zhao, Junzhi Liu, Yuting Tang, Lumeng Zhang, Xiaoguang Ge, Minglong Chen, Qiang Wen, Lei Zhu, Qingjie Ma. Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer. Biomaterials Advances 2022; 141: 213115 doi: 10.1016/j.bioadv.2022.213115
|
| 135 |
Junmei Hao, Wenfeng Zhang, Yan Lyu, Jiarui Zou, Yunyun Zhang, Jiahong Lyu, Jianbo Zhang, Shuishan Xie, Cuiping Zhang, Jiandi Zhang, Fangrong Tang. Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.737794
|
| 136 |
Luis Molina Calistro, Yennyfer Arancibia, Marcela Alejandra Olivera, Sigrid Domke, Rodrigo Flavio Torres. Interaction of GPER-1 with the endocrine signaling axis in breast cancer. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1494411
|
| 137 |
Mohammed Salah Ayoup, Yasmin Wahby, Hamida Abdel-Hamid, Marwa M. Abu-Serie, Sherif Ramadan, Assem Barakat, Mohamed Teleb, Magda M. F. Ismail. Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer. RSC Advances 2023; 13(40): 27722 doi: 10.1039/D3RA04029A
|
| 138 |
Willemijne A M E Schrijver, Karijn P M Suijkerbuijk, Carla H van Gils, Elsken van der Wall, Cathy B Moelans, Paul J van Diest. Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute 2018; 110(6): 568 doi: 10.1093/jnci/djx273
|
| 139 |
Haider Ali, Nawaid Hussain Khan, Dalila Cano, Guadalupe Cano, Meliha Celik, Sama Lilo, Angel Fabia, A. Yama, Efrain Gudino, Beyza Nur Beker. Non-coding RNA biomarkers in basal-like breast cancer. Clinica Chimica Acta 2025; 576: 120408 doi: 10.1016/j.cca.2025.120408
|
| 140 |
Swetha Raghavan, Ganesh Venkatraman, Suresh K. Rayala. Cloning and functional characterization of human Pak1 promoter by steroid hormones. Gene 2018; 646: 120 doi: 10.1016/j.gene.2017.12.039
|
| 141 |
Chengsen Chai, H. Helena Wu, Yasser Abuetabh, Consolato Sergi, Roger Leng. Regulation of the tumor suppressor PTEN in triple-negative breast cancer. Cancer Letters 2022; 527: 41 doi: 10.1016/j.canlet.2021.12.003
|
| 142 |
Renée L. Flaherty, Matthew Owen, Aidan Fagan-Murphy, Haya Intabli, David Healy, Anika Patel, Marcus C. Allen, Bhavik A. Patel, Melanie S. Flint. Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer. Breast Cancer Research 2017; 19(1) doi: 10.1186/s13058-017-0823-8
|
| 143 |
Humberto De Vitto, Ann M. Bode, Zigang Dong. The PGC-1/ERR network and its role in precision oncology. npj Precision Oncology 2019; 3(1) doi: 10.1038/s41698-019-0081-6
|
| 144 |
Yong-Moon Lee, Man Hwan Oh, Jai-Hyang Go, Kyudong Han, Song-Yi Choi. Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication. Genes & Genomics 2020; 42(12): 1381 doi: 10.1007/s13258-020-01014-7
|
| 145 |
Johanna Berfelde, Laura S. Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold V. Distel. FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International Journal of Molecular Sciences 2024; 25(4): 2110 doi: 10.3390/ijms25042110
|
| 146 |
Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco P. Cammarata, Giorgio Russo, Massimo Ippolito, Giacomo Cuttone, Giovanni Li Volti, Nunzio Vicario, Rosalba Parenti. The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression. Biomedicines 2022; 10(4): 806 doi: 10.3390/biomedicines10040806
|
| 147 |
Mario Campone, François-Clément Bidard, Patrick Neven, Lei Wang, Bin Ling, Yvonne Dong, Gautier Paux, Christina Herold, Ugo De Giorgi. AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer. Breast Cancer Research 2023; 25(1) doi: 10.1186/s13058-023-01740-2
|
| 148 |
Andreína Fernandes, Adriana Pesci-Feltri, Isabel García-Fleury, Marco López, Vincent Guida, Marisol De Macedo, María Correnti. Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes. World Journal of Clinical Oncology 2018; 9(7): 123-132 doi: 10.5306/wjco.v9.i7.123
|
| 149 |
Jamin Koo, Kyucheol Choi, Peter Lee, Amanda Polley, Raghavendra Sumanth Pudupakam, Josephine Tsang, Elmer Fernandez, Enyang James Han, Stanley Park, Deanna Swartzfager, Nicholas Seah Xi Qi, Melody Jung, Mary Ocnean, Hyun Uk Kim, Sungwon Lim. Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model. Veterinary Sciences 2021; 8(12): 301 doi: 10.3390/vetsci8120301
|
| 150 |
Emma Rewcastle, Ivar Skaland, Einar Gudlaugsson, Silja Kavlie Fykse, Jan P. A. Baak, Emiel A. M. Janssen. The Ki67 dilemma: investigating prognostic
cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast Cancer Research and Treatment 2024; 207(1): 1 doi: 10.1007/s10549-024-07352-4
|
| 151 |
Dongchen Lu, Wei Han, Kai Lu. Identification of key microRNAs involved in tumorigenesis and prognostic microRNAs in breast cancer. Mathematical Biosciences and Engineering 2020; 17(4): 2923 doi: 10.3934/mbe.2020164
|
| 152 |
Nawal A. Alarfaj, Maha F. El-Tohamy, Hesham Oraby. New label-free ultrasensitive electrochemical immunosensor-based Au/MoS2/rGO nanocomposites for CA 27-29 breast cancer antigen detection. New Journal of Chemistry 2018; 42(13): 11046 doi: 10.1039/C8NJ01388H
|
| 153 |
Stanley C. Eluu, John D. Obayemi, Danyuo Yiporo, Ali A. Salifu, Augustine O. Oko, Killian Onwudiwe, Toyin Aina, Josephine C. Oparah, Chukwudi C. Ezeala, Precious O. Etinosa, Sarah A. Osafo, Malachy C. Ugwu, Charles O. Esimone, Winston O. Soboyejo. Luteinizing Hormone-Releasing Hormone (LHRH)-Conjugated Cancer Drug Delivery from Magnetite Nanoparticle-Modified Microporous Poly-Di-Methyl-Siloxane (PDMS) Systems for the Targeted Treatment of Triple Negative Breast Cancer Cells. Journal of Functional Biomaterials 2024; 15(8): 209 doi: 10.3390/jfb15080209
|
| 154 |
Endale Hadgu, Daniel Seifu, Wondemagegnhu Tigneh, Yonas Bokretsion, Abebe Bekele, Markos Abebe, Thomas Sollie, Sofia D. Merajver, Christina Karlsson, Mats G. Karlsson. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Women's Health 2018; 18(1) doi: 10.1186/s12905-018-0531-2
|
| 155 |
Edoardo Isnaldi, Domenico Ferraioli, Lorenzo Ferrando, Sylvain Brohée, Fabio Ferrando, Piero Fregatti, Davide Bedognetti, Alberto Ballestrero, Gabriele Zoppoli. Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer. Breast Cancer Research and Treatment 2019; 177(2): 335 doi: 10.1007/s10549-019-05313-w
|
| 156 |
Jun Wang, Zhiyong Zhou. Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00635-0
|
| 157 |
Merve Gulsen Bal Albayrak, Turgay Simsek, Gurler Akpinar, Murat Kasap, Nuh Zafer Canturk. Proteomic insights into lymph node metastasis in breast cancer subtypes: Key biomarkers and pathways. Pathology - Research and Practice 2025; 269: 155938 doi: 10.1016/j.prp.2025.155938
|
| 158 |
Brygida Berse, Julie A. Lynch. Molecular Diagnostic Testing in Breast Cancer. Seminars in Oncology Nursing 2015; 31(2): 108 doi: 10.1016/j.soncn.2015.02.008
|
| 159 |
Xiwen Wu, Ying Zhang, Gehao Liang, Huizhen Ye. Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1199883
|
| 160 |
Evren Algın Yapar, Merve Nur Ozdemir, Simona Cavalu, Özlem Akbal Dagıstan, Yıldız Ozsoy, Murat Kartal. Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives. Current Pharmaceutical Biotechnology 2025; 26(6): 795 doi: 10.2174/0113892010299183240529094844
|
| 161 |
Flavia Ultimescu, Mihai Mitran, Anca Potecă, Elvira Brătilă, Maria Olinca. De la determinismul genetic la abordarea clinică – rolul imunohistochimiei în clasificarea carcinoamelor mamare. Ginecologia.ro 2023; 1(39): 26 doi: 10.26416/Gine.39.1.2023.7787
|
| 162 |
Laiping Xie, Yuhang Wang, Andi Wan, Lin Huang, Qing Wang, Wanyan Tang, Xiaowei Qi, Xiaofei Hu. Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2025.2460272
|
| 163 |
Mao, MD Bing, Duan, MD Shaobo, Liu, MD Ruiqing, Li, PhD Na, Li, PhD Yaqiong, Zhang, MD Lianzhong. The Roles of Ultrasound-Based Radiomics In Precision Diagnosis and Treatment of Different Cancers: A Literature Review. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2020; 4(4): 291 doi: 10.37015/AUDT.2020.200051
|
| 164 |
Sofia Magalhães, Carla Luís, Abel Duarte. Fructose-Derived Carbon Dots as Selective Antitumor Agents in Breast Cancer Therapy: Synthesis, Characterization, and Biological Evaluation. J 2024; 7(4): 584 doi: 10.3390/j7040035
|
| 165 |
María Eléxpuru Zabaleta, Tamara Yuliett Forbes-Hernández, Jesus Simal-Gandara, José Luis Quiles, Danila Cianciosi, Beatriz Bullon, Francesca Giampieri, Maurizio Battino. Effect of polyphenols on HER2-positive breast cancer and related miRNAs: Epigenomic regulation. Food Research International 2020; 137: 109623 doi: 10.1016/j.foodres.2020.109623
|
| 166 |
Aleix Prat, Nadia Solovieff, Fabrice André, Joyce O'Shaughnessy, David A. Cameron, Wolfgang Janni, Gabe S. Sonke, Yoon-Sim Yap, Denise A. Yardley, Ann H. Partridge, Astrid Thuerigen, Juan Pablo Zarate, Agnes Lteif, Fei Su, Lisa A. Carey. Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7. Clinical Cancer Research 2024; 30(4): 793 doi: 10.1158/1078-0432.CCR-23-0561
|
| 167 |
Ningning Song, Kuan Yang, Yongxiang Li. Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female. Breast Cancer 2025; doi: 10.1007/s12282-025-01696-5
|
| 168 |
Hermann Nabi. Personalized Approaches for the Prevention and Treatment of Breast Cancer. Journal of Personalized Medicine 2022; 12(8): 1201 doi: 10.3390/jpm12081201
|
| 169 |
Petros Papalexis, Vasiliki Georgakopoulou, Panagiotis Drossos, Eirini Thymara, Aphrodite Nonni, Andreas Lazaris, George Zografos, Demetrios Spandidos, Nikolaos Kavantzas, Georgia Eleni Thomopoulou. Precision medicine in breast cancer (Review). Molecular and Clinical Oncology 2024; 21(5) doi: 10.3892/mco.2024.2776
|
| 170 |
Samina Khokher, Muhammad Usman Qureshi, Saqib Mahmood, Sadia Sadiq. Determinants of Advanced Stage at Initial Diagnosis of Breast Cancer in Pakistan: Adverse Tumor Biology vs Delay in Diagnosis. Asian Pacific Journal of Cancer Prevention 2016; 17(2): 759 doi: 10.7314/APJCP.2016.17.2.759
|
| 171 |
Ramiah R. Vickers, Garhett L. Wyatt, Lilia Sanchez, Jordyn J. VanPortfliet, A. Phillip West, Weston W. Porter. Loss of STING impairs lactogenic differentiation. Development 2024; 151(19) doi: 10.1242/dev.202998
|
| 172 |
Weiyang Tao, Chunyang Wang, Bifa Zhu, Guoqiang Zhang, Da Pang. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression. Bioscience Reports 2019; 39(4) doi: 10.1042/BSR20181618
|
| 173 |
Peter McAnena, Kahraman Tanriverdi, Catherine Curran, K. Gilligan, Jane E. Freedman, James A. L. Brown, Michael J. Kerin. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5636-y
|
| 174 |
Sang-Yun Lee, Hyun Ju Hwang, Bosung Ku, Dong Woo Lee. Cell Proliferation Receptor-Enhanced 3D High-Throughput Screening Model for Optimized Drug Efficacy Evaluation in Breast Cancer Cells. Analytical Chemistry 2022; 94(34): 11838 doi: 10.1021/acs.analchem.2c02222
|
| 175 |
Oscar J. Zacarías-Lara, David Méndez-Luna, Gustavo Martínez-Ruíz, José R. García-Sanchéz, Manuel J. Fragoso-Vázquez, Martiniano Bello, Elvia Becerra-Martínez, Juan B. García-Vázquez, José Correa-Basurto. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(6): 760 doi: 10.2174/1871520618666181119094144
|
| 176 |
Shwetha Sekar, Yashashwini Subbamanda, Narasimha Pullaguri, Ankush Sharma, Chittaranjan Sahu, Rahul Kumar, Anamika Bhargava. Isoform-specific expression of T-type voltage-gated calcium channels and estrogen receptors in breast cancer reveals specific isoforms that may be potential targets. Current Research in Biotechnology 2022; 4: 459 doi: 10.1016/j.crbiot.2022.09.009
|
| 177 |
Jimmy T. Efird, Charulata Jindal, Tithi Biswas. On the Frontiers of Breast Cancer Diagnosis and Treatment: Current and Future Directions in a Rapidly Changing Field. Medicina 2022; 58(8): 1026 doi: 10.3390/medicina58081026
|
| 178 |
Rancés Blanco, Diego Carrillo-Beltrán, Juan P. Muñoz, Alejandro H. Corvalán, Gloria M. Calaf, Francisco Aguayo. Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent?. Biology 2021; 10(8): 804 doi: 10.3390/biology10080804
|
| 179 |
Anna Szymanowska, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Paola Amero. Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment. Non-Coding RNA 2023; 9(5): 52 doi: 10.3390/ncrna9050052
|
| 180 |
Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Byeongju Kang, Heejung Keum, Yee Soo Chae, Soo Jung Lee, Ji-Young Park, Nora Jee-Young Park, Tae-Du Jung, Ho Yong Park. Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study. Annals of Surgical Oncology 2023; 30(8): 4669 doi: 10.1245/s10434-023-13191-2
|
| 181 |
Ayat G. Lashen, Nabeelah Almalki, Michael Toss, Sameer Mirza, Mohammed Imad Malki, Catrin S. Rutland, Jennie N. Jeyapalan, Andrew R. Green, Nigel P. Mongan, Srinivasan Madhusudan, Emad A. Rakha. The characteristics and prognostic significance of histone H1 expression in breast cancer. Pathology 2024; 56(6): 826 doi: 10.1016/j.pathol.2024.03.012
|
| 182 |
Su-Jeong Kim, Incheol Seo, Min Hee Kim, Joo-Won Park, Shin Kim, Woo-Jae Park. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01930-z
|
| 183 |
Mashan L. Abdullah, Mohamed M. Hafez, Ali Al-Hoshani, Othman Al-Shabanah. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2392-5
|
| 184 |
Dziugas Jurgutis, Greta Jarockyte, Vilius Poderys, Jelena Dodonova-Vaitkuniene, Sigitas Tumkevicius, Aurimas Vysniauskas, Ricardas Rotomskis, Vitalijus Karabanovas. Exploring BODIPY-Based Sensor for Imaging of Intracellular Microviscosity in Human Breast Cancer Cells. International Journal of Molecular Sciences 2022; 23(10): 5687 doi: 10.3390/ijms23105687
|
| 185 |
Harjot Athwal, Arpitha Kochiyanil, Vasudeva Bhat, Alison L. Allan, Armen Parsyan. Centrosomes and associated proteins in pathogenesis and treatment of breast cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1370565
|
| 186 |
Alla Turshudzhyan, James Vredenburgh. Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment. Journal of Oncology Pharmacy Practice 2021; 27(7): 1770 doi: 10.1177/1078155220985598
|
| 187 |
Muhammad Zubair Afzal, Linda T. Vahdat. Evolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine. Journal of Personalized Medicine 2024; 14(7): 719 doi: 10.3390/jpm14070719
|
| 188 |
Sami A Alsaeed, Michael Toss, Mansour Alsaleem, Mohammed Aleskandarany, Chitra Joseph, Sasagu Kurozumi, Graham Ball, Nigel Mongan, Andrew Green, Emad Rakha. Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer. Journal of Clinical Pathology 2022; 75(4): 263 doi: 10.1136/jclinpath-2020-207106
|
| 189 |
Simone U. Dalm, Anieta M. Sieuwerts, Maxime P. Look, Marleen Melis, Carolien H.M. van Deurzen, John A. Foekens, Marion de Jong, John W.M. Martens. Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy. Journal of Nuclear Medicine 2015; 56(10): 1487 doi: 10.2967/jnumed.115.160739
|
| 190 |
Ziling Yan, Haihui Huang, Qianqian Wang, Yanjie Kong, Xia Liu. Function and mechanism of action of the TRPV1 channel in the development of triple-negative breast cancer. Acta Biochimica et Biophysica Sinica 2024; 56(7): 957 doi: 10.3724/abbs.2024068
|
| 191 |
Simone U. Dalm, Willemijne A. M. E. Schrijver, Anieta M. Sieuwerts, Maxime P. Look, Angelique C. J. Ziel - van der Made, Vanja de Weerd, John W. Martens, Paul J. van Diest, Marion de Jong, Carolien H. M. van Deurzen, Rajeev Samant. Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer. PLOS ONE 2017; 12(1): e0170536 doi: 10.1371/journal.pone.0170536
|
| 192 |
Richard Sean Lee, Kirti Sad, Dorelle V. Fawwal, Jennifer Marie Spangle. Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response. Cancers 2023; 15(15): 4005 doi: 10.3390/cancers15154005
|
| 193 |
Irma Soldevilla-Gallardo, Yolanda Villaseñor-Navarro, Sevastian S Medina-Ornelas, Cynthia Villarreal-Garza, Enrique Bargalló-Rocha, Claudia HS Caro-Sánchez, Lenny N Gallardo-Alvarado, Rodrigo Hernández-Ramírez, Liz M Arela-Quispe, Francisco O García-Pérez. Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Cancer Treatment and Research Communications 2018; 16: 24 doi: 10.1016/j.ctarc.2018.05.001
|
| 194 |
Domiziana Santucci, Eliodoro Faiella, Alessandro Calabrese, Bruno Beomonte Zobel, Andrea Ascione, Bruna Cerbelli, Giulio Iannello, Paolo Soda, Carlo de Felice. On the Additional Information Provided by 3T-MRI ADC in Predicting Tumor Cellularity and Microscopic Behavior. Cancers 2021; 13(20): 5167 doi: 10.3390/cancers13205167
|
| 195 |
Erdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, Kubilay Karaboyun, Okan Avcı, Ahmet Yolcu, Sibel Özkan Gürdal, Meltem Öznur. A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy. Revista da Associação Médica Brasileira 2023; 69(3): 434 doi: 10.1590/1806-9282.20221255
|
| 196 |
Cengiz Yılmaz, Baha Zengel, Orhan Üreyen, Zehra Hilal Adıbelli, Funda Taşlı, Hasan Taylan Yılmaz, Özlem Özdemir, Demet Kocatepe Çavdar, Hülya Mollamehmetoğlu, Umut Çakıroğlu, Yaşar İmren, Savaş Yakan, Enver İlhan. A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience. Cancers 2025; 17(2): 163 doi: 10.3390/cancers17020163
|
| 197 |
Radwa M. Fawzy, Amal A. Abdel-Aziz, Khalid Bassiouny, Aysam M. Fayed. Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line. Journal of Genetic Engineering and Biotechnology 2024; 22(1): 100339 doi: 10.1016/j.jgeb.2023.100339
|
| 198 |
Rashmi Dewangan, Nidhi Agrawal, S. K. Lanjhiyana, Meenakshi Jaiswal. Exploring the antineoplastic potential of novel NSAID derivatives in combatting mammary tumorigenesis: a comprehensive review. Medicinal Chemistry Research 2025; 34(4): 764 doi: 10.1007/s00044-025-03377-6
|
| 199 |
Zuzana Budkova, Anna Karen Sigurdardottir, Eirikur Briem, Jon Thor Bergthorsson, Snævar Sigurdsson, Magnus Karl Magnusson, Gunnhildur Asta Traustadottir, Thorarinn Gudjonsson, Bylgja Hilmarsdottir. Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00461
|
| 200 |
Zhengfei Guo, Richard W. Dong, Yusheng Wu, Shengli Dong, Suresh K. Alahari. Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment. Oncogene 2025; 44(17): 1135 doi: 10.1038/s41388-025-03378-0
|
| 201 |
Deepraj Sarmah, Wesley O. Meredith, Ian K. Weber, Madison R. Price, Marc R. Birtwistle, Attila Csikász-Nagy. Predicting anti-cancer drug combination responses with a temporal cell state network model. PLOS Computational Biology 2023; 19(5): e1011082 doi: 10.1371/journal.pcbi.1011082
|
| 202 |
Stephany Corrêa, Carolina Panis, Renata Binato, Ana Cristina Herrera, Luciana Pizzatti, Eliana Abdelhay. Identifying potential markers in Breast Cancer subtypes using plasma label-free proteomics. Journal of Proteomics 2017; 151: 33 doi: 10.1016/j.jprot.2016.07.030
|
| 203 |
Cristiano Guttà, Christoph Morhard, Markus Rehm, Zhaolei Zhang. Applying a GAN-based classifier to improve transcriptome-based prognostication in breast cancer. PLOS Computational Biology 2023; 19(4): e1011035 doi: 10.1371/journal.pcbi.1011035
|
| 204 |
Carina Bernardo, Júlio Santos, Céu Costa, Ana Tavares, Teresina Amaro, Igor Marques, Maria João Gouveia, Vítor Félix, Vera Afreixo, Paul J. Brindley, José Manuel Costa, Francisco Amado, Luisa Helguero, Lúcio L. Santos. Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation. Urologic Oncology: Seminars and Original Investigations 2020; 38(9): 738.e23 doi: 10.1016/j.urolonc.2020.04.022
|
| 205 |
Dhananjay B. Alagundagi, Sudeep D. Ghate, Vinay Kumar J. Rajendra, Pavan Gollapalli, Vijith V. Shetty, Caren D’Souza, Praveenkumar Shetty, Prakash Patil. Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance. 3 Biotech 2023; 13(1) doi: 10.1007/s13205-022-03422-w
|
| 206 |
F.C. Nunes, A.C. Bertagnolli, G.E. Lavalle, T.L. Silveira, D. Balabram, G.D. Cassali. The prognostic significance of immunophenotypes in canine malignant mammary tumors. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2022; 74(2): 299 doi: 10.1590/1678-4162-12273
|
| 207 |
Fares Saeed H. Al-Mansour, Hassan H. Almasoudi, Ali Albarrati. Mapping molecular landscapes in triple-negative breast cancer: insights from spatial transcriptomics. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04057-3
|
| 208 |
Guochong Jia, Yaohua Yang, Jie Ping, Shuai Xu, Lili Liu, Xingyi Guo, Ran Tao, Jirong Long, Wei Zheng. Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data. International Journal of Cancer 2023; 152(11): 2314 doi: 10.1002/ijc.34472
|
| 209 |
Kurt Buchegger, Ismael Riquelme, Tamara Viscarra, Carmen Ili, Priscilla Brebi, Tim Huang, Juan Roa. Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer. International Journal of Molecular Sciences 2017; 18(8): 1525 doi: 10.3390/ijms18081525
|
| 210 |
Sofiullah Abubakar, Stuart More, Naima Tag, Afusat Olabinjo, Ahmed Isah, Ismaheel Lawal. Differences in Tumour Aggressiveness Based on Molecular Subtype and Race Measured by [18F]FDG PET Metabolic Metrics in Patients with Invasive Carcinoma of the Breast. Diagnostics 2023; 13(12): 2059 doi: 10.3390/diagnostics13122059
|
| 211 |
Yi Guo, Yuzhou Hu, Mengyun Qiao, Yuanyuan Wang, Jinhua Yu, Jiawei Li, Cai Chang. Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal Carcinoma. Clinical Breast Cancer 2018; 18(3): e335 doi: 10.1016/j.clbc.2017.08.002
|
| 212 |
Hao Tang, Salwa Sebti, Rossella Titone, Yunyun Zhou, Ciro Isidoro, Theodora S. Ross, Hanina Hibshoosh, Guanghua Xiao, Milton Packer, Yang Xie, Beth Levine. Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis. EBioMedicine 2015; 2(3): 255 doi: 10.1016/j.ebiom.2015.01.008
|
| 213 |
Roberta Fiume, Yvette Stijf-Bultsma, Zahid H. Shah, Willem Jan Keune, David R. Jones, Julian Georg Jude, Nullin Divecha. PIP4K and the role of nuclear phosphoinositides in tumour suppression. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(6): 898 doi: 10.1016/j.bbalip.2015.02.014
|
| 214 |
Yuhua Wang, Chaoxian Xu, Ningcheng Jiang, Liqin Zheng, Jinshu Zeng, Caimin Qiu, Hongqin Yang, Shusen Xie. Quantitative analysis of the cell‐surface roughness and viscoelasticity for breast cancer cells discrimination using atomic force microscopy. Scanning 2016; 38(6): 558 doi: 10.1002/sca.21300
|
| 215 |
Kaiming Zhang, Liqin Ping, Xueqi Ou, Meiheban Bazhabayi, Xiangsheng Xiao. A Systemic Inflammation Response Score for Prognostic Prediction of Breast Cancer Patients Undergoing Surgery. Journal of Personalized Medicine 2021; 11(5): 413 doi: 10.3390/jpm11050413
|
| 216 |
Tansel Ozyer, Reyhan Zeynep Pek, Muhammed Talha Zavalsiz, Melis Serdar, Sleiman Alhajj, Lama Alhajj, Jon Rokne, Reda Alhajj, Kashfia Sailunaz. Investigating The Roles of microRNAs / lncRNAs in Characterizing Breast Cancer Subtypes and Prognosis. Proceedings of the International Conference on Advances in Social Networks Analysis and Mining 2023; : 588 doi: 10.1145/3625007.3627340
|
| 217 |
Shristi Bhattarai, Bruna M. Sugita, Emanuelle Nunes-Souza, Aline S. Fonseca, Darshan Shimoga Chandrashekar, Mahak Bhargava, Luciane R. Cavalli, Ritu Aneja. Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer. International Journal of Molecular Sciences 2024; 25(24): 13679 doi: 10.3390/ijms252413679
|
| 218 |
Shaymaa Azawi, Martina Rincic, Thomas Liehr. Cytogenomic characteristics of murine breast cancer cell line JC. Molecular Cytogenetics 2021; 14(1) doi: 10.1186/s13039-020-00524-z
|
| 219 |
D. Tomic, B. Pirkic, K. Skala, L. Kranjcevic. Predicting the effectiveness of multi-drug cancer therapies. 2019 42nd International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO) 2019; : 375 doi: 10.23919/MIPRO.2019.8757131
|
| 220 |
Jocelyn Gal, Caroline Bailleux, David Chardin, Thierry Pourcher, Julia Gilhodes, Lun Jing, Jean-Marie Guigonis, Jean-Marc Ferrero, Gerard Milano, Baharia Mograbi, Patrick Brest, Yann Chateau, Olivier Humbert, Emmanuel Chamorey. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Computational and Structural Biotechnology Journal 2020; 18: 1509 doi: 10.1016/j.csbj.2020.05.021
|
| 221 |
Primariadewi Rustamadji, Elvan Wiyarta. Association of Src with Nottingham Prognostic Index in Breast Cancer: Implications for Breast Cancer Prognostication. Journal of Nature and Science of Medicine 2024; 7(2): 90 doi: 10.4103/jnsm.jnsm_192_23
|
| 222 |
Jennifer L. Plank-Bazinet, Susan G. Kornstein, Janine Austin Clayton, Worta McCaskill-Stevens, Lauren Wood, Nakela Cook, Salman M. Tajuddin, Gina M. Brown, Tamara Harris, Michele K. Evans, Lisa Begg, Claudette E. Brooks, Leah R. Miller, Amy Caroline Mistretta, Terri L. Cornelison. A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity. Journal of Women's Health 2016; 25(1): 4 doi: 10.1089/jwh.2015.5666
|
| 223 |
Jeremy Joon Ho Goh, Corinna Jie Hui Goh, Qian Wei Lim, Songjing Zhang, Cheng-Gee Koh, Keng-Hwee Chiam. Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24511-z
|
| 224 |
Sylvia Annabel Dass, Kim Liu Tan, Rehasri Selva Rajan, Noor Fatmawati Mokhtar, Elis Rosliza Mohd Adzmi, Wan Faiziah Wan Abdul Rahman, Tengku Ahmad Damitri Al-Astani Tengku Din, Venugopal Balakrishnan. Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities. Medicina 2021; 57(1): 62 doi: 10.3390/medicina57010062
|
| 225 |
William Sebastian, Lauren Forchette, Kelsey Donoughe, Yibei Lun, Anisha Verma, Tuoen Liu. Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. Cancers 2023; 15(4): 1303 doi: 10.3390/cancers15041303
|
| 226 |
Mustafa Erhan Ozer, Pemra Ozbek Sarica, Kazim Yalcin Arga. New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines. OMICS: A Journal of Integrative Biology 2020; 24(5): 241 doi: 10.1089/omi.2020.0001
|
| 227 |
Mariausilia Franchina, Cristina Pizzimenti, Vincenzo Fiorentino, Maurizio Martini, Giuseppina Rosaria Rita Ricciardi, Nicola Silvestris, Antonio Ieni, Giovanni Tuccari. Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes. International Journal of Molecular Sciences 2023; 24(16): 12795 doi: 10.3390/ijms241612795
|
| 228 |
Kathirvel Kalaimani, Shana Balachandran, Lokesh Kumar Boopathy, Anitha Roy, Bhuvaneshwari Jayachandran, Sangamithra Sankaranarayanan, Madan Kumar Arumugam. Recent advancements in small interfering RNA based therapeutic approach on breast cancer. European Journal of Pharmacology 2024; 981: 176877 doi: 10.1016/j.ejphar.2024.176877
|
| 229 |
Yi Liu, Jiandong Wang, Mengxi Jiang. Copper-related genes predict prognosis and characteristics of breast cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1145080
|
| 230 |
Swapnil Kumar, Ramakrishna Ramaswamy, Vaibhav Vindal, Alok Srivastava. Subtype-specific network organization of molecular complexes in breast cancer. Journal of Biosciences 2023; 48(3) doi: 10.1007/s12038-023-00351-5
|
| 231 |
Majed S. AlFayi, Mohd Saeed, Irfan Ahmad, Mohd Adnan Kausar, Samra Siddiqui, Saba Irem, Faisal Fawaz Alshammari, Riadh Badraoui, Dharmendra Kumar Yadav. Unveiling the therapeutic role of penfluridol and BMS-754,807: NUDT5 inhibition in breast cancer. Chemical Physics Impact 2025; 10: 100871 doi: 10.1016/j.chphi.2025.100871
|
| 232 |
Kalhara R. Menikdiwela, Chanaka Kahathuduwa, Michelle L. Bolner, Rakhshanda Layeequr Rahman, Naima Moustaid-Moussa. Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer. Biomedicines 2022; 10(11): 2931 doi: 10.3390/biomedicines10112931
|
| 233 |
Surya Nath Pandey, M. Arockia Babu, Haider Ali, Malathi H, Laxmidhar Maharana, Kavita Goyal, Mohit Rana, Mohd Imran. MUC1 as a diagnostic biomarker and siRNA-based therapeutic target in breast cancer: A clinical chemistry perspective. Clinica Chimica Acta 2025; 576: 120387 doi: 10.1016/j.cca.2025.120387
|
| 234 |
SHILPA A. GAJBHIYE, MORESHWAR P. PATIL. SOLID LIPID NANOPARTICLES: A REVIEW ON DIFFERENT TECHNIQUES AND APPROACHES TO TREAT BREAST CANCER. International Journal of Applied Pharmaceutics 2023; : 52 doi: 10.22159/ijap.2023v15i2.46970
|
| 235 |
Gemma A. Barron, Marie Goua, Klaus W.J. Wahle, Giovanna Bermano. Circulating levels of angiogenesis-related growth factors in breast cancer: A study to profile proteins responsible for tubule formation. Oncology Reports 2017; 38(3): 1886 doi: 10.3892/or.2017.5803
|
| 236 |
Sagarika Banerjee, Tian Tian, Zhi Wei, Natalie Shih, Michael D. Feldman, Kristen N. Peck, Angela M. DeMichele, James C. Alwine, Erle S. Robertson. Distinct Microbial Signatures Associated With Different Breast Cancer Types. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00951
|
| 237 |
Xiao Zheng, Cong Xu, Kumar Ganesan, Haiyong Chen, Yuen Shan Cheung, Jianping Chen. Does Laterality in Breast Cancer still have the Importance to be
Studied? A Meta-analysis of Patients with Breast Cancer. Current Medicinal Chemistry 2024; 31(22): 3360 doi: 10.2174/0109298673241301231023060322
|
| 238 |
Deyu Zhang, Xiaojie Xu, Qinong Ye. Metabolism and immunity in breast cancer. Frontiers of Medicine 2021; 15(2): 178 doi: 10.1007/s11684-020-0793-6
|
| 239 |
Nuri Lee, Min-Jeong Park, Wonkeun Song, Kibum Jeon, Seri Jeong. Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer. International Journal of Molecular Sciences 2020; 21(22): 8807 doi: 10.3390/ijms21228807
|
| 240 |
Asaf Evrim Evren, Demokrat Nuha, Sam Dawbaa, Abdullah Burak Karaduman, Begüm Nurpelin Sağlik, Leyla Yurttaş.
Novel oxadiazole-thiadiazole derivatives: synthesis, biological evaluation, and
in silico
studies
. Journal of Biomolecular Structure and Dynamics 2024; 42(16): 8688 doi: 10.1080/07391102.2023.2247087
|
| 241 |
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, Maria Sinicropi, Alessia Catalano. Targeting Breast Cancer: An Overlook on Current Strategies. International Journal of Molecular Sciences 2023; 24(4): 3643 doi: 10.3390/ijms24043643
|
| 242 |
Jan Korbecki, Mateusz Bosiacki, Katarzyna Barczak, Ryta Łagocka, Agnieszka Brodowska, Dariusz Chlubek, Irena Baranowska-Bosiacka. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer. International Journal of Molecular Sciences 2023; 24(8): 7262 doi: 10.3390/ijms24087262
|
| 243 |
Seri Jeong, Nuri Lee, Min-Jeong Park, Kibum Jeon, Wonkeun Song. Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer. Cancers 2021; 13(20): 5225 doi: 10.3390/cancers13205225
|
| 244 |
Manuel Gámez-Chiachio, David Sarrió, Gema Moreno-Bueno. Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs. Cancers 2022; 14(18): 4543 doi: 10.3390/cancers14184543
|
| 245 |
Nazan Gökşen Tosun. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(5): 3249 doi: 10.1007/s00210-023-02807-9
|
| 246 |
Luke Yongkyu Kwon, Zhongli Cai, Azza Al-Mahrouki, Raymond M. Reilly. Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR. iScience 2024; 27(5): 109750 doi: 10.1016/j.isci.2024.109750
|
| 247 |
Ewout W. Steyerberg, Liesbeth C. de Wreede, David van Klaveren, Patrick M. M. Bossuyt. Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling. Medical Decision Making 2021; 41(3): 354 doi: 10.1177/0272989X21991173
|
| 248 |
Eliya Farah, Chantelle Carbonell, Devon J. Boyne, Darren R. Brenner, Jan-Willem Henning, Daniel Moldaver, Simran Shokar, Winson Y. Cheung. Treatment Patterns and Health Outcomes among Patients with HER2 IHC0/-Low Metastatic or Recurrent Breast Cancer. Cancers 2024; 16(3): 518 doi: 10.3390/cancers16030518
|
| 249 |
Nurul Akmar Misron, Lai-Meng Looi, Nik Raihan Nik Mustapha. Cyclooxygenase-2 Expression in Invasive Breast Carcinomas of No Special Type and Correlation with Pathological Profiles Suggest a Role in Tumorigenesis Rather than Cancer Progression. Asian Pacific Journal of Cancer Prevention 2015; 16(4): 1553 doi: 10.7314/APJCP.2015.16.4.1553
|
| 250 |
Anuka S. Mendis, Ira Thabrew, Meran K. Ediriweera, Sameera R. Samarakoon, Kamani H. Tennekoon, Achyut Adhikari, Egodage D. de Silva. Isolation of a New Sesquiterpene Lactone From Vernonia Zeylanica (L) Less and its Anti-Proliferative Effects in Breast Cancer Cell Lines. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(3): 410 doi: 10.2174/1871520619666181128163359
|
| 251 |
Beidi Jia, David Lim, Yisha Zhang, Chao Dong, Zhihui Feng. Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis. Japanese Journal of Radiology 2023; 41(6): 648 doi: 10.1007/s11604-022-01383-x
|
| 252 |
Shuai Wang, Haoyi Zi, Mengxuan Li, Jing Kong, Cong Fan, Yujie Bai, Jianing Sun, Ting Wang. Development and validation of a mitotic catastrophe-related genes prognostic model for breast cancer. PeerJ 2024; 12: e18075 doi: 10.7717/peerj.18075
|
| 253 |
Armin Imanparast, Amir Reza Ameri, Neda Attaran, Soheil Sharifi, Ali Tamayol, Ameneh Sazgarnia, Seyed Ali Mousavi Shaegh. A preclinical design approach for translation of biohybrid photosensitive nanoplatform for photodynamic therapy of breast cancer. Journal of Controlled Release 2025; 378: 543 doi: 10.1016/j.jconrel.2024.12.021
|
| 254 |
Arya Mariam Roy, Vasanthan Muthusamy Kumarasamy, Ajay Dhakal, Ruth O’Regan, Shipra Gandhi. A review of treatment options in HER2‐low breast cancer and proposed treatment sequencing algorithm. Cancer 2023; 129(18): 2773 doi: 10.1002/cncr.34904
|
| 255 |
Nina Petrović, Irina Nakashidze, Milica Nedeljković. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?. Journal of Mammary Gland Biology and Neoplasia 2021; 26(2): 157 doi: 10.1007/s10911-021-09478-3
|
| 256 |
Marketa Lastovickova, Dana Strouhalova, Janette Bobalova. Use of Lectin-based Affinity Techniques in Breast Cancer Glycoproteomics: A Review. Journal of Proteome Research 2020; 19(5): 1885 doi: 10.1021/acs.jproteome.9b00818
|
| 257 |
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli. Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?. Current Oncology 2023; 30(1): 1220 doi: 10.3390/curroncol30010094
|
| 258 |
Wooyoung Jang, Jonghyun Lee, Kyong Hwa Park, Aeree Kim, Sung Hak Lee, Sangjeong Ahn. Molecular Classification of Breast Cancer Using Weakly Supervised Learning. Cancer Research and Treatment 2025; 57(1): 116 doi: 10.4143/crt.2024.113
|
| 259 |
Min Ji Bak, Soumyasri Das Gupta, Joseph Wahler, Nanjoo Suh. Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. Seminars in Cancer Biology 2016; : 170 doi: 10.1016/j.semcancer.2016.03.001
|
| 260 |
Anna Wawruszak, Lidia Borkiewicz, Estera Okon, Wirginia Kukula-Koch, Syeda Afshan, Marta Halasa. Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers 2021; 13(18): 4700 doi: 10.3390/cancers13184700
|
| 261 |
Rajeev Kharb, Kashif Haider, Kumari Neha, Mohammad S. Yar. Aromatase inhibitors: Role in postmenopausal breast cancer. Archiv der Pharmazie 2020; 353(8) doi: 10.1002/ardp.202000081
|
| 262 |
Sireesha V. Garimella, Karthik Krishna Chittibomma, Siri Chandana Gampa. Multi-Omics Technology in Human Health and Diseases. 2025; : 173 doi: 10.1016/B978-0-443-13595-8.00008-8
|
| 263 |
Hui-Yu Lin, Chia-Hao Kuei, Hsun-Hua Lee, Che-Hsuan Lin, Yen-Lin Chen, Chi-Long Chen, Yuan-Feng Lin. TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer. Journal of Molecular Medicine 2020; 98(9): 1255 doi: 10.1007/s00109-020-01952-5
|
| 264 |
Li Li, Ling Lin, Jamunarani Veeraraghavan, Yiheng Hu, Xian Wang, Sanghoon Lee, Ying Tan, Rachel Schiff, Xiao-Song Wang. Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01325-3
|
| 265 |
Abigail B. Clark, Suzanne D. Conzen. Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype. The Journal of Steroid Biochemistry and Molecular Biology 2024; 243: 106518 doi: 10.1016/j.jsbmb.2024.106518
|
| 266 |
Qinmei Li, James D. Dormer, Priyanka Daryani, Deji Chen, Zhenfeng Zhang, Baowei Fei, Horst K. Hahn, Kensaku Mori. Radiomics analysis of MRI for predicting molecular subtypes of breast cancer in young women. Medical Imaging 2019: Computer-Aided Diagnosis 2019; : 148 doi: 10.1117/12.2512056
|
| 267 |
Mukaddes Yilmaz, Eda Erdiş, Mahmut Uçar, Birsen Yücel. Prognostic Importance of Panimmune-Inflammation Value and PILE Scores in Non-Metastatic Luminal A Breast Cancer. Breast Care 2025; 20(1): 27 doi: 10.1159/000543304
|
| 268 |
Teodora Costea, Oana Cezara Vlad, Luminita-Claudia Miclea, Constanta Ganea, János Szöllősi, Maria-Magdalena Mocanu. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. International Journal of Molecular Sciences 2020; 21(2): 401 doi: 10.3390/ijms21020401
|
| 269 |
Jing He, Ling Tong, Ping Wu, Yibo Wu, Weifeng Shi, Ling Chen. Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study. International Journal of General Medicine 2023; : 507 doi: 10.2147/IJGM.S396871
|
| 270 |
Alessandra Quarta, Antonio Gaballo, Biswajita Pradhan, Srimanta Patra, Mrutyunjay Jena, Andrea Ragusa. Beneficial Oxidative Stress-Related trans-Resveratrol Effects in the Treatment and Prevention of Breast Cancer. Applied Sciences 2021; 11(22): 11041 doi: 10.3390/app112211041
|
| 271 |
Yuna Shang, Jiayu Wang, Yinyin Feng, Zhengyu Liu, Jiayi Lu, Sijia Deng, Li Li, Hongxu Zhang, Liantao Li, Zhongyan Wang, Zhimou Yang. A dual-targeted trinity of antibody–peptide–drug delivery consortium to combat HER2+ tumor. Chemical Communications 2024; 60(93): 13742 doi: 10.1039/D4CC05115G
|
| 272 |
Sadeq Rezaei, Majid Babaei. A systematic literature review on direct and indirect costs of triple-negative breast cancer. Cost Effectiveness and Resource Allocation 2023; 21(1) doi: 10.1186/s12962-023-00503-2
|
| 273 |
Miroslawa Püsküllüoğlu, Marek Ziobro, Joanna Lompart, Agnieszka Rudzińska, Tomasz Zemełka, Justyna Jaworska, Sebastian Ochenduszko, Aleksandra Grela-Wojewoda. Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study. Cancers 2024; 16(16): 2894 doi: 10.3390/cancers16162894
|
| 274 |
Emily Tinsley, Philip Bredin, Sinead Toomey, Bryan T. Hennessy, Simon J. Furney. KMT2C and KMT2D aberrations in breast cancer. Trends in Cancer 2024; 10(6): 519 doi: 10.1016/j.trecan.2024.02.003
|
| 275 |
Nikita Jinna, Yate-Ching Yuan, Padmashree Rida. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers. International Journal of Molecular Sciences 2023; 24(22): 16072 doi: 10.3390/ijms242216072
|
| 276 |
Shailima Rampogu, Mugahed A. Al-antari, Tae Hwan Oh, Baji Shaik. A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10300-0
|
| 277 |
Chia-Chia Liu, Jamunarani Veeraraghavan, Ying Tan, Jin-Ah Kim, Xian Wang, Suet Kee Loo, Sanghoon Lee, Yiheng Hu, Xiao-Song Wang. A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers. Clinical Cancer Research 2021; 27(3): 785 doi: 10.1158/1078-0432.CCR-20-2769
|
| 278 |
Yuxin Xie, Qiheng Gou, Qianqian Wang, Xiaorong Zhong, Hong Zheng. The role of BRCA status on prognosis in patients with triple-negative breast cancer. Oncotarget 2017; 8(50): 87151 doi: 10.18632/oncotarget.19895
|
| 279 |
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers 2019; 11(9): 1334 doi: 10.3390/cancers11091334
|
| 280 |
Ziqi Yu, Mei Song, Lotfi Chouchane, Xiaojing Ma. Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy. Cancers 2021; 13(13): 3276 doi: 10.3390/cancers13133276
|
| 281 |
Susmita Palmal, Nikhilanand Arya, Sriparna Saha, Somanath Tripathy. Integrative prognostic modeling for breast cancer: Unveiling optimal multimodal combinations using graph convolutional networks and calibrated random forest. Applied Soft Computing 2024; 154: 111379 doi: 10.1016/j.asoc.2024.111379
|
| 282 |
Youssef El-Ahmad, Veronique Croq, Christian Wehrey, Maysoun Shomali, Laurent Schio. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry. Volume 4. ACS Symposium Series 2022; 1423: 275 doi: 10.1021/bk-2022-1423.ch007
|
| 283 |
Lan Zhao, Victor H F Lee, Michael K Ng, Hong Yan, Maarten F Bijlsma. Molecular subtyping of cancer: current status and moving toward clinical applications. Briefings in Bioinformatics 2019; 20(2): 572 doi: 10.1093/bib/bby026
|
| 284 |
Joelle Makoukji, Nadine J. Makhoul, Maya Khalil, Sally El-Sitt, Ehab Saad Aldin, Mark Jabbour, Fouad Boulos, Emanuela Gadaleta, Ajanthah Sangaralingam, Claude Chelala, Rose-Mary Boustany, Arafat Tfayli. Gene expression profiling of breast cancer in Lebanese women. Scientific Reports 2016; 6(1) doi: 10.1038/srep36639
|
| 285 |
Gaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri, Pier Franco Conte. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 429 doi: 10.1007/978-3-030-56051-5_30
|
| 286 |
Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer. ACS Omega 2016; 1(6): 1412 doi: 10.1021/acsomega.6b00251
|
| 287 |
M.N. Gomes, T.N. Augustine, D. Moyo, E. Chivandi. Differential response of breast cancer cell lines to Kigelia africana, Ximenia caffra and Mimusops zeyheri seed oils. South African Journal of Botany 2019; 121: 463 doi: 10.1016/j.sajb.2018.12.017
|
| 288 |
I. Saranya, V. Sowfika Dharshini, R.L. Akshaya, P. Sakthi Subhashini, N. Selvamurugan. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review. International Journal of Biological Macromolecules 2024; 266: 131075 doi: 10.1016/j.ijbiomac.2024.131075
|
| 289 |
Reuben Jyong Kiat Foo, Siqi Tian, Ern Yu Tan, Wilson Wen Bin Goh. A novel survival prediction signature outperforms PAM50 and artificial intelligence-based feature-selection methods. Computational Biology and Chemistry 2023; 104: 107845 doi: 10.1016/j.compbiolchem.2023.107845
|
| 290 |
Nattarika Khuisangeam, Sirirut Jewmoung, Rattapoom Thaiwong, Suparat Tudsamran, Nattiya Hirankarn, Koramit Suppipat, Supannikar Tawinwung, Vladimir Jurisic. An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/2449373
|
| 291 |
Dattu Hawale, Leela Abichandani, Ranjit Ambad. Study of Glutathione S-Transferase, Its Isoenzyme (Pi), and Tumor Markers (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment). Journal of Pharmacy and Bioallied Sciences 2025; 17(Suppl 1): S113 doi: 10.4103/jpbs.jpbs_1790_24
|
| 292 |
Mohammad A. Alzubi, Sahib S. Sohal, Madhumitha Sriram, Tia H. Turner, Patricija Zot, Michael Idowu, J. Chuck Harrell. Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts. Clinical & Experimental Metastasis 2019; 36(3): 257 doi: 10.1007/s10585-019-09968-z
|
| 293 |
Raúl Peña, Josep Baulida. Snail1 as a key prognostic biomarker of cancer-associated fibroblasts in breast tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(3): 189316 doi: 10.1016/j.bbcan.2025.189316
|
| 294 |
Jiaqing Hao, Rong Jin, Yanmei Yi, Xingshan Jiang, Jianyu Yu, Zhen Xu, Nicholas J. Schnicker, Michael S. Chimenti, Sonia L. Sugg, Bing Li. Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Research 2024; 26(1) doi: 10.1186/s13058-024-01873-y
|
| 295 |
Xiao-Qiong Chen, Fan Zhang, Qi-Chen Su, Chi Zeng, Fu-Hui Xiao, Yu Peng. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-0811-1
|
| 296 |
Prarthana Chatterjee, Satarupa Banerjee. Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer. Biochemical Pharmacology 2023; 218: 115866 doi: 10.1016/j.bcp.2023.115866
|
| 297 |
Honey Pavithran, Ranjith Kumavath. Emerging role of pioneer transcription factors in targeted ERα positive breast cancer. Exploration of Targeted Anti-tumor Therapy 2021; doi: 10.37349/etat.2021.00031
|
| 298 |
Fu Ou-Yang, Mei-Ren Pan, Shu-Jyuan Chang, Chun-Chieh Wu, Shao-Yu Fang, Chung-Liang Li, Ming-Feng Hou, Chi-Wen Luo. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics. Life Sciences 2019; 238: 116963 doi: 10.1016/j.lfs.2019.116963
|
| 299 |
Anna De Blasio, Renza Vento, Riccardo Di Fiore. Mcl‐1 targeting could be an intriguing perspective to cure cancer. Journal of Cellular Physiology 2018; 233(11): 8482 doi: 10.1002/jcp.26786
|
| 300 |
Priyank A. Shenoy, Andy Kuo, German Leparc, Tobias Hildebrandt, Werner Rust, Janet R. Nicholson, Laura Corradini, Irina Vetter, Maree T. Smith. Transcriptomic characterisation of the optimised rat model of Walker 256 breast cancer cell‐induced bone pain. Clinical and Experimental Pharmacology and Physiology 2019; 46(12): 1201 doi: 10.1111/1440-1681.13165
|
| 301 |
Zongzhen He, Junying Zhang, Xiguo Yuan, Jianing Xi, Zhaowen Liu, Yuanyuan Zhang. Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables. Molecules 2019; 24(3): 631 doi: 10.3390/molecules24030631
|
| 302 |
Halima Alsamri, Hussain El Hasasna, Yusra Al Dhaheri, Ali H. Eid, Samir Attoub, Rabah Iratni. Carnosol, a Natural Polyphenol, Inhibits Migration, Metastasis, and Tumor Growth of Breast Cancer via a ROS-Dependent Proteasome Degradation of STAT3. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00743
|
| 303 |
Ying Pan, Qiancheng Zhao, Haitao He, Yubo Qi, Yujie Bai, Jia Zhao, Yiming Yang. TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1326023
|
| 304 |
Kuniko Horie, Kiyoshi Takagi, Toshihiko Takeiwa, Yuichi Mitobe, Hidetaka Kawabata, Takashi Suzuki, Kazuhiro Ikeda, Satoshi Inoue. Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells. Cells 2022; 11(22): 3610 doi: 10.3390/cells11223610
|
| 305 |
Hanna Fredholm, Kristina Magnusson, Linda S. Lindström, Hans Garmo, Sonja Eaker Fält, Henrik Lindman, Jonas Bergh, Lars Holmberg, Fredrik Pontén, Jan Frisell, Irma Fredriksson. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Research and Treatment 2016; 160(1): 131 doi: 10.1007/s10549-016-3983-9
|
| 306 |
Wadie D. Mahauad-Fernandez, Nicholas C. Borcherding, Weizhou Zhang, Chioma M. Okeoma, William B. Coleman. Bone Marrow Stromal Antigen 2 (BST-2) DNA Is Demethylated in Breast Tumors and Breast Cancer Cells. PLOS ONE 2015; 10(4): e0123931 doi: 10.1371/journal.pone.0123931
|
| 307 |
Linda Vidarsdottir, Elinborg J. Olafsdottir, Rosa B. Barkardottir, Olöf Bjarnadottir, Jon G. Jonasson, Stefan Sigurdsson, Laufey Tryggvadottir. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients. npj Breast Cancer 2023; 9(1) doi: 10.1038/s41523-023-00600-8
|
| 308 |
Jeeyeon Lee, Jae-Hwan Jeong, Jin Hyang Jung, Wan Wook Kim, Soo Jung Lee, Ji-Young Park, Jee Young Park, Seung Hee Kang, Eun Ae Kim, Jae Hyung Park, Yee Soo Chae, Ho Yong Park. Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer. Oncology 2019; 97(3): 180 doi: 10.1159/000501340
|
| 309 |
Qiang Liu, Zhongzhao Wang, Xiangyi Kong, Xiangyu Wang, Yihang Qi, Ran Gao, Yi Fang, Jing Wang. A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer. DNA and Cell Biology 2020; 39(4): 671 doi: 10.1089/dna.2019.5223
|
| 310 |
Akshada Gajbhiye, Raju Dabhi, Khushman Taunk, Garikapati Vannuruswamy, Sourav RoyChoudhury, Ragini Adhav, Shubhendu Seal, Anupama Mane, Santhakumari Bayatigeri, Manas K. Santra, Koel Chaudhury, Srikanth Rapole. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics. PROTEOMICS 2016; 16(17): 2403 doi: 10.1002/pmic.201600015
|
| 311 |
Zeyu Zhang, Xiaoting Li, Yingyan Han, Teng Ji, Xiaoyuan Huang, Qinglei Gao, Ding Ma. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. Biomedicine & Pharmacotherapy 2019; 118: 109341 doi: 10.1016/j.biopha.2019.109341
|
| 312 |
Hazel M. Quinn, Laura Battista, Valentina Scabia, Cathrin Brisken. Cancer Cell Dormancy. Methods in Molecular Biology 2024; 2811: 101 doi: 10.1007/978-1-0716-3882-8_7
|
| 313 |
Sara K. Jaradat, Nehad M. Ayoub, Ahmed H. Al Sharie, Julia M. Aldaod. Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241234780
|
| 314 |
Kaiming Zhang, Liqin Ping, Tian Du, Yan Wang, Ya Sun, Gehao Liang, Xi Wang, Xiaoming Xie, Weidong Wei, Xiangsheng Xiao, Jun Tang, Guoku Hu. A Novel Systematic Oxidative Stress Score Predicts the Prognosis of Patients with Operable Breast Cancer. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/9441896
|
| 315 |
Hung-I Harry Chen, Yu-Chiao Chiu, Tinghe Zhang, Songyao Zhang, Yufei Huang, Yidong Chen. GSAE: an autoencoder with embedded gene-set nodes for genomics functional characterization. BMC Systems Biology 2018; 12(S8) doi: 10.1186/s12918-018-0642-2
|
| 316 |
Juan C. Rodriguez, Gabriela A. Merino, Andrea S. Llera, Elmer A. Fernández. Massive integrative gene set analysis enables functional characterization of breast cancer subtypes. Journal of Biomedical Informatics 2019; 93: 103157 doi: 10.1016/j.jbi.2019.103157
|
| 317 |
Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan, Renu Vyas. A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential Biomarkers. Current Topics in Medicinal Chemistry 2022; 22(21): 1793 doi: 10.2174/1568026622666220907121942
|
| 318 |
Prathibha Sivaprakasam, Sureshkumar Anandasadagopan, Tamilselvi Alagumuthu, Ashok Kumar Pandurangan. Advanced Pharmacological Uses of Medicinal Plants and Natural Products. Advances in Medical Diagnosis, Treatment, and Care 2020; : 91 doi: 10.4018/978-1-7998-2094-9.ch005
|
| 319 |
Ezgi Antmen, Menekse Ermis, Ozgur Kuren, Kemal Beksac, Cigdem Irkkan, Vasif Hasirci. Nuclear Deformability of Breast Cells Analyzed from Patients with Malignant and Benign Breast Diseases. ACS Biomaterials Science & Engineering 2023; 9(3): 1629 doi: 10.1021/acsbiomaterials.2c01059
|
| 320 |
Changliang Liu, Houqian Gao, Zijian Zhao, Iman Rostami, Chen Wang, Ling Zhu, Yanlian Yang. Improved tumor targeting and penetration by a dual-functional poly(amidoamine) dendrimer for the therapy of triple-negative breast cancer. Journal of Materials Chemistry B 2019; 7(23): 3724 doi: 10.1039/C9TB00433E
|
| 321 |
Silvia Taralli, Armando Orlandi, Pia Clara Pafundi, Valeria Tempesta, Alba Di Leone, Letizia Pontolillo, Lorenzo Scardina, Margherita Lorusso, Ida Paris, Maria Lucia Calcagni. Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters. La radiologia medica 2025; 130(3): 422 doi: 10.1007/s11547-025-01961-9
|
| 322 |
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, Panagiotis Papageorgis. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers 2021; 13(17): 4363 doi: 10.3390/cancers13174363
|
| 323 |
Ming Zhao, Erin W. Howard, Amanda B. Parris, Zhiying Guo, Qingxia Zhao, Xiaohe Yang. Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK. Molecular Carcinogenesis 2017; 56(3): 849 doi: 10.1002/mc.22538
|
| 324 |
Pervej Alom Barbhuiya, Shahil Arman, Hrishika Paul, Saikat Sen, Biplab Kumar Dey, Manash Pratim Pathak. An Updated Review on the Early Detection and Drug Development
Targeting Breast Cancer. Current Womens Health Reviews 2024; 20(4) doi: 10.2174/1573404820666230713110902
|
| 325 |
Mengyang Liu, Xia Wang, Jun Wu, Peng Li. p53 gene mutations among patients involved with breast cancer: types of detection. American Journal of BioMedicine 2023; 11(2): 85 doi: 10.18081/2333-5106/2023.11/85
|
| 326 |
Sharda P. Singh, Jihyun Lee, Chhanda Bose, Hongzhi Li, Yate-Ching Yuan, Ashly Hindle, Sharad S. Singhal, Jonathan Kopel, Philip T. Palade, Catherine Jones, Rakhshanda L. Rahman, Sanjay Awasthi. Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers 2021; 13(13): 3329 doi: 10.3390/cancers13133329
|
| 327 |
Heba Ghozlan, Adrian Showalter, Eunkyung Lee, Xiang Zhu, Annette R. Khaled. Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.663877
|
| 328 |
Jéssica Reis Santos, Dan Linetzky Waitzberg, Ismael Dale Cotrim Guerreiro da Silva, Tharcisio Citrangulo Tortelli Junior, Luciana Rodrigues Carvalho Barros, Gisele André Baptista Canuto, Andréa Tedesco Faccio, Lydia Fumiko Yamaguchi, Massuo Jorge Kato, Marina Franco Maggi Tavares, Ana Cristina Martinez, Ângela Flavia Logullo, Raquel Suzana M.M. Torrinhas, Graziela Ravacci. Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study. Oncotarget 2020; 11(18): 1637 doi: 10.18632/oncotarget.27575
|
| 329 |
Anila Pema Kristo, Flutura Proko, Enkelejda Cuedari, Agron Dogjani. EFFICACY OF PALBOCICLIB ON POSITIVE METASTATIC BREAST CANCER RECEPTOR, IN REAL WORLD DATA STUDIES AND OUR EXPERIENCE IN ONCOLOGY SERVICE. GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2022; : 127 doi: 10.36106/gjra/3009467
|
| 330 |
Stefan Lennard Krautschneider, Fabian M. Troschel, Eduardo Vadillo, Hans Theodor Eich, Martin Götte, Nancy Adriana Espinoza-Sánchez, Burkhard Greve. Enzymatic Digestion of Cell-surface Heparan Sulfate Alters the Radiation Response in Triple-negative Breast Cancer Cells. Archives of Medical Research 2022; 53(8): 826 doi: 10.1016/j.arcmed.2022.11.004
|
| 331 |
Juan Feng, Jun Ren, Xiuqi Li, Xue Zhang, Qingfeng Yang, Zankai Wu, Le Cui, Lingxia Liao, Yiping Gong, Dedong Cao. Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients. International Journal of Molecular Sciences 2022; 23(18): 10312 doi: 10.3390/ijms231810312
|
| 332 |
Ibrahim Alradwan, Pei Zhi, Tian Zhang, HoYin Lip, Abdulmottaleb Zetrini, Chunsheng He, Jeffrey T. Henderson, Andrew M. Rauth, Xiao Yu Wu. Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer. Journal of Controlled Release 2025; 377: 661 doi: 10.1016/j.jconrel.2024.11.061
|
| 333 |
Maëva Lion, Alexandre Harlé, Julia Salleron, Carole Ramacci, Mario Campone, Jean-Louis Merlin. Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer. Oncology Letters 2016; 12(3): 2028 doi: 10.3892/ol.2016.4891
|
| 334 |
Sabiyah Akhter, Malik Muzafar Manzoor, Sameer Ahmad Mir, Tahirah Khaliq, Phalisteen Sultan, Qazi Parvaiz Hassan. Extracts and isolated compounds from the <i>Acorus calamus</i> L. (sweet flag) rhizome showed distinct antimetastatic activity against MDA-MB-231 breast cancer cells. Medicinal Plant Biology 2024; 3(1): 0 doi: 10.48130/mpb-0024-0021
|
| 335 |
Mingyang Sun, Chia-Lun Chang, Chang-Yun Lu, Szu-Yuan Wu, Jiaqiang Zhang. Survival Impact of Long-Term Tramadol Use on Breast Cancer for Patients with Chronic Pain: A Propensity Score-Matched Population-Based Cohort Study. Journal of Personalized Medicine 2022; 12(3): 384 doi: 10.3390/jpm12030384
|
| 336 |
Valeria Romeo, Thomas H. Helbich, Katja Pinker. Breast PET/MRI Hybrid Imaging and Targeted Tracers. Journal of Magnetic Resonance Imaging 2023; 57(2): 370 doi: 10.1002/jmri.28431
|
| 337 |
Kajal Rajput, Mohammad Nafees Ansari, Somesh K. Jha, Trishna Pani, Nihal Medatwal, Somdeb Chattopadhyay, Avinash Bajaj, Ujjaini Dasgupta. Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells. Cancers 2022; 14(18): 4496 doi: 10.3390/cancers14184496
|
| 338 |
Zhihong Gong, Jie Wang, Dan Wang, Matthew F Buas, Xuefeng Ren, Jo L Freudenheim, Steven A Belinsky, Song Liu, Christine B Ambrosone, Michael J Higgins. Differences in microRNA expression in breast cancer between women of African and European ancestry. Carcinogenesis 2019; 40(1): 61 doi: 10.1093/carcin/bgy134
|
| 339 |
Nurul Wafiqah Saipol Bahrin, Siti Nur Idayu Matusin, Aklimah Mustapa, Lu Zen Huat, Sriyani Perera, Mas Rina Wati Haji Abdul Hamid. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis. Systematic Reviews 2024; 13(1) doi: 10.1186/s13643-024-02520-5
|
| 340 |
Jeeyeon Lee, Eun-Ae Kim, Jieun Kang, Yee Soo Chae, Ho Yong Park, Byeongju Kang, Soo Jung Lee, In Hee Lee, Ji-Young Park, Nora Jee-young Park, Jin Hyang Jung. Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer. BMC Molecular and Cell Biology 2024; 25(1) doi: 10.1186/s12860-024-00510-y
|
| 341 |
Pouria Samadi, Sahar Saki, Fatemeh Karimi Dermani, Mona Pourjafar, Massoud Saidijam. Emerging ways to treat breast cancer: will promises be met?. Cellular Oncology 2018; 41(6): 605 doi: 10.1007/s13402-018-0409-1
|
| 342 |
Akhila R James, Sakthidasan Jayaprakash, Lakshmi M Sundeep. In-Vitro Cytotoxicity, Apoptotic Property, and Gene Expression Changes Induced by Naringenin-7-O-Glucoside in Triple-Negative Breast Cancer. Cureus 2024; doi: 10.7759/cureus.58634
|
| 343 |
Huixin Wu, William J. Van Der Pol, Laura G. Dubois, Casey D. Morrow, Trygve O. Tollefsbol. Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations. International Journal of Molecular Sciences 2023; 24(10): 9015 doi: 10.3390/ijms24109015
|
| 344 |
Izabela Laczmanska, Rafal Matkowski, Stanislaw Supplitt, Pawel Karpinski, Mariola Abrahamowska, Lukasz Laczmanski, Adam Maciejczyk, Ewelina Czykalko, Ewelina Iwaneczko, Piotr Kasprzak, Bartłomiej Szynglarewicz, Maria Sasiadek. Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. Breast Cancer Research and Treatment 2024; 208(3): 501 doi: 10.1007/s10549-024-07441-4
|
| 345 |
Stephanie Cabarcas-Petroski, Patricio I. Meneses, Laura Schramm. A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07569-8
|
| 346 |
Sudeepa Ghosh, Rahmat Khanam, Avik Acharya Chowdhury. The Evolving Roles of Bacopa monnieri as Potential Anti-Cancer Agent: A Review. Nutrition and Cancer 2021; 73(11-12): 2166 doi: 10.1080/01635581.2020.1841248
|
| 347 |
Maiquidieli Dal Berto, Giovana Tavares dos Santos, Aniúsca Vieira dos Santos, Andrew Oliveira Silva, José Eduardo Vargas, Rafael José Vargas Alves, Fernanda Barbisan, Ivana Beatrice Mânica da Cruz, Claudia Giuliano Bica. Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis. Discover Oncology 2021; 12(1) doi: 10.1007/s12672-021-00432-7
|
| 348 |
B. H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Mohammad Ali Abdullah Almoyad, Shadma Wahab, Waleed H. Almalki, Prashant Kesharwani. Nanosponges as an Emerging Platform for Cancer Treatment and Diagnosis. Advanced Functional Materials 2024; 34(7) doi: 10.1002/adfm.202307074
|
| 349 |
Maria Rosaria Miranda, Vincenzo Vestuto, Giuseppina Amodio, Michele Manfra, Giacomo Pepe, Pietro Campiglia. Antitumor Mechanisms of Lycium barbarum Fruit: An Overview of In Vitro and In Vivo Potential. Life 2024; 14(3): 420 doi: 10.3390/life14030420
|
| 350 |
Zhifang Huang, Li Chen, Yong Wang, Lina Fu, Renhua Lv. Molecular markers, pathology, and ultrasound features of invasive breast cancer. Clinical Imaging 2021; 79: 85 doi: 10.1016/j.clinimag.2021.03.039
|
| 351 |
Vijayakumar Shrihastini, Pandiyan Muthuramalingam, Sivakumar Adarshan, Mariappan Sujitha, Jen-Tsung Chen, Hyunsuk Shin, Manikandan Ramesh. Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. Cancers 2021; 13(24): 6222 doi: 10.3390/cancers13246222
|
| 352 |
YING YANG, HUAN CONG, CUICUI HAN, LILING YUE, HAIYING DONG, JICHENG LIU. 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway. Oncology Reports 2015; 34(4): 1755 doi: 10.3892/or.2015.4166
|
| 353 |
Anukriti Singh, Nidhi Srivastava, Sonal Amit, S.N. Prasad, M.P. Misra, Bushra Ateeq. Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population. Translational Oncology 2018; 11(2): 233 doi: 10.1016/j.tranon.2017.12.007
|
| 354 |
Xin Hua, Fangfang Duan, Wenyu Zhai, Chenge Song, Chang Jiang, Li Wang, Jiajia Huang, Huanxin Lin, Zhongyu Yuan. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer. Journal of Inflammation Research 2022; : 381 doi: 10.2147/JIR.S338421
|
| 355 |
Animesh Kar, Nihal Medatwal, Kajal Rajput, Susmita Mandal, Trishna Pani, Ali Khan, Pankaj Sharma, Ajit Singh Oberoi, Gayatri Vishwakarma, SVS Deo, Mohit Kumar Jolly, Avinash Bajaj, Ujjaini Dasgupta. Unique sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes. International Journal of Cancer 2023; 152(11): 2410 doi: 10.1002/ijc.34423
|
| 356 |
Shayne D. Wierbowski, Robert Fragoza, Siqi Liang, Haiyuan Yu. Extracting complementary insights from molecular phenotypes for prioritization of disease-associated mutations. Current Opinion in Systems Biology 2018; 11: 107 doi: 10.1016/j.coisb.2018.09.006
|
| 357 |
Changda Li, Yan Yan, Wenjun Lin, Yue Zhang. Enhancing cancer subtype classification through convolutional neural networks: a deepinsight analysis of TCGA gene expression data. Health Information Science and Systems 2025; 13(1) doi: 10.1007/s13755-025-00349-3
|
| 358 |
Ciara F. Loughrey, Sarah Maguire, Paweł Dłotko, Lu Bai, Nick Orr, Anna Jurek-Loughrey. A novel method for subgroup discovery in precision medicine based on topological data analysis. BMC Medical Informatics and Decision Making 2025; 25(1) doi: 10.1186/s12911-025-02852-9
|
| 359 |
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav. Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02111-9
|
| 360 |
Jiaqiang Zhang, Chia-Lun Chang, Chang-Yun Lu, Ho-Min Chen, Szu-Yuan Wu. Paravertebral block in regional anesthesia with propofol sedation reduces locoregional recurrence in patients with breast cancer receiving breast conservative surgery compared with volatile inhalational without propofol in general anesthesia. Biomedicine & Pharmacotherapy 2021; 142: 111991 doi: 10.1016/j.biopha.2021.111991
|
| 361 |
Ashley H. Larnder, Amee R. Manges, Rachel A. Murphy. The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancer. International Journal of Cancer 2025; doi: 10.1002/ijc.35427
|
| 362 |
Mohammad Mehedi Hasan, Parvathy Mohanan, Shabana Bibi, Catherine Babu, Yohan Joe Roy, Ashlyn Mathews, Govinda Khatri, Stavros P. Papadakos. Breast Cancer Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 7: 69 doi: 10.1007/16833_2023_176
|
| 363 |
Rayol Mendonca-Neto, Zhi Li, David Fenyö, Claudio T. Silva, Fabíola G. Nakamura, Eduardo F. Nakamura. A Gene Selection Method Based on Outliers for Breast Cancer Subtype Classification. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2022; 19(5): 2547 doi: 10.1109/TCBB.2021.3132339
|
| 364 |
Feifei Yan, Sara Göransson, Helene Olofsson, Christos Vogiatzakis, Anagha Acharekar, Staffan Strömblad. Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer. Cell Communication and Signaling 2025; 23(1) doi: 10.1186/s12964-025-02276-y
|
| 365 |
Lyvia Eloiza de Freitas Meirelles, Maria Vitória Felipe de Souza, Lucimara Rodrigues Carobeli, Fabrício Morelli, Natália Lourenço Mari, Edilson Damke, Cristiane Suemi Shinobu Mesquita, Jorge Juarez Vieira Teixeira, Marcia Edilaine Lopes Consolaro, Vânia Ramos Sela da Silva. Combination of Conventional Drugs with Biocompounds Derived from Cinnamic Acid: A Promising Option for Breast Cancer Therapy. Biomedicines 2023; 11(2): 275 doi: 10.3390/biomedicines11020275
|
| 366 |
Stanislaw Supplitt, Pawel Karpinski, Maria Sasiadek, Lukasz Laczmanski, Dorota Kujawa, Rafal Matkowski, Piotr Kasprzak, Mariola Abrahamowska, Adam Maciejczyk, Ewelina Iwaneczko, Izabela Laczmanska. The analysis of transcriptomic signature of TNBC—searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity. Journal of Applied Genetics 2025; 66(1): 171 doi: 10.1007/s13353-024-00876-x
|
| 367 |
Heng Jiang, Sara Cartwright, David G Wagner, Jairam Krishnamurthy, Juan A Santamaria-Barria. Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Postpartum High-Risk Basal-Type Breast Cancer. Cureus 2024; doi: 10.7759/cureus.62338
|
| 368 |
Warapan Numprasit, Supaporn Yangngam, Jaturawitt Prasopsiri, Jean A. Quinn, Joanne Edwards, Chanitra Thuwajit. Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1087270
|
| 369 |
Behrooz Omidvar-Tehrani. Heterogeneous Data Management, Polystores, and Analytics for Healthcare. Lecture Notes in Computer Science 2019; 11470: 107 doi: 10.1007/978-3-030-14177-6_9
|
| 370 |
Yanjiao Ren, Yimeng Gao, Wei Du, Weibo Qiao, Wei Li, Qianqian Yang, Yanchun Liang, Gaoyang Li. Classifying breast cancer using multi-view graph neural network based on multi-omics data. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1363896
|
| 371 |
Marisabel Mecca, Marzia Sichetti, Martina Giuseffi, Eugenia Giglio, Claudia Sabato, Francesca Sanseverino, Graziella Marino. Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies. Nutrients 2024; 16(12): 1883 doi: 10.3390/nu16121883
|
| 372 |
Marie-Juliet Brown, Soukaina Bahsoun, Mhairi A. Morris, Elizabeth C. Akam. Determining Conditions for Successful Culture of Multi-Cellular 3D Tumour Spheroids to Investigate the Effect of Mesenchymal Stem Cells on Breast Cancer Cell Invasiveness. Bioengineering 2019; 6(4): 101 doi: 10.3390/bioengineering6040101
|
| 373 |
Nivruthi Sasi, Dilipkumar Preetha, Saranya Iyyappan, Nagarajan Selvamurugan. Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression. Seminars in Oncology 2025; 52(2): 152340 doi: 10.1016/j.seminoncol.2025.152340
|
| 374 |
Mirza Mohamod Zahir Uddin Bhuiyan. Breast Cancer Characteristics in Young Women Under 50 Years Old in Mankweng Hospital, South Africa. European Journal of Medical and Health Sciences 2025; 7(2): 8 doi: 10.24018/ejmed.2025.7.2.2249
|
| 375 |
Sebastian Simu, Iasmina Marcovici, Amadeus Dobrescu, Daniel Malita, Cristina Adriana Dehelean, Dorina Coricovac, Flavius Olaru, George Andrei Draghici, Dan Navolan. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel. Molecules 2021; 26(9): 2776 doi: 10.3390/molecules26092776
|
| 376 |
Carla Luís, Fernando Schmitt, Rute Fernandes, Nuno Coimbra, Joana Rigor, Paula Dias, Dina Leitão, Rúben Fernandes, Raquel Soares. Breast Cancer Molecular Subtypes Differentially Express Gluconeogenic Rate-Limiting Enzymes—Obesity as a Crucial Player. Cancers 2023; 15(20): 4936 doi: 10.3390/cancers15204936
|
| 377 |
Sergey V. Nikulin, Boris Ya. Alekseev, Nataliya S. Sergeeva, Pavel A. Karalkin, Elizaveta K. Nezhurina, Valentina A. Kirsanova, Irina K. Sviridova, Suraja A. Akhmedova, Nadezhda N. Volchenko, Larisa V. Bolotina, Andrey I. Osipyants, Dmitry M. Hushpulian, Maxim A. Topchiy, Andrey F. Asachenko, Anastasia P. Koval, Dmitry S. Shcherbo, Vsevolod I. Kiselev, Dmitry S. Mikhaylenko, Udo Schumacher, Andrey A. Poloznikov. Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3′-diindolylmethane and chemotherapy drugs. Biochimie 2020; 179: 217 doi: 10.1016/j.biochi.2020.10.007
|
| 378 |
Ehsan Sohrabi, Masoumeh Moslemi, Ehsan Rezaie, Nahid Nafissi, Mansoor Khaledi, Hamed Afkhami, Javad Fathi, Ali Zekri. The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer. Genes & Genomics 2021; 43(9): 1065 doi: 10.1007/s13258-021-01116-w
|
| 379 |
Divya Jindal, Sarthak Sinha, Vinayak Agarwal, Vaishnavi Sisodia, Manisha Singh. Combinatorial Assessment of Doxorubicin with Chlorogenic acid by in silico studies and development of its polymeric-nanoparticle against breast cancer. Materials Today: Proceedings 2023; doi: 10.1016/j.matpr.2023.02.131
|
| 380 |
Yu-Fei Wang, Jie Han. OTOR in breast carcinoma as a potent prognostic predictor correlates with cell proliferation, migration, and invasiveness. Biochemistry and Cell Biology 2019; 97(6): 750 doi: 10.1139/bcb-2018-0305
|
| 381 |
Ricardo Cunha de Oliveira, Sávio Pinho dos Reis, Giovanna C. Cavalcante. Mutations in Structural Genes of the Mitochondrial Complex IV May Influence Breast Cancer. Genes 2023; 14(7): 1465 doi: 10.3390/genes14071465
|
| 382 |
Amjad Z. Alrosan, Ghaith B. Heilat, Khaled Alrosan, Ahmad Shannag, Ehab M. Alshalout. NEDD4 signaling: a new frontier in the diagnosis and treatment of breast and ovarian cancers. Medical Oncology 2025; 42(6) doi: 10.1007/s12032-025-02751-z
|
| 383 |
Qing Yan. Translational Bioinformatics and Systems Biology Methods for Personalized Medicine. 2017; : 133 doi: 10.1016/B978-0-12-804328-8.00011-5
|
| 384 |
Wafaa S. Ramadan, Iman M. Talaat, Mahmood Y. Hachim, Annette Lischka, Timo Gemoll, Raafat El-Awady. The impact of CBP expression in estrogen receptor-positive breast cancer. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01060-2
|
| 385 |
Guillermo Arturo Valencia, Patricia Rioja, Zaida Morante, Rossana Ruiz, Hugo Fuentes, Carlos A Castaneda, Tatiana Vidaurre, Silvia Neciosup, Henry L Gomez. Immunotherapy in triple-negative breast cancer: A literature review and new advances. World Journal of Clinical Oncology 2022; 13(3): 219-236 doi: 10.5306/wjco.v13.i3.219
|
| 386 |
David K. Lim, Naim U. Rashid, Joseph G. Ibrahim. Model-based feature selection and clustering of RNA-seq data for unsupervised subtype discovery. The Annals of Applied Statistics 2021; 15(1) doi: 10.1214/20-AOAS1407
|
| 387 |
Riya Sharma, Priyanka Naithani, Pallavi Sharma, Aarti Grover, Neelam Goel, Harmanjit Singh, Dwividendra Kumar Nim, Vivek Kumar Garg, Charles Odilichukwu R. Okpala, Harpal Singh Buttar, Dharambir Kashyap. Cancer of the Breast. 2025; : 113 doi: 10.1016/B978-0-443-24838-2.00007-0
|
| 388 |
Junwei Luo, Yading Feng, Xuyang Wu, Ruimin Li, Jiawei Shi, Wenjing Chang, Junfeng Wang. ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05412-y
|
| 389 |
Jose Manuel Sanchez-Lopez, Miguel Angel Juarez-Mancera, Benjamin Bustamante, Araceli Ruiz-Silvestre, Magali Espinosa, Gretel Mendoza-Almanza, Gisela Ceballos-Cancino, Jorge Melendez-Zajgla, Vilma Maldonado, Floria Lizarraga. Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses. RNA Biology 2024; 21(1): 601 doi: 10.1080/15476286.2024.2355393
|
| 390 |
Ajaz Ahmad Waza, Najeebul Tarfeen, Sabhiya Majid, Yasmeena Hassan, Rashid Mir, Mohd Younis Rather, Naseer Ue Din Shah. Metastatic Breast Cancer, Organotropism and Therapeutics: A Review. Current Cancer Drug Targets 2021; 21(10): 813 doi: 10.2174/1568009621666210806094410
|
| 391 |
Rupeng Dai, Xueting Bao, Chao Liu, Xunkai Yin, Zhenzhen Zhu, Zhe Zheng, Bo Wang, Kundi Yang, Hongmei Wen, Wei Li, Haohao Zhu, Qianming Du, Jian Liu. Drug discovery of N-methyl-pyrazole derivatives as potent selective estrogen receptor degrader (SERD) for the treatment of breast cancer. European Journal of Medicinal Chemistry 2024; 279: 116894 doi: 10.1016/j.ejmech.2024.116894
|
| 392 |
Yi-Ching Huang, Yao-Lung Kuo, Kuo-Ting Lee, Hui-Ping Hsu, Zhu-Jun Loh, Jui-Hung Tsai, Shuen-Ru Yang, Chun-Hui Lee, Shang-Hung Chen, Wei-Pang Chung. Real-world Utilization of the 21-gene Assay in Taiwanese Female Patients with Early-stage Breast Cancer. Journal of Cancer Research and Practice 2022; 9(3): 87 doi: 10.4103/2311-3006.355306
|
| 393 |
Javed Iqbal, Banzeer Ahsan Abbasi, Riffat Batool, Tariq Mahmood, Barkat Ali, Ali Talha Khalil, Sobia Kanwal, Sayed Afzal Shah, Riaz Ahmad. Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch. European Journal of Pharmacology 2018; 827: 125 doi: 10.1016/j.ejphar.2018.03.007
|
| 394 |
Harmony I. Saunders, Sean M. Holloran, Gloria M. Trinca, Antonio Artigues, Maite Villar, Julio C. Tinoco, Wagner Barbosa Dias, Lauryn R. Werner, Eilidh I. Chowanec, Amanda Heard, Prabhakar Chalise, Chad Slawson, Christy R. Hagan. Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer. Journal of Biological Chemistry 2024; 300(11): 107886 doi: 10.1016/j.jbc.2024.107886
|
| 395 |
V.A. Kushnarev, A.G. Kudaibergenova, L.E. Zavalishina. The use of intralaboratory and external quality control of immunohistochemical studies to improve the detection of estrogen and progesterone receptors. Arkhiv patologii 2021; 83(3): 5 doi: 10.17116/patol2021830215
|
| 396 |
Silvia J. Serrano-Gómez, María Carolina Sanabria-Salas, Jone Garay, Melody C. Baddoo, Gustavo Hernández-Suarez, Juan Carlos Mejía, Oscar García, Lucio Miele, Laura Fejerman, Jovanny Zabaleta, Amanda Ewart Toland. Ancestry as a potential modifier of gene expression in breast tumors from Colombian women. PLOS ONE 2017; 12(8): e0183179 doi: 10.1371/journal.pone.0183179
|
| 397 |
Mei Liu, Zhiyang Li, Jingjing Yang, Yanyun Jiang, Zhongsi Chen, Zeeshan Ali, Nongyue He, Zhifei Wang. Cell‐specific biomarkers and targeted biopharmaceuticals for breast cancer treatment. Cell Proliferation 2016; 49(4): 409 doi: 10.1111/cpr.12266
|
| 398 |
Sima Ebrahimabadi, Majid Shahbazi, Mona Akbari, Masoud Golalipour, Touraj Farazmandfar. Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor‐overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors. The Journal of Gene Medicine 2019; 21(6) doi: 10.1002/jgm.3095
|
| 399 |
Xiaofeng Shi, Cheng Liang, Hong Wang. Multiview Robust Graph-Based Clustering for Cancer Subtype Identification. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2023; 20(1): 544 doi: 10.1109/TCBB.2022.3143897
|
| 400 |
Yiling Wang, Audrey Minden. Current Molecular Combination Therapies Used for the Treatment of Breast Cancer. International Journal of Molecular Sciences 2022; 23(19): 11046 doi: 10.3390/ijms231911046
|
| 401 |
Hae-Ock Lee, Woong-Yang Park. Translational Research in Breast Cancer. Advances in Experimental Medicine and Biology 2021; 1187: 205 doi: 10.1007/978-981-32-9620-6_10
|
| 402 |
Sadia Tasleem, Jarlath C. Bolger, Michael E. Kelly, Michael R. Boland, Dermot Bowden, Karl J. Sweeney, Carmel Malone. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact. Irish Journal of Medical Science (1971 -) 2018; 187(4): 1009 doi: 10.1007/s11845-018-1746-9
|
| 403 |
Tushar H. More, Sourav RoyChoudhury, Joel Christie, Khushman Taunk, Anupama Mane, Manas K. Santra, Koel Chaudhury, Srikanth Rapole. Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples. Oncotarget 2018; 9(2): 2678 doi: 10.18632/oncotarget.23626
|
| 404 |
Narges Takhshid, Hossein Fahimi. Diagnostic Potential of miR-30a and miR-200c in Invasive Breast Ductal Carcinoma. Precision Medicine and Clinical OMICS 2021; 1(1) doi: 10.5812/pmco.117729
|
| 405 |
Simona F. Shaitelman, Bethany M. Anderson, Douglas W. Arthur, Jose G. Bazan, Jennifer R. Bellon, Lisa Bradfield, Charlotte E. Coles, Naamit K. Gerber, Madeera Kathpal, Leonard Kim, Christine Laronga, Icro Meattini, Elizabeth M. Nichols, Lori J. Pierce, Matthew M. Poppe, Patricia A. Spears, Shaveta Vinayak, Timothy Whelan, Janice A. Lyons. Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology 2024; 14(2): 112 doi: 10.1016/j.prro.2023.11.001
|
| 406 |
Ali Mussa, Nor Hayati Ismail, Mahasin Hamid, Mohammad A. I. Al-Hatamleh, Anthony Bragoli, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, Vuk Uskoković, Rosline Hassan. Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03218-1
|
| 407 |
Kah Min Yap, Mahendran Sekar, Shivkanya Fuloria, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Vetriselvan Subramaniyan, Chandrakant Kokare, Pei Teng Lum, M Yasmin Begum, Shankar Mani, Dhanalekshmi Unnikrishnan Meenakshi, Kathiresan V Sathasivam, Neeraj Kumar Fuloria. Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature. International Journal of Nanomedicine 2021; : 7891 doi: 10.2147/IJN.S328135
|
| 408 |
Kaushik Das, Subhojit Paul, Arnab Ghosh, Saurabh Gupta, Tanmoy Mukherjee, Prem Shankar, Anshul Sharma, Shiva Keshava, Subhash C. Chauhan, Vivek Kumar Kashyap, Deepak Parashar. Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. Cancers 2023; 15(19): 4879 doi: 10.3390/cancers15194879
|
| 409 |
W H Lee, L Y Choong, T H Jin, N N Mon, S Chong, C S Liew, T Putti, S Y Lu, C Harteneck, Y P Lim. TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein. Oncogenesis 2017; 6(5): e338 doi: 10.1038/oncsis.2017.39
|
| 410 |
Maryam Solaimani, Sahar Hosseinzadeh, Mozhgan Abasi. Non-coding RNAs, a double-edged sword in breast cancer prognosis. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03679-0
|
| 411 |
Charlotta D. Mock, Brian C. Jordan, Chelliah Selvam. Recent advances of curcumin and its analogues in breast cancer prevention and treatment. RSC Advances 2015; 5(92): 75575 doi: 10.1039/C5RA14925H
|
| 412 |
Linda Perron, Sue-Ling Chang, Jean-Marc Daigle, Nathalie Vandal, Isabelle Theberge, Caroline Diorio, Julie Lemieux, Eric Pelletier, Jacques Brisson. Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program. Journal of Medical Screening 2019; 26(3): 154 doi: 10.1177/0969141318816736
|
| 413 |
Zhaojun Ren, Mengmeng Lv, Qiao Yu, Jun Bao, Kexin Lou, Xiujuan Li. MicroRNA‐370‐3p shuttled by breast cancer cell‐derived extracellular vesicles induces fibroblast activation through the CYLD/Nf‐κB axis to promote breast cancer progression. The FASEB Journal 2021; 35(3) doi: 10.1096/fj.202001430RR
|
| 414 |
Eyyad Nassar, Nourhan Hassan, Eslam A. El-Ghonaimy, Hebatallah Hassan, Mahmoud Salah Abdullah, Theresa V. Rottke, Ludwig Kiesel, Burkhard Greve, Sherif Abdelaziz Ibrahim, Martin Götte. Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes. Cancers 2021; 13(10): 2318 doi: 10.3390/cancers13102318
|
| 415 |
|
| 416 |
Eva Baranovicova, Peter Racay, Pavol Zubor, Marek Smolar, Eva Kudelova, Erika Halasova, Dana Dvorska, Zuzana Dankova. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls. Molecular and Cellular Probes 2022; 66: 101862 doi: 10.1016/j.mcp.2022.101862
|
| 417 |
Krista Heinolainen, Silva Saarinen, Simona Vertuani, Antti Ellonen, Antti Karlsson, Meri Utriainen, Peter Carlqvist, Jami Mandelin, Barbro Holm. Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practice. Journal of Cancer Research and Clinical Oncology 2023; 149(11): 9139 doi: 10.1007/s00432-023-04723-0
|
| 418 |
Ana Maria Valbuena-Garcia, Silvia Juliana Trujillo-Cáceres, Juliana Alexandra Hernández Vargas, Sandra Diaz, Lizbeth Acuña, Sandra Perdomo, Marion Piñeros. Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort. The Lancet Regional Health - Americas 2025; 43: 101018 doi: 10.1016/j.lana.2025.101018
|
| 419 |
Zohour Ibrahim Rashwan, Samah Ramadan Shaheen, Ayah Shaban Abd-El Fattah Abd-El Rasoul, Neama Mohamed Fouad Kamel, Hamida Ahmed Mostafa Darweesh. Empowering mind-body wellness: effect of bundling seated exercises and psychoeducational rehabilitation using the teach-back approach on fatigue and coping of women postmastectomy. BMC Women's Health 2024; 24(1) doi: 10.1186/s12905-024-03242-5
|
| 420 |
Tzu-Yang Tseng, Chiao-Hui Hsieh, Jie-Yu Liu, Hsuan-Cheng Huang, Hsueh-Fen Juan. Single-cell and multi-omics integration reveals cholesterol biosynthesis as a synergistic target with HER2 in aggressive breast cancer. Computational and Structural Biotechnology Journal 2025; 27: 1719 doi: 10.1016/j.csbj.2025.04.030
|
| 421 |
Jae Heon Jeong, Jae Won Yun, Ha Young Kim, Chan Yeong Heo, Sejoon Lee. Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion. Journal of Clinical Medicine 2021; 10(4): 582 doi: 10.3390/jcm10040582
|
| 422 |
E. Amiri Souri, A. Chenoweth, A. Cheung, S. N. Karagiannis, S. Tsoka. Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer. British Journal of Cancer 2021; 125(5): 748 doi: 10.1038/s41416-021-01455-1
|
| 423 |
Heidi Ko, RJ Seager, Sarabjot Pabla, Maria-Fernanda Senosain, Erik Van Roey, Shuang Gao, Kyle Strickland, Rebecca Previs, Michelle Green, Maureen Cooper, Mary Nesline, Stephanie Hastings, Kobina Amoah, Shengle Zhang, Jeffrey Conroy, Taylor Jensen, Marcia Eisenberg, Brian Caveney, Eric Severson, Shakti Ramkissoon, Shipra Gandhi. Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer. Breast Cancer: Targets and Therapy 2024; : 483 doi: 10.2147/BCTT.S476394
|
| 424 |
L. Gelsomino, S. Panza, C. Giordano, I. Barone, G. Gu, E. Spina, S. Catalano, S. Fuqua, S. Andò. Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines. Cancer Letters 2018; 428: 12 doi: 10.1016/j.canlet.2018.04.023
|
| 425 |
Anamika Bhargava, Sumit Saha. T-Type voltage gated calcium channels: a target in breast cancer?. Breast Cancer Research and Treatment 2019; 173(1): 11 doi: 10.1007/s10549-018-4970-0
|
| 426 |
Elham Safarzadeh, Shahryar Hashemzadeh, Pascal H.G. Duijf, Behzad Mansoori, Vahid Khaze, Ali Mohammadi, Tohid Kazemi, Mehdi Yousefi, Milad Asadi, Hamed Mohammadi, Farhad Babaie, Behzad Baradaran. Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer. Journal of Cellular Physiology 2019; 234(4): 3515 doi: 10.1002/jcp.26896
|
| 427 |
M. Dorso, Payal T. Patel, Aleksandr Pankov, Jacob A. Boyer, Rajesh K. Soni, Isabella S. Del Priore, Omar Hayatt, Amanda Kulick, Connor J. Hagen, Elisa de Stanchina, Melissa R. Junttila, Anneleen Daemen, Lori S. Friedman, Ronald C. Hendrickson, Sarat Chandarlapaty. A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer. Cancer Research Communications 2023; 3(9): 1788 doi: 10.1158/2767-9764.CRC-23-0310
|
| 428 |
Dong Hyeok Kim, Kyung Eun Lee. Discovering Breast Cancer Biomarkers Candidates through mRNA Expression Analysis Based on The Cancer Genome Atlas Database. Journal of Personalized Medicine 2022; 12(10): 1753 doi: 10.3390/jpm12101753
|
| 429 |
Kshitij RB Singh, Gunjan Nagpure, Jay Singh, Ravindra Pratap Singh. Nanotechnology for Drug Delivery and Pharmaceuticals. 2023; : 3 doi: 10.1016/B978-0-323-95325-2.00010-9
|
| 430 |
Xiao Zhao, Des R. Richardson. The role of the NDRG1 in the pathogenesis and treatment of breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(3): 188871 doi: 10.1016/j.bbcan.2023.188871
|
| 431 |
Tuba DEVRİM, Merva AYDEMİR. MEME KANSERİ BİYOPSİ ve REZEKSİYON MATERYALLERİNDE HORMON RESEPTÖRLERİ (ER/PgR) ve HER2 DEĞERLERİNİN KARŞILAŞTIRILMASI. SDÜ Tıp Fakültesi Dergisi 2020; 27(2): 154 doi: 10.17343/sdutfd.598845
|
| 432 |
Alexis K. Elfstrum, Aditi S. Bapat, Kathryn L. Schwertfeger. Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer. Cancer Medicine 2024; 13(3) doi: 10.1002/cam4.7053
|
| 433 |
Hui-Yu Chang, Yu-Kai Tseng, Yu-Chia Chen, Chih-Wen Shu, Miaw-I. Lin, Huei-Han Liou, Ting-Ying Fu, Yun-Chung Lin, Luo-Ping Ger, Ming-Hsin Yeh, Pei-Feng Liu. High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes. Surgical Oncology 2018; 27(2): 314 doi: 10.1016/j.suronc.2018.05.002
|
| 434 |
Giang Le Minh, Emily M. Esquea, Tejsi T. Dhameliya, Jessica Merzy, Mi-Hye Lee, Lauren E. Ball, Mauricio J. Reginato. Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1141834
|
| 435 |
Patrick M. Collins, Micheal J. Brennan, Jessie A. Elliott, Sami Abd Elwahab, Kevin Barry, Karl Sweeney, Carmel Malone, Aoife Lowery, Ray Mclaughlin, Michael J. Kerin. Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome. The American Journal of Surgery 2021; 222(2): 368 doi: 10.1016/j.amjsurg.2020.11.053
|
| 436 |
Akhil Behringer, Darko Stoimenovski, Martin Porsch, Katrin Hoffmann, Gerhard Behre, Ivo Grosse, Thomas Kalinski, Johannes Haybaeck, Norbert Nass. Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration. Biomolecules 2022; 12(7): 916 doi: 10.3390/biom12070916
|
| 437 |
Suman Kumar Samanta, Paramita Choudhury, Partha Pratim Sarma, Bhaskarjyoti Gogoi, Neelutpal Gogoi, Rajlakshmi Devi. Dietary phytochemicals/nutrients as promising protector of breast cancer development: a comprehensive analysis. Pharmacological Reports 2022; 74(4): 583 doi: 10.1007/s43440-022-00373-0
|
| 438 |
Jan Paredes Mogica, Haiming Tang, Yuanxin Liang, Minghao Zhong, Pei Hui, Malini Harigopal, Uma Krishnamurti, Neal A. Fischbach, Haiying Zhan. Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature. The Breast 2023; 72: 103586 doi: 10.1016/j.breast.2023.103586
|
| 439 |
Maryann Kwa, Andreas Makris, Francisco J. Esteva. Clinical utility of gene-expression signatures in early stage breast cancer. Nature Reviews Clinical Oncology 2017; 14(10): 595 doi: 10.1038/nrclinonc.2017.74
|
| 440 |
Ming Yao, Dingli Ye, Yuchong Wang, Tongxu Shen, Jieqiong Yan, Da Zou, Shuangyan Sun. Application of DCE-MRI radiomics and heterogeneity analysis in predicting luminal and non-luminal subtypes of breast cancer. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1523507
|
| 441 |
Luca Frattaruolo, Marco Fiorillo, Matteo Brindisi, Rosita Curcio, Vincenza Dolce, Rodney Lacret, Andrew W. Truman, Federica Sotgia, Michael P. Lisanti, Anna Rita Cappello. Thioalbamide, A Thioamidated Peptide from Amycolatopsis alba, Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress. Cells 2019; 8(11): 1408 doi: 10.3390/cells8111408
|
| 442 |
Yakup Ergun, Baran Akagunduz, Cengiz Karacin, Sema Turker, Gokhan Ucar. The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis. Clinical Breast Cancer 2023; 23(6): 567 doi: 10.1016/j.clbc.2023.05.015
|
| 443 |
Akshat Dubey, Suyash Agrawal, Varun Agrawal, Tanishq Dubey, Arpita Jaiswal. Breast Cancer and the Brain: A Comprehensive Review of Neurological Complications. Cureus 2023; doi: 10.7759/cureus.48941
|
| 444 |
Dipak D. Gadade, Hariom Jha, Chetan Kumar, Farzan Khan. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-023-00573-2
|
| 445 |
Pawar Jayashree, Mulye Kalpita, Talker Judith, Ahirwar Sonu Singh, Kotnis Ashwin. Role of MicroRNA in Hypoxic Tumours and their Potential as
Biomarkers for Early Detection of Cancer. Current Molecular Medicine 2024; 24(5): 525 doi: 10.2174/0115665240268661231128094831
|
| 446 |
Farkhonde Hasannejad, Mohammad Darzi, Mehrdad Yasaei. Unveiling GBE1 as a hypoxia-related prognostic gene with significant impact on immune cell infiltration in HER2-enriched breast cancer. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02826-3
|
| 447 |
Christopher J. Hanley, Elodie Henriet, Orit Katarina Sirka, Gareth J. Thomas, Andrew J. Ewald. Tumor-Resident Stromal Cells Promote Breast Cancer Invasion through Regulation of the Basal Phenotype. Molecular Cancer Research 2020; 18(11): 1615 doi: 10.1158/1541-7786.MCR-20-0334
|
| 448 |
Sulieman Ibraheem Shelash Al-Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, Nataliya S. Gilmanova, Hashem O. Alsaab, Adel Alghamdi, Shakeel Ahmed Ansari, Ahmed Hussien Radie Alawady, Ali Hashiem Alsaalamy, Ahmed Jaber Ibrahim. Breast cancer vaccines; A comprehensive and updated review. Pathology - Research and Practice 2023; 249: 154735 doi: 10.1016/j.prp.2023.154735
|
| 449 |
Javier Cortes, Patrick Schöffski, Bruce A. Littlefield. Multiple modes of action of eribulin mesylate: Emerging data and clinical implications. Cancer Treatment Reviews 2018; 70: 190 doi: 10.1016/j.ctrv.2018.08.008
|
| 450 |
Moumita Roy, Fazle Hussain. Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles. International Journal of Molecular Sciences 2024; 25(10): 5348 doi: 10.3390/ijms25105348
|
| 451 |
Lip Ket Chin, Huiyan Li, Jae-Hyeok Choi, Yoshiko Iwamoto, Juhyun Oh, Jouha Min, Suk Kyung Beak, Dahyeon Yoo, Cesar M. Castro, Dongyoung Lee, Hyungsoon Im. Hydrogel Stamping for Rapid, Multiplexed, Point-of-Care Immunostaining of Cells and Tissues. ACS Applied Materials & Interfaces 2022; 14(24): 27613 doi: 10.1021/acsami.2c05071
|
| 452 |
Tao Wei, Ning Zhu, Weihua Jiang, Xiao-Liang Xing. Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.844642
|
| 453 |
Jamshid Hamdard, Mehmet Haluk Yücel, Harun Muğlu, Özgür Açıkgöz, Aslı Çakır, Ahmet Bilici, Ömer Fatih Ölmez. Clinical Outcomes in Early-Stage HER2-Low and HER2-Zero Breast Cancer: Single-Center Experience. Journal of Clinical Medicine 2025; 14(9): 2937 doi: 10.3390/jcm14092937
|
| 454 |
Manu Yadav, Ishita Vaishkiar, Ananya Sharma, Akanksha Shukla, Aradhana Mohan, Madhuri Girdhar, Anil Kumar, Tabarak Malik, Anand Mohan. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review. Open Biology 2024; 14(6) doi: 10.1098/rsob.230272
|
| 455 |
Ros Suzanna Ahmad Bustamam, Yu Kong Leong, Flora Li Tze Chong, Florence Wong Yoke Fui, Yew-Teik Cheong, Goh Kenny. A Retrospective, Observational Study to Determine the Patient and Tumor Characteristics of HER2-Positive Breast Cancer Patients Treated at Five Main Public Cancer Centers in Malaysia. Asian Journal of Oncology 2020; 6: 10 doi: 10.1055/s-0040-1708108
|
| 456 |
Mohammed Maray, Mohammed Alghamdi, Malik Bader Alazzam, Rahim Khan. Diagnosing Cancer Using IOT and Machine Learning Methods. Computational Intelligence and Neuroscience 2022; 2022: 1 doi: 10.1155/2022/9896490
|
| 457 |
Brian T. Crouch, Jennifer Gallagher, Roujia Wang, Joy Duer, Allison Hall, Mary Scott Soo, Philip Hughes, Timothy Haystead, Nirmala Ramanujam. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40252-y
|
| 458 |
Vandana Singh, Kuldeep Kumar, Deepika Purohit, Ravinder Verma, Parijat Pandey, Saurabh Bhatia, Vinay Malik, Vineet Mittal, Md. Habibur Rahman, Ghadeer M. Albadrani, Mohammed W. Arafah, Fatma M. El-Demerdash, Muhammad Furqan Akhtar, Ammara Saleem, Mohamed Kamel, Agnieszka Najda, Mohamed M. Abdel-Daim, Deepak Kaushik. Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer. Biomedicine & Pharmacotherapy 2021; 139: 111584 doi: 10.1016/j.biopha.2021.111584
|
| 459 |
Xuan-Hai Do, My Hanh Thi Hoang, Anh-Tuan Vu, Lai-Thanh Nguyen, Dung Thi Thuy Bui, Duy-Thanh Dinh, Xuan-Hung Nguyen, Uyen Thi Trang Than, Hien Thi Mai, Thuy Thanh To, Tra Ngoc Huong Nguyen, Nhung Thi My Hoang. Differential Cytotoxicity of Curcumin-Loaded Micelles on Human Tumor and Stromal Cells. International Journal of Molecular Sciences 2022; 23(20): 12362 doi: 10.3390/ijms232012362
|
| 460 |
Olivier Sibomana. FDA approves Datroway: a novel therapy for HR-positive, HER2-negative metastatic breast cancer. Annals of Medicine & Surgery 2025; 87(4): 2521 doi: 10.1097/MS9.0000000000003122
|
| 461 |
Suet Kee Loo, Megan E. Yates, Sichun Yang, Steffi Oesterreich, Adrian V. Lee, Xiao‐Song Wang. Fusion‐associatedcarcinomas of the breast: Diagnostic, prognostic, and therapeutic significance. Genes, Chromosomes and Cancer 2022; 61(5): 261 doi: 10.1002/gcc.23029
|
| 462 |
Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Heejung Keum, Ho Yong Park. Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer. Medicine 2023; 102(34): e34772 doi: 10.1097/MD.0000000000034772
|
| 463 |
Penghe Yang, Xiao Yang, Dehai Wang, Huijie Yang, Zhongbo Li, Chenmiao Zhang, Shuqing Zhang, Jian Zhu, Xin Li, Peng Su, Ting Zhuang. PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα. Oncogene 2024; 43(4): 248 doi: 10.1038/s41388-023-02905-1
|
| 464 |
Sarmad Al-Marsoummi, Emilie E. Vomhof-DeKrey, Marc D. Basson. Schlafens: Emerging Proteins in Cancer Cell Biology. Cells 2021; 10(9): 2238 doi: 10.3390/cells10092238
|
| 465 |
Sehee Wang, Hyun-Hwan Jeong, Kyung-Ah Sohn. ClearF: a supervised feature scoring method to find biomarkers using class-wise embedding and reconstruction. BMC Medical Genomics 2019; 12(S5) doi: 10.1186/s12920-019-0512-9
|
| 466 |
Joanna Huszno, Zofia Kolosza. Molecular characteristics of breast cancer according to clinicopathological factors. Molecular and Clinical Oncology 2019; doi: 10.3892/mco.2019.1869
|
| 467 |
Suman Bhadra, Sohini Kulavi, Jaya Bandyopadhyay. Precision paradigm in breast cancer management: A mini review. Revista de Senología y Patología Mamaria 2025; 38(3): 100703 doi: 10.1016/j.senol.2025.100703
|
| 468 |
Yan-Shuang Li, Hong-Chuan Jiang. Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer. Journal of Applied Genetics 2024; 65(4): 823 doi: 10.1007/s13353-024-00848-1
|
| 469 |
Chang-Yun Li, Wanhe Wang, Chung-Hang Leung, Guan-Jun Yang, Jiong Chen. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02011-0
|
| 470 |
Ilona Hagelstein, Laura Wessling, Alexander Rochwarger, Latifa Zekri, Boris Klimovich, Christian M. Tegeler, Gundram Jung, Christian M. Schürch, Helmut R. Salih, Martina S. Lutz. Targeting CD276 for T cell-based immunotherapy of breast cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05689-4
|
| 471 |
'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 2020; : 313 doi: 10.1007/978-981-15-1067-0_12
|
| 472 |
Ísis Salviano Soares de Amorim, Isabelle Xavier Dias, Daphne Pinheiro, Simone Nunes de Carvalho, Pedro Nicolau-Neto, Juliana Alves Rodrigues, Priscyanne Barreto Siqueira, Matheus da Silva Oliveira, Carolina Panis, Adenilson de Souza da Fonseca, Andre Luiz Mencalha. Profiles of Expression of SAV1 in Normoxia or Hypoxia Microenviroment are Associated with Breast Cancer Prognosis. Archives of Medical Research 2023; 54(2): 79 doi: 10.1016/j.arcmed.2022.12.007
|
| 473 |
Riccardo Lobefaro, Luigi Mariani, Giorgia Peverelli, Francesca Ligorio, Giovanni Fucà, Alessandro Rametta, Emma Zattarin, Rita Leporati, Daniele Presti, Beatrice Cantarelli, Catherine Depretto, Andrea Vingiani, Siranoush Manoukian, Gianfranco Scaperrotta, Giulia V. Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison. Clinical Breast Cancer 2023; 23(3): e151 doi: 10.1016/j.clbc.2022.12.008
|
| 474 |
Pravesh Dhiman, CN Patil, Sneha Konimeni, Meenakshi Meenu. Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival Outcomes. Cureus 2025; doi: 10.7759/cureus.78798
|
| 475 |
T. Bonacho, F. Rodrigues, J. Liberal. Immunohistochemistry for diagnosis and prognosis of breast cancer: a review. Biotechnic & Histochemistry 2020; 95(2): 71 doi: 10.1080/10520295.2019.1651901
|
| 476 |
Aishwarya Laxmi, Sourbh Suren Garg, Arnika Singh, Pranav Kumar Prabhakar, Jeena Gupta. Histone Modifying Potential of Dietary Phytochemicals: Implications in Treating Breast Cancer. Current Pharmacology Reports 2023; 9(6): 489 doi: 10.1007/s40495-023-00338-8
|
| 477 |
Franco Caramia, Terence P. Speed, Hui Shen, Ygal Haupt, Sue Haupt. Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes. Cells 2023; 12(18): 2245 doi: 10.3390/cells12182245
|
| 478 |
Jia Yao, Shengwei Li, Xiaosheng Wang. Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.781848
|
| 479 |
Oliver Oey, Wynne Wijaya, Andrew Redfern. Eribulin in breast cancer: Current insights and therapeutic perspectives. World Journal of Experimental Medicine 2024; 14(2): 92558 doi: 10.5493/wjem.v14.i2.92558
Abstract(641) |
Core Tip(586) |
Full Article(HTML)(2749)
|
Full Article with Cover (PDF)-1622K(190)
|
Audio-493K(6)
|
Peer-Review Report-229K(59)
|
Answering Reviewers-86K(51)
|
Supplementary Material-131K(55)
|
Full Article (PDF)-1366K(185)
|
Full Article (XML)-216K(59)
|
Times Cited (3)
|
Total Visits (6303)
|
Open
|
| 480 |
Jamileh Kadkhoda, Ali Tarighatnia, Mohammad Reza Tohidkia, Nader D. Nader, Ayuob Aghanejad. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends. Life Sciences 2022; 298: 120499 doi: 10.1016/j.lfs.2022.120499
|
| 481 |
Namita Pendharkar, Akshada Gajbhiye, Khushman Taunk, Sourav RoyChoudhury, Snigdha Dhali, Shubhendu Seal, Anupama Mane, Subodhini Abhang, Manas K. Santra, Koel Chaudhury, Srikanth Rapole. Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers. Journal of Proteomics 2016; 132: 112 doi: 10.1016/j.jprot.2015.11.024
|
| 482 |
Lokman Varisli, Garrett M. Dancik, Veysel Tolan, Spiros Vlahopoulos. Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. Cancers 2023; 15(21): 5242 doi: 10.3390/cancers15215242
|
| 483 |
Reyhaneh Farghadani, Rakesh Naidu. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. Cancers 2021; 13(14): 3427 doi: 10.3390/cancers13143427
|
| 484 |
Veronica Zelli, Andrea Manno, Chiara Compagnoni, Rasheed Oyewole Ibraheem, Francesca Zazzeroni, Edoardo Alesse, Fabrizio Rossi, Claudio Arbib, Alessandra Tessitore. Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04720-4
|
| 485 |
Yiqing Yan, Lun Li, Zixin Wang, Jian Pang, Xinyu Guan, Yunchang Yuan, Zhenkun Xia, Wenjun Yi. A comprehensive analysis of the role of QPRT in breast cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42566-4
|
| 486 |
Feng Lin, Hang Li, Jianlin Shen, Zhixin Lin, Yu Chen. Construction and Validation of a Seven Anoikis-Related lncRNA Risk Model for Breast Cancer. Indian Journal of Surgery 2024; 86(5): 915 doi: 10.1007/s12262-023-03996-6
|
| 487 |
Fei-Yu Chen, Zhi-Yang Zhou, Ke-Jing Zhang, Jian Pang, Shou-Man Wang. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01580-6
|
| 488 |
Ali H. Abdulwahhab, Oğuz Bayat, Abdullahi A. Ibrahim. HAFMAB-Net: hierarchical adaptive fusion based on multilevel attention-enhanced bottleneck neural network for breast histopathological cancer classification. Signal, Image and Video Processing 2025; 19(5) doi: 10.1007/s11760-025-04001-1
|
| 489 |
Amrita R Valluri, Gloria J Carter, Inna Robrahn, Wendie A Berg. Triple-Negative Breast Cancer: Radiologic-Pathologic Correlation. Journal of Breast Imaging 2025; 7(3): 331 doi: 10.1093/jbi/wbae085
|
| 490 |
Ahmet Necati Sanli. Gender-related differences in survival in locally advanced luminal A breast cancer patients. Journal of Surgery and Medicine 2025; 9(5): 57 doi: 10.28982/josam.7833
|
| 491 |
Jiang Li, Haisu Tao, Wenqiang Wang, Jian Li, Erlei Zhang, Fu Wang. The Detection and Verification of Two Heterogeneous Subgroups and a Risk Model Based on Ferroptosis-Related Genes in Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1182383
|
| 492 |
Alberto Bouzón, Ángela Iglesias, Benigno Acea, Cristina Mosquera, Paz Santiago, Joaquín Mosquera. Evaluation of MRI accuracy after primary systemic therapy in breast cancer patients considering tumor biology: optimizing the surgical planning. Radiology and Oncology 2019; 53(2): 171 doi: 10.2478/raon-2019-0023
|
| 493 |
Young Ryul Park, Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Chan Sub Park, Ryu Kyung Lee, Yee Soo Chae, Soo Jung Lee, Ji-Young Park, Jee Young Park, Ho Yong Park. Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. Asian Journal of Surgery 2020; 43(3): 467 doi: 10.1016/j.asjsur.2019.05.010
|
| 494 |
Luca Cattelani, Vittorio Fortino, Sofia Forslund. Identifying gene expression-based biomarkers in online learning environments. Bioinformatics Advances 2022; 2(1) doi: 10.1093/bioadv/vbac074
|
| 495 |
Shuroug A. Alowais, Sahar S. Alghamdi, Nada Alsuhebany, Tariq Alqahtani, Abdulrahman I. Alshaya, Sumaya N. Almohareb, Atheer Aldairem, Mohammed Alrashed, Khalid Bin Saleh, Hisham A. Badreldin, Majed S. Al Yami, Shmeylan Al Harbi, Abdulkareem M. Albekairy. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Medical Education 2023; 23(1) doi: 10.1186/s12909-023-04698-z
|
| 496 |
Kimito Yamada, Toshihide Nishimura, Midori Wakiya, Eiichi Satoh, Tetsuya Fukuda, Keigo Amaya, Yasuhiko Bando, Hiroshi Hirano, Takashi Ishikawa. Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81509-9
|
| 497 |
Miguel Pereira-Silva, Ivana Jarak, Carmen Alvarez-Lorenzo, Angel Concheiro, Ana Cláudia Santos, Francisco Veiga, Ana Figueiras. Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies. Journal of Controlled Release 2020; 323: 442 doi: 10.1016/j.jconrel.2020.04.041
|
| 498 |
Y. Naeimzadeh, S. Ilbeigi, H. Dastsooz, M. Rafiee Monjezi, Y. Mansoori, S. M. B. Tabei, Yuan Li. Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/8236853
|
| 499 |
Jessica A Kretzmann, Kelly L Irving, Nicole M Smith, Cameron W Evans. Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox. NAR Cancer 2021; 3(4) doi: 10.1093/narcan/zcab048
|
| 500 |
Marta Klimczak, Przemyslaw Biecek, Alicja Zylicz, Maciej Zylicz. Heat shock proteins create a signature to predict the clinical outcome in breast cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43556-1
|
| 501 |
|
| 502 |
Chunyuan Li, Xinliang Zhu, Jiawen Yao, Junzhou Huang. Hierarchical Transformer for Survival Prediction Using Multimodality Whole Slide Images and Genomics. 2022 26th International Conference on Pattern Recognition (ICPR) 2022; : 4256 doi: 10.1109/ICPR56361.2022.9956296
|
| 503 |
Zhen Huang, Longjie Xia, Xiao Zhou, Changyuan Wei, Qinguo Mo. ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis. Biochemical and Biophysical Research Communications 2019; 514(1): 24 doi: 10.1016/j.bbrc.2019.04.101
|
| 504 |
Connor Edvall, Narendra Kale, Sakurako Tani, Shubhashri Ambhore, Rayat Hossain, Chukwuebuka Ozoude, Karl Van Horsen, Jiyan Mohammad, Daniel M. Tuvin, Santo Kalathingal, Jagadish Loganathan, Yongki Choi, Venkatachalem Sathish, James Brown, Sanku Mallik. Hypoxia-Responsive Polymersomes for Stemness Reduction in Patient-Derived Solid Tumor Spheroids. ACS Applied Bio Materials 2025; 8(4): 2916 doi: 10.1021/acsabm.4c01735
|
| 505 |
Ahmed M. Alaa, Deepti Gurdasani, Adrian L. Harris, Jem Rashbass, Mihaela van der Schaar. Machine learning to guide the use of adjuvant therapies for breast cancer. Nature Machine Intelligence 2021; 3(8): 716 doi: 10.1038/s42256-021-00353-8
|
| 506 |
Giuliana De Gregoriis, Juliene Antonio Ramos, Priscila Valverde Fernandes, Giselle Maria Vignal, Rafael Canfield Brianese, Dirce Maria Carraro, Alvaro N. Monteiro, Claudio José Struchiner, Guilherme Suarez-Kurtz, Rosane Vianna-Jorge, Marcelo Alex de Carvalho. DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis. Cancer Biology & Therapy 2017; 18(6): 439 doi: 10.1080/15384047.2017.1323590
|
| 507 |
Hejer Aliyeva, Mahira Amirova, Huseyn Abıyev, Khaleddin Musayev, Javanshir Rahimov. Operational Mechanisms as a Reliable Tool for the Challenging Task of Differentiating Neoplasms
. Applied and Computational Mathematics 2025; 14(3): 101 doi: 10.11648/j.acm.20251403.11
|
| 508 |
Yu-Wei Chang, Kamaleshwar P. Singh, Aamir Ahmad. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. PLOS ONE 2017; 12(3): e0174227 doi: 10.1371/journal.pone.0174227
|
| 509 |
Nehad M. Ayoub, Salam Sardiah, Qusai Y. Al-Share, Mohammad S. Alkader, Filomena de Nigris. Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset. PLOS ONE 2024; 19(9): e0310557 doi: 10.1371/journal.pone.0310557
|
| 510 |
Amritha Sathyanarayanan, Aparna Natarajan, Oviya Revathi Paramasivam, Prarthana Gopinath, Gopisetty Gopal. Comprehensive analysis of genomic alterations, clinical outcomes, putative functions and potential therapeutic value of MMP11 in human breast cancer. Gene Reports 2020; 21: 100852 doi: 10.1016/j.genrep.2020.100852
|
| 511 |
Ravi Doddapaneni, Jason D. Tucker, Pei J. Lu, Qi L. Lu. Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells. International Journal of Molecular Sciences 2025; 26(6): 2661 doi: 10.3390/ijms26062661
|
| 512 |
Menha Swellam, Magda Sayed Mahmoud, Maha Hashim, Naglaa M Hassan, Mohamed Emam Sobeih, Amira M Nageeb. Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study. Journal of Cellular Biochemistry 2019; 120(6): 8975 doi: 10.1002/jcb.28168
|
| 513 |
Dingming Wu, Dongfang Wang, Michael Q. Zhang, Jin Gu. Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification. BMC Genomics 2015; 16(1) doi: 10.1186/s12864-015-2223-8
|
| 514 |
Junsha An, Cheng Peng, Xiaofang Xie, Fu Peng. New Advances in Targeted Therapy of HER2-Negative Breast Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.828438
|
| 515 |
Sebastien Taurin, Haifa Alkhalifa. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses. Neoplasia 2020; 22(12): 663 doi: 10.1016/j.neo.2020.09.009
|
| 516 |
Li Huang, Jing Ma, Min Cui. Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells. Immunologic Research 2021; 69(6): 558 doi: 10.1007/s12026-021-09237-w
|
| 517 |
Mohamed H.A. Soliman, Nashwa M. Mahmoud, Aml B. Mohamed, Howayda E. Khaled. Synthesis, anticancer evaluation, and molecular docking study of some arylidenehydrazono analogues. Canadian Journal of Chemistry 2023; 101(6): 353 doi: 10.1139/cjc-2022-0276
|
| 518 |
Alexandra N. McMahon, Isildinha M. Reis, Cristiane Takita, Jean L. Wright, Jennifer J. Hu. Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer. Cancers 2025; 17(5): 891 doi: 10.3390/cancers17050891
|
| 519 |
Ana Canadas, Marta Santos, Ricardo Pinto, Rui Medeiros, Patrícia Dias‐Pereira. Catechol‐o‐methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours. Veterinary and Comparative Oncology 2018; 16(4): 664 doi: 10.1111/vco.12438
|
| 520 |
Yi-Hsuan Huang, Sung-How Sue, Zih-Syuan Wu, Shih-Ming Huang, Shih-Yu Lee, Zhi-Fu Wu. Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.811716
|
| 521 |
James A. MacLeod, Yan Gao, Christine Hall, William J. Muller, Taranjit S. Gujral, Peter A. Greer. Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib. Oncotarget 2018; 9(70): 33382 doi: 10.18632/oncotarget.26078
|
| 522 |
Miroslawa Püsküllüoğlu, Małgorzata Pieniążek, Manuela Las-Jankowska, Joanna Streb, Marek Ziobro, Renata Pacholczak-Madej, Paulina Kilian-Van Miegem, Agnieszka Rudzińska, Aleksandra Grela-Wojewoda, Aleksandra Łacko, Michał Jarząb, Anna Polakiewicz-Gilowska. Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study. Oncology and Therapy 2024; 12(4): 787 doi: 10.1007/s40487-024-00307-1
|
| 523 |
Maryam Khalid, Rehan Zafar Paracha, Maryum Nisar, Sumaira Malik, Salma Tariq, Iqra Arshad, Amnah Siddiqa, Zamir Hussain, Jamil Ahmad, Amjad Ali. Long non‐coding RNAs and their targets as potential biomarkers in breast cancer. IET Systems Biology 2021; 15(5): 137 doi: 10.1049/syb2.12020
|
| 524 |
Pia Giovannelli, Marzia Di Donato, Ferdinando Auricchio, Gabriella Castoria, Antimo Migliaccio. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41016-4
|
| 525 |
Sang-Ho Yoon, Jin-Wu Nam. Clustering malignant cell states using universally variable genes. Briefings in Bioinformatics 2023; 25(1) doi: 10.1093/bib/bbad460
|
| 526 |
P. M. Sokolov, A. V. Karaulov, A. V. Sukhanova, I. R. Nabiev. Tumor microenvironment biomarkers in breast cancer. Russian Journal of Biotherapy 2023; 22(1): 19 doi: 10.17650/1726-9784-2023-22-1-19-27
|
| 527 |
Kimberly A. Kraynyak, Angela Bodles-Brakhop, Mark Bagarazzi. Cancer Vaccines. Current Topics in Microbiology and Immunology 2015; 405: 55 doi: 10.1007/82_2015_431
|
| 528 |
Javed Iqbal, Banzeer Ahsan Abbasi, Riaz Ahmad, Tariq Mahmood, Sobia Kanwal, Barkat Ali, Ali Talha Khalil, Sayed Afzal Shah, Muhammad Maqsood Alam, Hussain Badshah. Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications. Biomedicine & Pharmacotherapy 2018; 108: 752 doi: 10.1016/j.biopha.2018.09.096
|
| 529 |
Ifeanyichukwu O. Nwosu, Stephen R. Piccolo. A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in breast cancer. Cancer Biology & Therapy 2021; 22(7-9): 417 doi: 10.1080/15384047.2021.1953902
|
| 530 |
David Clement, Emmanuel Agu, Muhammad A. Suleiman, John Obayemi, Steve Adeshina, Wole Soboyejo. Multi-Class Breast Cancer Histopathological Image Classification Using Multi-Scale Pooled Image Feature Representation (MPIFR) and One-Versus-One Support Vector Machines. Applied Sciences 2022; 13(1): 156 doi: 10.3390/app13010156
|
| 531 |
Erandi A. Serrano-Carbajal, Jesús Espinal-Enríquez, Enrique Hernández-Lemus. Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00097
|
| 532 |
Juana Moro, Agustina Grinpelc, Paula Lucía Farré, Rocío Belén Duca, Ezequiel Lacunza, Karen Daniela Graña, Georgina Daniela Scalise, Guillermo Nicolás Dalton, Cintia Massillo, Flavia Piccioni, Federico Dimase, Emilio Batagelj, Adriana De Siervi, Paola De Luca. miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome. International Journal of Molecular Sciences 2023; 24(23): 16758 doi: 10.3390/ijms242316758
|
| 533 |
Sigurd A Saastad, Anette H Skjervold, Borgny Ytterhus, Monica Jernberg Engstrøm, Anna M Bofin. PD-L1 protein expression in breast cancer. Journal of Clinical Pathology 2024; 77(11): 730 doi: 10.1136/jcp-2023-208942
|
| 534 |
Yingnan Wu, Zhenzhen Wang, Shan Yu, Dongzhe Liu, Litao Sun. LncmiRHG-MIR100HG: A new budding star in cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.997532
|
| 535 |
Yinji Cui, Meiying Song, Su Young Kim. Prognostic significance of fatty acid binding protein‐4 in the invasive ductal carcinoma of the breast. Pathology International 2019; 69(2): 68 doi: 10.1111/pin.12756
|
| 536 |
Suchi Chaturvedi, Mainak Biswas, Sushabhan Sadhukhan, Avinash Sonawane. Role of EGFR and FASN in breast cancer progression. Journal of Cell Communication and Signaling 2023; 17(4): 1249 doi: 10.1007/s12079-023-00771-w
|
| 537 |
Chiara Focaccetti, Daniela Nardozi, Monica Benvenuto, Valeria Lucarini, Valentina Angiolini, Raffaele Carrano, Manuel Scimeca, Francesca Servadei, Alessandro Mauriello, Patrizia Mancini, Zein Mersini Besharat, Michele Milella, Silvia Migliaccio, Elisabetta Ferretti, Loredana Cifaldi, Laura Masuelli, Camilla Palumbo, Roberto Bei. Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice. International Journal of Molecular Sciences 2024; 25(11): 6259 doi: 10.3390/ijms25116259
|
| 538 |
Carolina Mathias, Clarice S. Groeneveld, Sheyla Trefflich, Erika P. Zambalde, Rubens S. Lima, Cícero A. Urban, Karin B. Prado, Enilze M. S. F. Ribeiro, Mauro A. A. Castro, Daniela F. Gradia, Jaqueline C. de Oliveira. Novel lncRNAs Co-Expression Networks Identifies LINC00504 with Oncogenic Role in Luminal A Breast Cancer Cells. International Journal of Molecular Sciences 2021; 22(5): 2420 doi: 10.3390/ijms22052420
|
| 539 |
Tala M. Abu Samaan, Marek Samec, Alena Liskova, Peter Kubatka, Dietrich Büsselberg. Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 2019; 9(12): 789 doi: 10.3390/biom9120789
|
| 540 |
Yan Gu, Taosha Li, Anil Kapoor, Pierre Major, Damu Tang. Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis. Genes 2020; 11(8): 874 doi: 10.3390/genes11080874
|
| 541 |
Esra Küpeli Akkol, Yasin Genç, Büşra Karpuz, Eduardo Sobarzo-Sánchez, Raffaele Capasso. Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. Cancers 2020; 12(7): 1959 doi: 10.3390/cancers12071959
|
| 542 |
Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke, Michelino de Laurentiis, Eva Schumacher-Wulf, Daniel Eiger, Sarah Heeson, Andrés Cardona, Özgür Özyilkan, Flavia Morales-Vàsquez, Ciara Metcalfe, Marc Hafner, Eleonora Restuccia, Joyce O’Shaughnessy. heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12179-9
|
| 543 |
Nikita Janakarajan, Mara Graziani, María Rodríguez Martínez, Marieke Kuijjer. Phenotype driven data augmentation methods for transcriptomic data. Bioinformatics Advances 2024; 5(1) doi: 10.1093/bioadv/vbaf124
|
| 544 |
Matteo Brindisi, Manuela Curcio, Luca Frattaruolo, Giuseppe Cirillo, Antonella Leggio, Vittoria Rago, Fiore Pasquale Nicoletta, Anna Rita Cappello, Francesca Iemma. CD44-targeted nanoparticles with GSH-responsive activity as powerful therapeutic agents against breast cancer. International Journal of Biological Macromolecules 2022; 221: 1491 doi: 10.1016/j.ijbiomac.2022.09.157
|
| 545 |
Alba Di Leone, Antonio Franco, Virginia Castagnetta, Marta Silenzi, Cristina Accetta, Beatrice Carnassale, Sabatino D’Archi, Flavia De Lauretis, Enrico Di Guglielmo, Federica Gagliardi, Stefano Magno, Francesca Moschella, Maria Natale, Alejandro Martin Sanchez, Lorenzo Scardina, Riccardo Masetti, Gianluca Franceschini. Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer. Cancers 2025; 17(10): 1619 doi: 10.3390/cancers17101619
|
| 546 |
Esmanur Eren, Jyotirmoyee Das, Trygve O. Tollefsbol. Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer. Nutrients 2024; 16(23): 4143 doi: 10.3390/nu16234143
|
| 547 |
Dayan A. Carrion-Estrada, Paola Briseño-Diaz, Sandra Delfín-Azuara, Arturo Aguilar-Rojas, Miguel Vargas. Technologies in Cell Culture - A Journey From Basics to Advanced Applications. Biochemistry 2024; 54 doi: 10.5772/intechopen.113019
|
| 548 |
Carolina Cortes-Urrea, Fernando Bueno-Gutiérrez, Melissa Solarte, Miguel Guevara-Burbano, Fabian Tobar-Tosse, Patricia E. Vélez-Varela, Juan Carlos Bonilla, Guillermo Barreto, Jaime Velasco-Medina, Pedro A. Moreno, Javier De Las Rivas. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations. Biomolecules 2020; 10(5): 698 doi: 10.3390/biom10050698
|
| 549 |
Valeria Romeo, Renato Cuocolo, Luca Sanduzzi, Vincenzo Carpentiero, Martina Caruso, Beatrice Lama, Dimitri Garifalos, Arnaldo Stanzione, Simone Maurea, Arturo Brunetti. MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer. Cancers 2023; 15(6): 1840 doi: 10.3390/cancers15061840
|
| 550 |
Thi Mong Quynh Pham, Thanh Hai Phan, Thanh Xuan Jasmine, Thuy Thi Thu Tran, Le Anh Khoa Huynh, Thi Loan Vo, Thi Huong Thoang Nai, Thuy Trang Tran, My Hoang Truong, Ngan Chau Tran, Van Thien Chi Nguyen, Trong Hieu Nguyen, Thi Hue Hanh Nguyen, Nguyen Duy Khang Le, Thanh Dat Nguyen, Duy Sinh Nguyen, Dinh Kiet Truong, Thi Thanh Thuy Do, Minh-Duy Phan, Hoa Giang, Hoai-Nghia Nguyen, Le Son Tran. Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1127086
|
| 551 |
Constantinos Demetriou, Naila Abid, Michael Butterworth, Larissa Lezina, Pavandeep Sandhu, Lynne Howells, Ian R. Powley, James H. Pringle, Zahirah Sidat, Omar Qassid, Dave Purnell, Monika Kaushik, Kaitlin Duckworth, Helen Hartshorn, Anne Thomas, Jacqui A. Shaw, Marion MacFarlane, Catrin Pritchard, Gareth J. Miles. An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-63170-0
|
| 552 |
Mariana Gallo, Elena Ferrari, Federica Brugnoli, Anna Terrazzan, Pietro Ancona, Stefano Volinia, Valeria Bertagnolo, Carlo M. Bergamini, Alberto Spisni, Thelma A. Pertinhez, Nicoletta Bianchi. Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites. International Journal of Molecular Sciences 2025; 26(3): 969 doi: 10.3390/ijms26030969
|
| 553 |
Ahmet Ozveren, Melis Ridvanogullari Donger, Sedat Motor, Gulcan Bulut. The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer. Integrative Cancer Therapies 2023; 22 doi: 10.1177/15347354231165938
|
| 554 |
María José Bravo, Antonio Manuel Burgos-Molina, Marilina García-Aranda, Maximino Redondo, Teresa Téllez. Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy. Cancers 2023; 15(23): 5499 doi: 10.3390/cancers15235499
|
| 555 |
Paola Tapia-Uriol, Lorena Becerra-Goicochea, Víctor Campos-Valderrama, Juana del Valle-Mendoza, Miguel Angel Aguilar-Luis, Wilmer Gianfranco Silva-Caso. Characterization of intrinsic subtypes of breast cancer and their relationship with staging: an observational study. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1553910
|
| 556 |
Hong Liu, Wen-Dong Xu, Zi-Hao Shang, Xiang-Dong Wang, Hai-Yan Zhou, Ke-Wen Ma, Huan Zhou, Jia-Lin Qi, Jia-Rui Jiang, Li-Lan Tan, Hui-Min Zeng, Hui-Juan Cai, Kuan-Song Wang, Yue-Liang Qian. Breast Cancer Molecular Subtype Prediction on Pathological Images with Discriminative Patch Selection and Multi-Instance Learning. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858453
|
| 557 |
Ilda Rodrigues, Rute Fernandes, Ana Ferreira, Deolinda Pereira, Rúben Fernandes, Raquel Soares, Carla Luís. Is Progesterone Receptor a Neglected Feature in Breast Cancer? A Retrospective Study Analysing the Clinicopathological Characteristics of Breast Cancer Based on Progesterone Receptor Status. Clinical Breast Cancer 2025; 25(4): e331 doi: 10.1016/j.clbc.2024.11.018
|
| 558 |
Shunchao Yan, Xin Jiao, Huawei Zou, Kai Li. Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0296-y
|
| 559 |
Priscilla Dinkar Moyya, Mythili Asaithambi, Anandh Kilpattu Ramaniharan. Progesterone Receptor Status Analysis in Breast Cancer Patients using DCE- MR Images and Gabor Derived Anisotropy Index. 2022 IEEE International Symposium on Medical Measurements and Applications (MeMeA) 2022; : 1 doi: 10.1109/MeMeA54994.2022.9856476
|
| 560 |
Arya Rajesh, Evan Easley, Chikezie O. Madu, Yi Lu. Latest Research on Breast Cancer - Molecular Insights, Diagnostic Advances and Therapeutic Innovations. Oncology 2024; 4 doi: 10.5772/intechopen.1008202
|
| 561 |
Erdem Çiçek, İpek Munar, Sesil Agopcan Çınar, Sinan Başçeken, Gerald Monard, Viktorya Aviyente, Fethiye Aylin Sungur. Computational insights into substrate-assisted citrullination mechanisms of PAD2 isozyme: A comparative analysis of reaction pathways. Journal of Molecular Graphics and Modelling 2025; 140: 109107 doi: 10.1016/j.jmgm.2025.109107
|
| 562 |
Manzoor Ahmad Mir, Hina Qayoom. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. 2023; : 1 doi: 10.1007/978-981-19-8911-7_1
|
| 563 |
Luca Boscolo Bielo, Dario Trapani, Eleonora Nicolò, Carmine Valenza, Lorenzo Guidi, Carmen Belli, Elias Kotteas, Antonio Marra, Aleix Prat, Nicola Fusco, Carmen Criscitiello, Harold J. Burstein, Giuseppe Curigliano. The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer. Cancer Treatment Reviews 2024; 128: 102761 doi: 10.1016/j.ctrv.2024.102761
|
| 564 |
Anthony Caputo, Kavya Vipparthi, Peter Bazeley, Erinn Downs-Kelly, Patrick McIntire, Lauren A. Duckworth, Ying Ni, Bo Hu, Ruth A. Keri, Mihriban Karaayvaz. Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1/2 Mutation Carriers. Molecular Cancer Research 2024; 22(2): 169 doi: 10.1158/1541-7786.MCR-23-0489
|
| 565 |
Ram Mohan Ram Kumar, Suresh Joghee. Enhancing breast cancer treatment through pharmacogenomics: A narrative review. Clinica Chimica Acta 2024; 562: 119893 doi: 10.1016/j.cca.2024.119893
|
| 566 |
Elizabeth McDonough, Margarida Barroso, Fiona Ginty, David T Corr. Modeling intratumor heterogeneity in breast cancer. Biofabrication 2025; 17(1): 012009 doi: 10.1088/1758-5090/ad9b50
|
| 567 |
James R. Castle, Nan Lin, Jinpeng Liu, Anna Maria V. Storniolo, Aditi Shendre, Lifang Hou, Steve Horvath, Yunlong Liu, Chi Wang, Chunyan He. Estimating breast tissue-specific DNA methylation age using next-generation sequencing data. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00834-4
|
| 568 |
Nandini Verma. Transcription and Translation in Health and Disease. 2023; : 49 doi: 10.1016/B978-0-323-99521-4.00006-4
|
| 569 |
Eva Lorsy, Aylin Sophie Topuz, Cordelia Geisler, Sarah Stahl, Stefan Garczyk, Saskia von Stillfried, Mareike Hoss, Oleg Gluz, Arndt Hartmann, Ruth Knüchel, Edgar Dahl, Irina U Agoulnik. Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer. PLOS ONE 2016; 11(7): e0160077 doi: 10.1371/journal.pone.0160077
|
| 570 |
Jeeyeon Lee, Eun Hye Lee, Ho Yong Park, Wan Wook Kim, Ryu Kyung Lee, Yee Soo Chae, Soo Jung Lee, Jee-Eun Kim, Byeong-il Kang, Jee Young Park, Ji-Young Park, Jin Hyang Jung. Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5608-2
|
| 571 |
R. M. Parks, L. H. Alfarsi, A. R. Green, K. L. Cheung. Biology of primary breast cancer in older women beyond routine biomarkers. Breast Cancer 2021; 28(5): 991 doi: 10.1007/s12282-021-01266-5
|
| 572 |
Hong-Fei Gao, Ci-Qiu Yang, Min-Yi Cheng, Teng Zhu, Mei Yang, Liu-Lu Zhang, Kun Wang. Prognostic Significance of Mesenchymal–Epithelial Transition in Triple-Negative Breast Cancers. Clinical Breast Cancer 2018; 18(5): e961 doi: 10.1016/j.clbc.2018.04.021
|
| 573 |
Christopher Butler, Samuel Sprowls, Gabor Szalai, Tasneem Arsiwala, Pushkar Saralkar, Benjamin Straight, Shea Hatcher, Evan Tyree, Michael Yost, William J. Kohler, Benjamin Wolff, Emily Putnam, Paul Lockman, Tuoen Liu. Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene. Translational Oncology 2020; 13(6): 100775 doi: 10.1016/j.tranon.2020.100775
|
| 574 |
Mehmet Emrah Yaman, Haci Mehmet Kayili, Mevlut Albayrak, Yucel Kadioglu, Bekir Salih. Differential N-glycosylation profiling of formalin-fixed paraffin-embedded (FFPE) invasive ductal carcinoma tissues using MALDI-TOF-MS. Molecular Omics 2021; 17(3): 394 doi: 10.1039/D0MO00150C
|
| 575 |
Alejandro Rios-Hoyo, Naing-Lin Shan, Philipp L. Karn, Lajos Pusztai. A Guide to Breast Cancer Research. Advances in Experimental Medicine and Biology 2025; 1464: 435 doi: 10.1007/978-3-031-70875-6_21
|
| 576 |
Ivan Budimir, Čedna Tomasović-Lončarić, Kristina Kralik, Josipa Čonkaš, Domagoj Eljuga, Rado Žic, Božo Gorjanc, Hrvoje Tucaković, Doroteja Caktaš, Josip Jaman, Valentino Lisek, Zlatko Vlajčić, Krešimir Martić, Petar Ozretić. Higher Expressions of SHH and AR Are Associated with a Positive Receptor Status and Have Impact on Survival in a Cohort of Croatian Breast Cancer Patients. Life 2022; 12(10): 1559 doi: 10.3390/life12101559
|
| 577 |
Mahdi Sadeghi, Soheila Kashanian, Seyed Morteza Naghib, Fateme Haghiralsadat, Davood Tofighi. An Efficient Electrochemical Biosensor Based on Pencil Graphite Electrode Mediated by 2D Functionalized Graphene Oxide to Detect HER2 Breast Cancer Biomarker. International Journal of Electrochemical Science 2022; 17(4): 220459 doi: 10.20964/2022.04.62
|
| 578 |
Amanda Crosbie, Trong Kim Le, Ying Zhang, Rolee Das, Felipe Ades, Catherine Davis, Anagha Gogate. Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancers. Future Oncology 2023; 19(3): 229 doi: 10.2217/fon-2022-0801
|
| 579 |
Blessing Atim Aderibigbe, Tobeka Naki, Vanessa Steenkamp, Mutshinyalo Nwamadi, Suprakas Sinha Ray, Mohammed Olusegun Balogun, William Morwa Reagile Matshe. Physicochemical andin vitrocytotoxicity evaluation of polymeric drugs for combination cancer therapy. International Journal of Polymeric Materials and Polymeric Biomaterials 2020; 69(17): 1134 doi: 10.1080/00914037.2019.1667802
|
| 580 |
Sedighe Forouhari, Zahra Beygi, Zahra Mansoori, Sara Hajsharifi, Fatemeh Heshmatnia, Seyed Mohammad Gheibihayat. Liposomes: Ideal drug delivery systems in breast cancer. Biotechnology and Applied Biochemistry 2022; 69(5): 1867 doi: 10.1002/bab.2253
|
| 581 |
Xiaomei Li, Buu Truong, Taosheng Xu, Lin Liu, Jiuyong Li, Thuc D. Le. Uncovering the roles of microRNAs/lncRNAs in characterising breast cancer subtypes and prognosis. BMC Bioinformatics 2021; 22(1) doi: 10.1186/s12859-021-04215-3
|
| 582 |
Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Genes 2021; 12(8): 1206 doi: 10.3390/genes12081206
|
| 583 |
Shuying Sun, Jael Dammann, Pierce Lai, Christine Tian. Thorough statistical analyses of breast cancer co-methylation patterns. BMC Genomic Data 2022; 23(1) doi: 10.1186/s12863-022-01046-w
|
| 584 |
Shuang Qiu, Guobing Chen, Juan Peng, Jia Liu, Jumin Chen, Jianjun Wang, Li Li, Kunxian Yang. LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway. FEBS Open Bio 2020; 10(5): 817 doi: 10.1002/2211-5463.12833
|
| 585 |
Ilana Schlam, Ruth Moges, Stefania Morganti, Sara M. Tolaney, Paolo Tarantino. Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2. Critical Reviews in Oncology/Hematology 2023; 190: 104090 doi: 10.1016/j.critrevonc.2023.104090
|
| 586 |
Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk, Rolando Garcia-Milian, Denise M. Wolf, Laura A. Huppert, Rita Nanda, Gillian L. Hirst, Erin F. Cobain, Laura J. van ’t Veer, Laura J. Esserman, Lajos Pusztai. Hormone Receptor–Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers. Clinical Cancer Research 2025; 31(2): 403 doi: 10.1158/1078-0432.CCR-24-1553
|
| 587 |
Manal A. Abbas, Aya Y. Al-Kabariti, Chris Sutton. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 2024; 241: 106523 doi: 10.1016/j.jsbmb.2024.106523
|
| 588 |
Logenthiran Machap, Kohbalan Moorthy. Survival analysis for the identified cancer gene subtype from the co-clustering algorithm. 2022 International Conference on Electrical, Computer and Energy Technologies (ICECET) 2022; : 1 doi: 10.1109/ICECET55527.2022.9872811
|
| 589 |
Silvia Cascianelli, Iva Milojkovic, Marco Masseroli. A novel machine learning-based workflow to capture intra-patient heterogeneity through transcriptional multi-label characterization and clinically relevant classification. Journal of Biomedical Informatics 2025; 166: 104817 doi: 10.1016/j.jbi.2025.104817
|
| 590 |
Anna Höller, Bich Doan Nguyen-Sträuli, Heike Frauchiger-Heuer, Alexander Ring. “Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”. Breast Cancer: Targets and Therapy 2023; : 525 doi: 10.2147/BCTT.S340741
|
| 591 |
Cynthia Ong, Christian M. Blue, Jamal Khan, Xiaoyan Deng, Dipankar Bandyopadhyay, Raphael J. Louie, Kandace P. McGuire. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?. Annals of Surgical Oncology 2023; doi: 10.1245/s10434-023-14407-1
|
| 592 |
Lin Yang, Shuangling Wu, Chunhui Ma, Shuhui Song, Feng Jin, Yamei Niu, Wei-Min Tong. RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.611191
|
| 593 |
Susmita Palmal, Nikhilanand Arya, Sriparna Saha, Somanath Tripathy. Neural Information Processing. Communications in Computer and Information Science 2023; 1794: 187 doi: 10.1007/978-981-99-1648-1_16
|
| 594 |
Yasemin Çetin-Kaya. Equilibrium Optimization-Based Ensemble CNN Framework for Breast Cancer Multiclass Classification Using Histopathological Image. Diagnostics 2024; 14(19): 2253 doi: 10.3390/diagnostics14192253
|
| 595 |
Bharti Mangla, Priya Mittal, Pankaj Kumar, Geeta Aggarwal. Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials. Medical Oncology 2024; 41(7) doi: 10.1007/s12032-024-02414-5
|
| 596 |
Wen‐Jing Liu, Gang Zhao, Chen‐Yan Zhang, Chang‐Qing Yang, Xiang‐Bin Zeng, Jin Li, Kun Zhu, Shi‐Qi Zhao, Hui‐Meng Lu, Da‐Chuan Yin, Sheng‐Xiang Lin. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer. Journal of Cellular Biochemistry 2020; 121(4): 2756 doi: 10.1002/jcb.29515
|
| 597 |
Suyeon Ahn, Ahreum Kwon, Yun Hyun Huh, Sangmyung Rhee, Woo Keun Song. Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer. Oncogenesis 2022; 11(1) doi: 10.1038/s41389-022-00422-6
|
| 598 |
Laura Lopez-Gonzalez, Alicia Sanchez Cendra, Cristina Sanchez Cendra, Eduardo David Roberts Cervantes, Javier Cassinello Espinosa, Tatiana Pekarek, Oscar Fraile-Martinez, Cielo García-Montero, Ana María Rodriguez-Slocker, Laura Jiménez-Álvarez, Luis G. Guijarro, Soledad Aguado-Henche, Jorge Monserrat, Melchor Alvarez-Mon, Leonel Pekarek, Miguel A. Ortega, Raul Diaz-Pedrero. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. Medicina 2024; 60(1): 168 doi: 10.3390/medicina60010168
|
| 599 |
А. Ю. Шаманова , Е. Л. Казачков , Л. В. Ярина , В. М. Власова . Метапластическая карцинома молочной железы. Подходы к морфологической диагностике. Обзор литературы. Oncopathology 2024; 7(2) doi: 10.17650/2618-7019-2024-7-2-10-17
|
| 600 |
Prathibha Sivaprakasam, Sureshkumar Anandasadagopan, Tamilselvi Alagumuthu, Ashok Kumar Pandurangan. Research Anthology on Advancements in Women's Health and Reproductive Rights. 2022; : 318 doi: 10.4018/978-1-6684-6299-7.ch017
|
| 601 |
Monica Fedele, Laura Cerchia, Sabrina Battista. Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression. Cells 2024; 13(4): 350 doi: 10.3390/cells13040350
|
| 602 |
Vladimir Vidović, Ivana Davidov, Zoran Ružić, Mihajlo Erdeljan, Annamaria Galfi Vukomanović, Bojana Blagojević. Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors. Molecules 2025; 30(7): 1411 doi: 10.3390/molecules30071411
|
| 603 |
Masoud Hassanzadeh Makoui, Maryam Mobini, Shiva Fekri, Lobat Geranpayeh, Hedieh Moradi Tabriz, Zahra Madjd, Elham Kalantari, Maryam Hosseini, Mostafa Hosseini, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani, Mohammad Mehdi Amiri, Fazel Shokri. Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer. Clinical Breast Cancer 2024; 24(1): e9 doi: 10.1016/j.clbc.2023.09.013
|
| 604 |
Yalan Dai, Xinyi Zhang, Yingjun Ou, Linglin Zou, Duoli Zhang, Qingfan Yang, Yi Qin, Xiuju Du, Wei Li, Zhanpeng Yuan, Zhangang Xiao, Qinglian Wen. Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01183-4
|
| 605 |
Diane Ojo, Maryam Seliman, Damu Tang. Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer. BBA Clinical 2017; 8: 56 doi: 10.1016/j.bbacli.2017.07.004
|
| 606 |
Simone U. Dalm, John W.M. Martens, Anieta M. Sieuwerts, Carolien H.M. van Deurzen, Stuart J. Koelewijn, Erik de Blois, Theodosia Maina, Berthold A. Nock, Luc Brunel, Jean-Alain Fehrentz, Jean Martinez, Marion de Jong, Marleen Melis. In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer. Journal of Nuclear Medicine 2015; 56(5): 752 doi: 10.2967/jnumed.114.153023
|
| 607 |
Gowri Manohari Balachander, Rajesh Kotcherlakota, Biswadeep Nayak, Dhaval Kedaria, Annapoorni Rangarajan, Kaushik Chatterjee. 3D Tumor Models for Breast Cancer: Whither We Are and What We Need. ACS Biomaterials Science & Engineering 2021; 7(8): 3470 doi: 10.1021/acsbiomaterials.1c00230
|
| 608 |
Akshada Gajbhiye, Raju Dabhi, Khushman Taunk, Mashanipalya G. Jagadeeshaprasad, Sourav RoyChoudhury, Anupama Mane, Santhakumari Bayatigeri, Koel Chaudhury, Manas K. Santra, Srikanth Rapole. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes. Journal of Proteomics 2017; 163: 1 doi: 10.1016/j.jprot.2017.05.007
|
| 609 |
Alexander M. Scherbakov, Yury V. Kuznetsov, Margarita A. Yastrebova, Alvina I. Khamidullina, Danila V. Sorokin, Maria O. Tserfas, Inna S. Levina. Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα. Brazilian Journal of Pharmaceutical Sciences 2023; 59 doi: 10.1590/s2175-97902023e22540
|
| 610 |
Pei-Feng Liu, Chih-Wen Shu, Hsiu-Chen Yang, Cheng-Hsin Lee, Huei-Han Liou, Luo-Ping Ger, Yen-Dun Tony Tzeng, Wen-Ching Wang. Combined Evaluation of MAP1LC3B and SQSTM1 for Biological and Clinical Significance in Ductal Carcinoma of Breast Cancer. Biomedicines 2021; 9(11): 1514 doi: 10.3390/biomedicines9111514
|
| 611 |
Zhengyu Lu, Yangzhi Cao, Dan Zhang, Xin Meng, Bin Guo, Deyu Kong, Yushe Yang. Discovery of Thieno[2,3-e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability. Journal of Medicinal Chemistry 2022; 65(7): 5724 doi: 10.1021/acs.jmedchem.2c00008
|
| 612 |
Jahnvi Hora, Nishita Rambhia, Indra Mani. Clinical Application of Repurposed Drugs. Progress in Molecular Biology and Translational Science 2024; 207: 107 doi: 10.1016/bs.pmbts.2024.02.007
|
| 613 |
Anindita Das, Megan M. Barry, Cheyenne A. Ernst, Renuka Dahiya, Minhyung Kim, Spencer R. Rosario, Hin Ching Lo, Cuijuan Yu, Tao Dai, Zbigniew Gugala, Jianmin Zhang, Subhamoy Dasgupta, Hai Wang. Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER− breast cancer. Communications Biology 2024; 7(1) doi: 10.1038/s42003-024-07247-6
|
| 614 |
Anna Wawruszak, Jarogniew Luszczki, Arkadiusz Czerwonka, Estera Okon, Andrzej Stepulak. Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells. Cells 2022; 11(7): 1211 doi: 10.3390/cells11071211
|
| 615 |
Yazan R. Alhamdan, Nehad M. Ayoub, Sara K. Jaradat, Aymen Shatnawi, Rami J. Yaghan, Sourav Panja. BRAF Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer. International Journal of Breast Cancer 2024; 2024: 1 doi: 10.1155/2024/6373900
|
| 616 |
Aarthy Raghu, Meenakumari Balaiah, Sridevi Veluswami, Shirley Sundersingh, Rajkumar Thangarajan, Samson Mani. Identification of novel somatic cell-free DNA variants by next-generation sequencing in breast cancer patients. International Journal of Molecular and Immuno Oncology 2021; 6: 16 doi: 10.25259/IJMIO_25_2020
|
| 617 |
Joung Min Choi, Heejoon Chae. moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05273-5
|
| 618 |
Yumna Khan, Najeeb Ullah Khan, Ijaz Ali, Samiullah Khan, Aakif Ullah Khan, Aqib Iqbal, Brian D. Adams. Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan. Molecular Biology Reports 2023; 50(7): 6087 doi: 10.1007/s11033-023-08463-9
|
| 619 |
Khushman Taunk, Ravindra Taware, Tushar H. More, Priscilla Porto-Figueira, Jorge A. M. Pereira, Rajkishore Mohapatra, Dharmesh Soneji, José S. Câmara, H. A. Nagarajaram, Srikanth Rapole. A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast. RSC Advances 2018; 8(44): 25040 doi: 10.1039/C8RA02083C
|
| 620 |
Guim Aguadé‐Gorgorió, José Costa, Ricard Solé. An oncospace for human cancers. BioEssays 2023; 45(5) doi: 10.1002/bies.202200215
|
| 621 |
Khoa A. Tran, Olga Kondrashova, Andrew Bradley, Elizabeth D. Williams, John V. Pearson, Nicola Waddell. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Medicine 2021; 13(1) doi: 10.1186/s13073-021-00968-x
|
| 622 |
Jin Zhang, Qiqi Xie, Xingfa Huo, Zhilin Liu, Mengting Da, Mingxue Yuan, Yi Zhao, Guoshuang Shen. Impact of intestinal dysbiosis on breast cancer metastasis and progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1037831
|
| 623 |
Hee Jeong Kim, Hak Hee Kim, Woo Jung Choi, Eun Young Chae, Hee Jung Shin, Joo Hee Cha. Correlation of shear-wave elastography parameters with the molecular subtype and axillary lymph node status in breast cancer. Clinical Imaging 2023; 101: 190 doi: 10.1016/j.clinimag.2023.06.006
|
| 624 |
Francesca Ligorio, Leonardo Provenzano, Claudio Vernieri. Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer. Current Opinion in Oncology 2023; 35(6): 491 doi: 10.1097/CCO.0000000000000986
|
| 625 |
Jia Li, Jingchun Yao, Liqiang Qi. Identification of TUBB2A as a Cancer-Immunity Cycle-Related Therapeutic Target in Triple-Negative Breast Cancer. Molecular Biotechnology 2024; 66(9): 2467 doi: 10.1007/s12033-023-00880-2
|
| 626 |
Jyoti Chandra, Nagashekhara Molugulu, Garima Gupta, Ayesha Siddiqua, Shadma Wahab, Prashant Kesharwani. Biomimetic nanoparticles: A revolutionary approach to breast cancer therapy using cell membrane coatings. Journal of Drug Delivery Science and Technology 2025; 107: 106849 doi: 10.1016/j.jddst.2025.106849
|
| 627 |
Mahtab Vasigh, Mohammadreza Karoobi, Austin D. Williams, Fasika Molla Abreha, Richard J. Bleicher, Seyed Mostafa Meshkati Yazd, Tahereh Shamsi, Ramesh Omranipour, Ahmad Elahi, David Farhat, Mehran Habibi, Pranshu Sahgal. Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis. The Breast Journal 2024; 2024(1) doi: 10.1155/2024/8866756
|
| 628 |
Toshihiko Takeiwa, Kazuhiro Ikeda, Yuichi Mitobe, Kuniko Horie-Inoue, Satoshi Inoue. Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer. Cancers 2020; 12(6): 1424 doi: 10.3390/cancers12061424
|
| 629 |
Jiaqiang Zhang, Chia-Lun Chang, Chang-Yun Lu, Ho-Min Chen, Szu-Yuan Wu. Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.708632
|
| 630 |
Madhumita Roy, Jaydip Biswas, Amitava Datta. Genetics and Epigenetics of Breast Cancer. 2023; : 1 doi: 10.1007/978-981-19-9925-3_1
|
| 631 |
Xingcong Ma, Xiaoyao Zhao, Wanjun Yan, Jun Yang, Xixi Zhao, Hong Zhang, Yuxin Hui, Shuqun Zhang. Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer. Cancer Biomarkers 2018; 21(3): 639 doi: 10.3233/CBM-170708
|
| 632 |
Agnieszka Barańska, Joanna Dolar-Szczasny, Wiesław Kanadys, Wiktoria Kinik, Dorota Ceglarska, Urszula Religioni, Robert Rejdak. Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies. Cancers 2022; 14(3): 574 doi: 10.3390/cancers14030574
|
| 633 |
Ranjit Nimbalkar, Akshay M. Baheti, Anil T. Pawar, Amol A. Tagalpallewar, Manasi R. Nimbalkar. Eleven years of disease free survival in a case of Invasive Ductal Carcinoma (IDC) Rt Breast grade 3, stage 3, treated with add on Ayurveda treatment: A case report. Journal of Ayurveda and Integrative Medicine 2024; 15(1): 100881 doi: 10.1016/j.jaim.2023.100881
|
| 634 |
Helen M. Palethorpe, Eric Smith, Yoko Tomita, Maryam Nakhjavani, Andrea J. Yool, Timothy J. Price, Joanne P. Young, Amanda R. Townsend, Jennifer E. Hardingham. Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines. Molecules 2019; 24(19): 3539 doi: 10.3390/molecules24193539
|
| 635 |
Riyo Morimoto-Kamata, Naoki Ohkura. Paclitaxel and Vinblastine Increase Plasminogen Activator Inhibitor-1 Production in Human Breast Cancer MCF-7 Cells but Not MDA-MB-231 Cells. Biological and Pharmaceutical Bulletin 2024; 47(9): 1494 doi: 10.1248/bpb.b24-00291
|
| 636 |
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, Marina Della Giulia, Fiorentino Izzo, Giuseppe Sanguineti, Paolo Marchetti, Marco Mazzotta, Raffaele Giusti, Andrea Botticelli, Teresa Gamucci, Clara Natoli, Antonino Grassadonia, Nicola Tinari, Laura Iezzi, Silverio Tomao, Federica Tomao, Giuseppe Tonini, Daniele Santini, Antonio Astone, Andrea Michelotti, Claudia De Angelis, Lucia Mentuccia, Angela Vaccaro, Emanuela Magnolfi, Alain Gelibter, Valentina Magri, Enrico Cortesi, Loretta D'Onofrio, Alessandra Cassano, Ernesto Rossi, Marina Cazzaniga, Luca Moscetti, Claudia Omarini, Federico Piacentini, Maria A. Fabbri, Angelo F. Scinto, Domenico Corsi, Luisa Carbognin, Emilio Bria, Nicla La Verde, Riccardo Samaritani, Carlo Garufi, Sandro Barni, Rosanna Mirabelli, Roberta Sarmiento, Enzo M. Veltri, Giuliana D'Auria, Ida Paris, Francesco Giotta, Vito Lorusso, Franca Cardillo, Elisabetta Landucci, Maria Mauri, Corrado Ficorella, Mario Roselli, Vincenzo Adamo, Giuseppina R.R. Ricciardi, Antonio Russo, Rossana Berardi, Mirco Pistelli, Elena Fiorio, Katia Cannita, Valentina Sini, Nicola D'Ostilio, Jennifer Foglietta, Filippo Greco, Claudio Zamagni, Ornella Garrone, Barbara Di Cocco, Editta Baldini, Lorenzo Livi, Isacco Desideri, Icro Meattini, Giuseppina Sarobba, Pietro Del Medico, Michele De Tursi, Daniele Generali, Ruggero De Maria, Emanuela Risi, Gennaro Ciliberto, Isabella Sperduti, Alice Villa, Maddalena Barba, Angelo Di Leo, Patrizia Vici. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. International Journal of Cancer 2020; 146(7): 1917 doi: 10.1002/ijc.32583
|
| 637 |
Fernando Ambriz-Barrera, Ernesto Rojas-Jiménez, Clara Estela Díaz-Velásquez, Aldo Hugo De-La-Cruz-Montoya, Héctor Martínez-Gregorio, Miguel Ruiz-De-La-Cruz, Antonio Huertas, Ana Lorena Montealegre, Carlos Castro-Rojas, Gabriela Acosta, Felipe Vaca-Paniagua, Sandra Perdomo, Elingarami Sauli. Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLOS ONE 2024; 19(9): e0308176 doi: 10.1371/journal.pone.0308176
|
| 638 |
Shaivy Malik, Sufian Zaheer. The impact of liquid biopsy in breast cancer: Redefining the landscape of non-invasive precision oncology. The Journal of Liquid Biopsy 2025; 8: 100299 doi: 10.1016/j.jlb.2025.100299
|
| 639 |
Irina V. Kolyadina, Inna P. Ganshina, Svetlana V. Kuzmicheva, Asiiat I. Tekeeva, James D. Kolokolov, Mikhail V. Volkonskii, Irina V. Poddubnaya. Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience. Journal of Modern Oncology 2020; 22(2): 98 doi: 10.26442/18151434.2020.2.200212
|
| 640 |
Evan D. Paul, Barbora Huraiová, Natália Valková, Natalia Matyasovska, Daniela Gábrišová, Soňa Gubová, Helena Ignačáková, Tomáš Ondris, Michal Gala, Liliane Barroso, Silvia Bendíková, Jarmila Bíla, Katarína Buranovská, Diana Drobná, Zuzana Krchňáková, Maryna Kryvokhyzha, Daniel Lovíšek, Viktoriia Mamoilyk, Veronika Mancikova, Nina Vojtaššáková, Michaela Ristová, Iñaki Comino-Méndez, Igor Andrašina, Pavel Morozov, Thomas Tuschl, Fresia Pareja, Jakob N. Kather, Pavol Čekan. The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer. Nature Communications 2025; 16(1) doi: 10.1038/s41467-024-55583-2
|
| 641 |
Dhanya Mary Louis, Lakshmi Malavika Nair, Archana George Vallonthaiel, M. P. Narmadha, D. K. Vijaykumar. Ki 67: a Promising Prognostic Marker in Early Breast Cancer—a Review Article. Indian Journal of Surgical Oncology 2023; 14(1): 122 doi: 10.1007/s13193-022-01631-6
|
| 642 |
Nosheen Akhtar, Uzma Azeem Awan, Rida Fatima Saeed, Asma Saleem Qazi, Sara Mumtaz, Samina Rubnawaz. Breast Cancer: From Bench to Personalized Medicine. 2022; : 337 doi: 10.1007/978-981-19-0197-3_14
|
| 643 |
Karin Potthoff, Oliver Stötzer, Ulrike Söling, Richard Hansen, Johanna Harde, Stephanie Dille, Arnd Nusch, Norbert Marschner. Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO. Clinical Breast Cancer 2020; 20(3): e315 doi: 10.1016/j.clbc.2019.11.003
|
| 644 |
Afsaneh Fendereski, Ebrahim Hajizadeh, Shahpar Haghighat, Aliakbar Rasekhi. Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes. BMC Women's Health 2022; 22(1) doi: 10.1186/s12905-022-01846-3
|
| 645 |
Woogwang Sim, Jungsul Lee, Chulhee Choi. Robust method for identification of prognostic gene signatures from gene expression profiles. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17213-4
|
| 646 |
Amrita Basu, Ganesan Ramamoorthi, Yongsheng Jia, Jon Faughn, Doris Wiener, Sabrina Awshah, Krithika Kodumudi, Brian J. Czerniecki. Immunotherapy of Cancer. Advances in Cancer Research 2019; 143: 295 doi: 10.1016/bs.acr.2019.03.006
|
| 647 |
Jeanne P. Uyisenga, Yvan Butera, Ahmed Debit, Claire Josse, Costas C. Ainhoa, Emile Karinganire, Aimee P. Cyuzuzo, Nicole Umurungi, Yves Kalinijabo, Simeon Uwimana, Leon Mutesa, Vincent Bours. Prevalence of Histological Characteristics of Breast Cancer in Rwanda in Relation to Age and Tumor Stages. Hormones and Cancer 2020; 11(5-6): 240 doi: 10.1007/s12672-020-00393-3
|
| 648 |
R. Bonfiglio, M.L. Di Pietro. The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine. Seminars in Cancer Biology 2021; 72: 11 doi: 10.1016/j.semcancer.2020.10.008
|
| 649 |
Sohiya Yotsukura, Masayuki Karasuyama, Ichigaku Takigawa, Hiroshi Mamitsuka. Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code. Briefings in Bioinformatics 2016; : bbw040 doi: 10.1093/bib/bbw040
|
| 650 |
Shaymaa Azawi, Thomas Liehr, Martina Rincic, Mattia Manferrari. Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka. International Journal of Molecular Sciences 2020; 21(13): 4716 doi: 10.3390/ijms21134716
|
| 651 |
Youngjun Park, Dominik Heider, Anne-Christin Hauschild. Integrative Analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence. Cancers 2021; 13(13): 3148 doi: 10.3390/cancers13133148
|
| 652 |
Yu Jin Lim, Sea-Won Lee, Noorie Choi, Jeanny Kwon, Keun-Yong Eom, Eunyoung Kang, Eun-Kyu Kim, Sung-Won Kim, Jee Hyun Kim, Yu Jung Kim, Se Hyun Kim, So Yeon Park, Jae-Sung Kim, In Ah Kim. Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice. Breast Cancer Research and Treatment 2017; 163(3): 555 doi: 10.1007/s10549-017-4206-8
|
| 653 |
Zhen Zhu, Hongyu Shen, Jialin Xu, Zheng Fang, Guanqun Wo, Ying Ma, Kai Yang, Yalin Wang, Qiang Yu, Jin-hai Tang. GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells. Drug Resistance Updates 2023; 69: 100974 doi: 10.1016/j.drup.2023.100974
|
| 654 |
David Starks, Luis Rojas‐Espaillat, Tobias Meissner, Rachel Elsey, Bing Xu, Maria Koenen, Shelley Feng, Annika VanOosbree, John Slunecka, John Lee, Casey B. Williams. A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers. Cancer Medicine 2023; 12(18): 18654 doi: 10.1002/cam4.6475
|
| 655 |
Mathias Öttl, Jana Steenpass, Frauke Wilm, Jingna Qiu, Matthias Rübner, Corinna Lang-Schwarz, Cecilia Taverna, Francesca Tava, Arndt Hartmann, Hanna Huebner, Matthias W. Beckmann, Peter A. Fasching, Andreas Maier, Ramona Erber, Katharina Breininger. Fully automatic HER2 tissue segmentation for interpretable HER2 scoring. Journal of Pathology Informatics 2025; 17: 100435 doi: 10.1016/j.jpi.2025.100435
|
| 656 |
Arshad Husain Rahmani, Ahmad Almatroudi, Amjad Ali Khan, Ali Yousif Babiker, Malak Alanezi, Khaled S. Allemailem. The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways. Molecules 2022; 27(22): 8023 doi: 10.3390/molecules27228023
|
| 657 |
Zhezhou Yu, Zhuo Wang, Xiangchun Yu, Zhe Zhang, Giosuè Lo Bosco. RNA-Seq-Based Breast Cancer Subtypes Classification Using Machine Learning Approaches. Computational Intelligence and Neuroscience 2020; 2020: 1 doi: 10.1155/2020/4737969
|
| 658 |
Luca Nicosia, Luciano Mariano, Aurora Gaeta, Sara Raimondi, Filippo Pesapane, Giovanni Corso, Paolo De Marco, Daniela Origgi, Claudia Sangalli, Nadia Bianco, Serena Carriero, Sonia Santicchia, Enrico Cassano. Preliminary Evaluation of Radiomics in Contrast-Enhanced Mammography for Prognostic Prediction of Breast Cancer. Cancers 2025; 17(12): 1926 doi: 10.3390/cancers17121926
|
| 659 |
Mahdieh Shokrollahi Barough, Neda Jalili, Soodabe Shafiee, Malihe Salehi, Nazanin Naseri, Mohammad Amin Javidi, Aysooda Hosseinzadeh, Leila Farahmand. Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression. International Immunopharmacology 2023; 124: 110792 doi: 10.1016/j.intimp.2023.110792
|
| 660 |
M. Rohini, A. Haritha Menon, N. Selvamurugan. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. International Journal of Biological Macromolecules 2018; 120: 310 doi: 10.1016/j.ijbiomac.2018.08.107
|
| 661 |
Sameh Nakhla, Ayman Rahawy, Mohamed Abd El Salam, Thana Shalaby, Mohamed Zaghloul, Eman El-Abd. Radiosensitizing and Phototherapeutic Effects of AuNPs are Mediated by Differential Noxa and Bim Gene Expression in MCF-7 Breast Cancer Cell Line. IEEE Transactions on NanoBioscience 2021; 20(1): 20 doi: 10.1109/TNB.2020.3028562
|
| 662 |
Gloria M. Calaf, Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo, Gopeshwar Narayan, Debasish Roy. Cell Adhesion Molecules Affected by Ionizing Radiation and Estrogen in an Experimental Breast Cancer Model. International Journal of Molecular Sciences 2022; 23(20): 12674 doi: 10.3390/ijms232012674
|
| 663 |
Saquib Z. Banday, Maniza Ayub, Malik T. Rasool, Sheikh Z. Ahmed, Aaqib Z. Banday, Shah Naveed, Faisal R. Guru, Mohmad H. Mir, Shareefa Akhter, Mudasir H. Bhat, Syed B. Yaseen, Fir Afroz, Gull M. Bhat, Mohammad M. Lone, Shiekh A. Aziz. Receptor subtype and outcome of breast cancer – Single-center experience from North India. Journal of Cancer Research and Therapeutics 2024; 20(5): 1486 doi: 10.4103/jcrt.jcrt_56_23
|
| 664 |
Jiajun Zhang, Jianhua Yin, Yang Heng, Ken Xie, Ao Chen, Ido Amit, Xiu-wu Bian, Xun Xu. Spatiotemporal Omics-Refining the landscape of precision medicine. Life Medicine 2022; 1(2): 84 doi: 10.1093/lifemedi/lnac053
|
| 665 |
Simone Aparecida de Bessa Garcia, Mafalda Araújo, Tiago Pereira, João Mouta, Renata Freitas. HOX genes function in Breast Cancer development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(2): 188358 doi: 10.1016/j.bbcan.2020.188358
|
| 666 |
Na Luo, KeJing Zhang, Xin Li, Yu Hu, Lei Guo. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer. Journal of Advanced Research 2025; 69: 313 doi: 10.1016/j.jare.2024.04.009
|
| 667 |
Muheng Liao, Jace Webster, Emily M. Coonrod, Katherine N. Weilbaecher, Christopher A. Maher, Nicole M. White. BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer. Clinical Breast Cancer 2024; 24(4): 368 doi: 10.1016/j.clbc.2024.02.007
|
| 668 |
Precilla S. Daisy, Kuduvalli S. Shreyas, T. S. Anitha. Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications. Molecular Biotechnology 2021; 63(2): 93 doi: 10.1007/s12033-020-00289-1
|
| 669 |
Sumon Kumar Saha, Madhurima Sarkar, Mahima Srivastava, Sarbajeet Dutta, Shamik Sen. Nuclear α‐actinin‐4 regulates breast cancer invasiveness and EMT. Cytoskeleton 2025; 82(3): 145 doi: 10.1002/cm.21901
|
| 670 |
John Redmond, Helen McCarthy, Paul Buchanan, Tanya J. Levingstone, Nicholas J. Dunne. Advances in biofabrication techniques for collagen-based 3D in vitro culture models for breast cancer research. Materials Science and Engineering: C 2021; 122: 111944 doi: 10.1016/j.msec.2021.111944
|
| 671 |
Muhanad Alhujaily. Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway. Biomolecules 2024; 14(5): 584 doi: 10.3390/biom14050584
|
| 672 |
Claudia Arias-Calvachi, Rancés Blanco, Gloria M. Calaf, Francisco Aguayo. Epstein–Barr Virus Association with Breast Cancer: Evidence and Perspectives. Biology 2022; 11(6): 799 doi: 10.3390/biology11060799
|
| 673 |
Thomas Cantore, Paola Gasperini, Riccardo Bevilacqua, Yari Ciani, Sanju Sinha, Eytan Ruppin, Francesca Demichelis. PRODE recovers essential and context-essential genes through neighborhood-informed scores. Genome Biology 2025; 26(1) doi: 10.1186/s13059-025-03501-0
|
| 674 |
Michele Sommariva, Maria Dolci, Tiziana Triulzi, Federico Ambrogi, Matteo Dugo, Loris De Cecco, Valentino Le Noci, Giancarla Bernardo, Martina Anselmi, Elena Montanari, Serenella M. Pupa, Lucia Signorini, Nicoletta Gagliano, Lucia Sfondrini, Serena Delbue, Elda Tagliabue. Impact of in vitro SARS-CoV-2 infection on breast cancer cells. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-63804-3
|
| 675 |
Jovita Byemerwa, Ching-Yi Chang, Donald P McDonnell. The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens. Endocrine Reviews 2025; doi: 10.1210/endrev/bnaf014
|
| 676 |
Deepali Bhadane, Dinisha Kamble, Mangesh Deval, Subhajit Das, Sandhya Sitasawad. NOX4 alleviates breast cancer cell aggressiveness by co-ordinating mitochondrial turnover through PGC1α/Drp1 axis. Cellular Signalling 2024; 115: 111008 doi: 10.1016/j.cellsig.2023.111008
|
| 677 |
Xiangru Wang, Hanghang Chen. Prognosis Prediction Through an Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Data in Triple-Negative Breast Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.928175
|
| 678 |
Kemal Kürşat BOZKURT, Özlem DURAK, İbrahim Metin ÇİRİŞ, Nilgün KAPUCUOĞLU, Tuba DEVRİM. Meme Kanserinde Moleküler Alt Tiplerin Klinikopatolojik Özelliklerle İlişkisi. SDÜ Tıp Fakültesi Dergisi 2020; 27(2): 160 doi: 10.17343/sdutfd.605500
|
| 679 |
Yujung Kim, Jaejik Kim. Identification of New Clusters from Labeled Data Using Mixture Models. Journal of Computational Biology 2022; 29(6): 585 doi: 10.1089/cmb.2021.0443
|
| 680 |
Jun Yang, Ling Guo, Yongqi Su, Yada Zhang. Screening of Key Genes for Triple-Negative Breast Cancer Based on a Differential Co-expression Method. 2022 41st Chinese Control Conference (CCC) 2022; : 5729 doi: 10.23919/CCC55666.2022.9901550
|
| 681 |
Sindhaghatta Venkatram, Maria Duran, Ked Fortuzi, Aam Baqui, Thanh-ha Luong, Gilda Diaz-Fuentes. Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer. Cureus 2024; doi: 10.7759/cureus.55712
|
| 682 |
Mehmet Taha Yildiz, Lütfi Tutar, Nazlı Irmak Giritlioğlu, Banu Bayram, Yusuf Tutar. miRNomics. Methods in Molecular Biology 2022; 2257: 293 doi: 10.1007/978-1-0716-1170-8_15
|
| 683 |
Silvia Taralli, Margherita Lorusso, Elisabetta Perrone, Germano Perotti, Luca Zagaria, Maria Lucia Calcagni. PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review. Cancers 2023; 15(3): 908 doi: 10.3390/cancers15030908
|
| 684 |
Samir Jana, Wende Li, Pin-Ji Lei, Zixiong Wang, Shaye Kibara, Peigen Huang, Dennis Jones. Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone Receptor Expression, Human Epidermal Growth Factor Receptor 2 Positivity, and Enrichment in Cancer and Mesenchymal Stem Cells. The American Journal of Pathology 2024; 194(6): 1137 doi: 10.1016/j.ajpath.2024.02.013
|
| 685 |
Micaela Giani, Yoel Genaro Montoyo-Pujol, Gloria Peiró, Rosa María Martínez-Espinosa. Haloarchaeal carotenoids exert an in vitro antiproliferative effect on human breast cancer cell lines. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34419-x
|
| 686 |
Ramesh Elango, Sameera Rashid, Radhakrishnan Vishnubalaji, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, Julie Decock, Omar M. E. Albagha, Nehad M. Alajez. Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. Cell Death & Disease 2023; 14(7) doi: 10.1038/s41419-023-05908-8
|
| 687 |
Ching-Ying Kuo, Teng-Song Weng, K. J. Senthil Kumar, Yen-Hsueh Tseng, Ta-Wei Tung, Sheng-Yang Wang, Hui-Chun Wang. Ethanol Extracts of Dietary Herb, Alpinia nantoensis, Exhibit Anticancer Potential in Human Breast Cancer Cells. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735419866924
|
| 688 |
Fernando Gonzalez-Salinas, Rocio Rojo, Claudia Martinez-Amador, Jessica Herrera-Gamboa, Victor Trevino. Transcriptomic and cellular analyses of CRISPR/Cas9-mediated edition of FASN show inhibition of aggressive characteristics in breast cancer cells. Biochemical and Biophysical Research Communications 2020; 529(2): 321 doi: 10.1016/j.bbrc.2020.05.172
|
| 689 |
Raquel González de Vega, María Luisa Fernández Sanchez, Noemí Eiro, Francisco J. Vizoso, Michael Sperling, Uwe Karst, Alfredo Sanz Medel. Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues. Analytical and Bioanalytical Chemistry 2018; 410(3): 913 doi: 10.1007/s00216-017-0537-x
|
| 690 |
�zlem Yersal, Muhammed Kaplan, Abdurrahman Işikdoğan, Nuriye �zdemir, Mehmet Aliustaoğlu, Sabri Barutca, Halil Erdoğdu, Nezih Meydan. Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era. Molecular and Clinical Oncology 2018; doi: 10.3892/mco.2018.1771
|
| 691 |
Chia-Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu, Ching-Ting Wei. Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer. Breast Cancer: Targets and Therapy 2024; : 23 doi: 10.2147/BCTT.S443292
|
| 692 |
Ravinder Verma, Kuldeep Kumar, Shailendra Bhatt, Manish Yadav, Manish Kumar, Priti Tagde, P.S. Rajinikanth, Abhishek Tiwari, Varsha Tiwari, Diksha Nagpal, Vineet Mittal, Deepak Kaushik. Untangling Breast Cancer: Trailing Towards Nanoformulations-based Drug Development. Recent Patents on Nanotechnology 2025; 19(1): 76 doi: 10.2174/1872210517666230731091046
|
| 693 |
Bryan John Abel Magoling, Anthony Yan‐Tang Wu, Yen‐Ju Chen, Wendy Wan‐Ting Wong, Steven Ting‐Yu Chuo, Hsi‐Chien Huang, Yun‐Chieh Sung, Hsin Tzu Hsieh, Poya Huang, Kang‐Zhang Lee, Kuan‐Wei Huang, Ruey‐Hwa Chen, Yunching Chen, Charles Pin‐Kuang Lai. Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers In Vivo. Advanced Materials 2023; 35(13) doi: 10.1002/adma.202208966
|
| 694 |
Maria Paula Duran Penteado, Anna Carolina Blanco Capassi Santos, Marcos Yuji Shiroma Graziano, Glaucia Luciano da Veiga, Auro del Giglio, Fernando Luiz Affonso Fonseca, Beatriz da Costa Aguiar Alves. Leukemia inhibitory factor in peripheral blood as a prognostic marker in breast cancer. Cancer Treatment and Research Communications 2025; 43: 100887 doi: 10.1016/j.ctarc.2025.100887
|
| 695 |
Nikitha Vobugari, Madhuri Chengappa, John Rickards, Anne Blaes. Innovations in Cardio-Oncology. 2025; : 405 doi: 10.1016/B978-0-443-29829-5.00016-5
|
| 696 |
Dong Hyun Moon, Jiyoon Park, Seonghun Kim, Sanghee Kim, Dong-Chan Oh, Sang Kook Lee. Methyl-oxazolomycin A: A novel oxazolomycin analog with potent selective estrogen receptor degrading activity in breast cancer cells. Biochemical Pharmacology 2025; 238: 116966 doi: 10.1016/j.bcp.2025.116966
|
| 697 |
Leonel Pekarek, Alicia Sánchez Cendra, Eduardo D. Roberts Cervantes, Cristina Sánchez Cendra, Oscar Fraile-Martinez, Cielo García-Montero, Raul Diaz-Pedrero, Diego Torres-Carranza, Laura Lopez-Gonzalez, Soledad Aguado-Henche, Antonio Rios-Parra, Luis M. García-Puente, Natalio García-Honduvilla, Julia Bujan, Melchor Alvarez-Mon, Miguel A. Saez, Miguel A. Ortega. Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review. International Journal of Molecular Sciences 2023; 24(9): 8396 doi: 10.3390/ijms24098396
|
| 698 |
Ian Landry, Vikram Sumbly, Mallorie Vest. Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature. Cureus 2022; doi: 10.7759/cureus.21970
|
| 699 |
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, Mazaher Maghsoudloo, Mahdieh Emadi, Atefeh Moradi, Behnaz Abedi, Parham Jabbarzadeh Kaboli. Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. Journal of Experimental & Clinical Cancer Research 2025; 44(1) doi: 10.1186/s13046-025-03394-8
|
| 700 |
Songmi Kim, Dong Hee Kim, Wooseok Lee, Yong-Moon Lee, Song-Yi Choi, Kyudong Han. The nature of triple-negative breast cancer classification and antitumoral strategies. Genomics & Informatics 2020; 18(4): e35 doi: 10.5808/GI.2020.18.4.e35
|
| 701 |
Nehad M. Ayoub, Ghaith M. Al-Taani, Amer E. Alkhalifa, Dalia R. Ibrahim, Aymen Shatnawi, Guan-Jun Yang. The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset. The Breast Journal 2024; 2024: 1 doi: 10.1155/2024/2582341
|
| 702 |
Peter Rusch, Alfred V. Hirner, Oliver Schmitz, Rainer Kimmig, Oliver Hoffmann, Maxim Diel. Zinc distribution within breast cancer tissue of different intrinsic subtypes. Archives of Gynecology and Obstetrics 2021; 303(1): 195 doi: 10.1007/s00404-020-05789-8
|
| 703 |
Huijie Pu, Xiaosha Wen, DiXian Luo, Zifen Guo. Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system. The Journal of Steroid Biochemistry and Molecular Biology 2023; 227: 106199 doi: 10.1016/j.jsbmb.2022.106199
|
| 704 |
Samipta Singh, Priya Singh, Nidhi Mishra, Priyanka Maurya, Neelu Singh, Raquibun Nisha, Shubhini A. Saraf. Advanced Drug Delivery Systems in the Management of Cancer. 2021; : 107 doi: 10.1016/B978-0-323-85503-7.00028-6
|
| 705 |
Hemaasri-Neya Girithar, Ananda Staats Pires, Seong Beom Ahn, Gilles J. Guillemin, Laurence Gluch, Benjamin Heng. Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials. British Journal of Cancer 2023; 129(2): 185 doi: 10.1038/s41416-023-02245-7
|
| 706 |
Samta Rani, Tanvir Ahmad, Sarfaraz Masood, Chandni Saxena. Diagnosis of breast cancer molecular subtypes using machine learning models on unimodal and multimodal datasets. Neural Computing and Applications 2023; 35(34): 24109 doi: 10.1007/s00521-023-09005-x
|
| 707 |
Amrita Singh Chandhoke, Ayan Chanda, Kunal Karve, Lili Deng, Shirin Bonni. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness. Oncotarget 2017; 8(13): 21001 doi: 10.18632/oncotarget.15471
|
| 708 |
Francesca Ruzzi, Arianna Palladini, Stine Clemmensen, Anette Strøbæk, Nicolaas Buijs, Tanja Domeyer, Jerzy Dorosz, Vladislav Soroka, Dagmara Grzadziela, Christina Jo Rasmussen, Ida Busch Nielsen, Max Soegaard, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Lorena Landuzzi, Pier-Luigi Lollini, Mette Thorn. Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine. Biomedicines 2022; 10(10): 2654 doi: 10.3390/biomedicines10102654
|
| 709 |
Shankar Suman, Trayambak Basak, Prachi Gupta, Sanjay Mishra, Vijay Kumar, Shantanu Sengupta, Yogeshwer Shukla. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. Journal of Proteomics 2016; 148: 183 doi: 10.1016/j.jprot.2016.07.033
|
| 710 |
Philippe Taniere, Brendan O’Sullivan, Matthew Evans, Frances Hughes. Bancroft's Theory and Practice of Histological Techniques. 2019; : 395 doi: 10.1016/B978-0-7020-6864-5.00020-7
|
| 711 |
Mashan L. Abdullah, Othman Al-Shabanah, Zeinab K. Hassan, Mohamed M. Hafez. Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition. International Journal of Molecular Sciences 2021; 22(17): 9243 doi: 10.3390/ijms22179243
|
| 712 |
Lijuan Shen, Youwu He, Chunhui Fang, Haiyan Qiu, Qing Chen, Fang Huang, Zhengyuan Wu. Cuproptosis-associated genes and immune microenvironment characterization in breast cancer. Medicine 2022; 101(50): e32301 doi: 10.1097/MD.0000000000032301
|
| 713 |
Mohammad Arshad Javed Shaikh, Khalid Saad Alharbi, Waleed Hassan Almalki, Syed Sarim Imam, Mohammed Albratty, Abdulkarim M. Meraya, Sami I. Alzarea, Imran Kazmi, Fahad A. Al-Abbasi, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Yogendra Singh, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta. Sodium alginate based drug delivery in management of breast cancer. Carbohydrate Polymers 2022; 292: 119689 doi: 10.1016/j.carbpol.2022.119689
|
| 714 |
Pallavi Kumari, Shweta Dang. Dual drug loaded nanostructured lipid carrier for cytotoxic effect against breast cancer - a drug repurposing approach. Surfaces and Interfaces 2023; 40: 103138 doi: 10.1016/j.surfin.2023.103138
|
| 715 |
Alton Hong, Jonathan Chua, Michael Cheng, Michael Law. Breast cancer subtypes in Australian Chinese women. ANZ Journal of Surgery 2020; 90(12): 2516 doi: 10.1111/ans.16313
|
| 716 |
Pasquale Simeone, Stefano Tacconi, Serena Longo, Paola Lanuti, Sara Bravaccini, Francesca Pirini, Sara Ravaioli, Luciana Dini, Anna M. Giudetti. Expanding Roles of De Novo Lipogenesis in Breast Cancer. International Journal of Environmental Research and Public Health 2021; 18(7): 3575 doi: 10.3390/ijerph18073575
|
| 717 |
Anna De Blasio, Giovanni Pratelli, Rosa Drago‐Ferrante, Christian Saliba, Shawn Baldacchino, Godfrey Grech, Giovanni Tesoriere, Christian Scerri, Renza Vento, Riccardo Di Fiore. Loss of MCL1 function sensitizes the MDA‐MB‐231 breast cancer cells to rh‐TRAIL by increasing DR4 levels. Journal of Cellular Physiology 2019; 234(10): 18432 doi: 10.1002/jcp.28479
|
| 718 |
Namrata Bhattacharya, Anja Rockstroh, Sanket Suhas Deshpande, Sam Koshy Thomas, Anunay Yadav, Chitrita Goswami, Smriti Chawla, Pierre Solomon, Cynthia Fourgeux, Gaurav Ahuja, Brett Hollier, Himanshu Kumar, Antoine Roquilly, Jeremie Poschmann, Melanie Lehman, Colleen C Nelson, Debarka Sengupta. Artificial intelligence approaches for tumor phenotype stratification from single-cell transcriptomic data. eLife 2025; 13 doi: 10.7554/eLife.98469.3
|
| 719 |
Yeliz ARMAN KARAKAYA, Sevda YILMAZ, Hande KARABAŞ. Meme kanseri trucut ve rezeksiyon materyallerinde yeni moleküler sınıflama, tanı ve hormon reseptörlerinin durumu tutarlı mı?. Pamukkale Medical Journal 2021; doi: 10.31362/patd.846610
|
| 720 |
Alina A. Kolomejtseva, Svetlana E. Bokova. Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research. Journal of Modern Oncology 2022; 24(1): 115 doi: 10.26442/18151434.2022.1.201440
|
| 721 |
Masrur Sobhan, Ananda Mohan Mondal. Evaluating SHAP’s Robustness in Precision Medicine: Effect of Filtering and Normalization. 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2023; : 3157 doi: 10.1109/BIBM58861.2023.10385704
|
| 722 |
Gilles Freyer, Caroline Rigault, Laure Guéroult Accolas, Anthony Barea, Narcisa Radu, Assia Ouamer, Mahasti Saghatchian. HERmione: Understanding the Needs of Patients Living with Metastatic HER2-Positive Breast Cancer Through a Cross-Sectional Survey in Parallel with Patients and Oncologists. Cancers 2025; 17(8): 1349 doi: 10.3390/cancers17081349
|
| 723 |
Gökhan GÖKALP. Spiküle Meme Kanserlerinin Histopatolojik Moleküler Biyobelirteçler ve Manyetik Rezonans Görüntüleme Arasındaki Korelasyonu. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2020; 46(1): 91 doi: 10.32708/uutfd.671934
|
| 724 |
Reetuparna Acharya, Pran Kishore Deb, Katharigatta N. Venugopala, Shakti Prasad Pattanayak. An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation. Pharmaceuticals 2024; 17(12): 1645 doi: 10.3390/ph17121645
|
| 725 |
AC Pereira, MGF Sales, LR Rodrigues. Advanced Biosensors for Health Care Applications. 2019; : 71 doi: 10.1016/B978-0-12-815743-5.00003-2
|
| 726 |
Thi Minh Thuc Nguyen, Roanh Dinh Le, Chu Van Nguyen. Breast cancer molecular subtype and relationship with clinicopathological profiles among Vietnamese women: A retrospective study. Pathology - Research and Practice 2023; 250: 154819 doi: 10.1016/j.prp.2023.154819
|
| 727 |
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar. Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies. Nanoscale Advances 2024; 6(9): 2270 doi: 10.1039/D4NA00086B
|
| 728 |
Alessandro Poli, Anna Maria Billi, Sara Mongiorgi, Stefano Ratti, James A. McCubrey, Pann-Ghill Suh, Lucio Cocco, Giulia Ramazzotti. Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C. Journal of Cellular Physiology 2016; 231(8): 1645 doi: 10.1002/jcp.25273
|
| 729 |
Mansoor Ali, Rameshwar N.K. Bamezai, Rana P. Singh. Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. OMICS: A Journal of Integrative Biology 2023; 27(9): 409 doi: 10.1089/omi.2023.0092
|
| 730 |
Yasmin M. Attia, Salama A. Salama, Samia A. Shouman, Cristina Ivan, Abdelrahman M. Elsayed, Paola Amero, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein. Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer. Pharmacological Reports 2022; 74(2): 366 doi: 10.1007/s43440-021-00346-9
|
| 731 |
Kento Karouji, Tsukasa Tominari, Reika Abe, Moe Sugasaki, Keisuke Ikeda, Chiho Matsumoto, Chisato Miyaura, Shinji Miyata, Yoshihiro Nomura, Yoshifumi Itoh, Michiko Hirata, Masaki Inada. Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer. Biochemical and Biophysical Research Communications 2025; 742: 151056 doi: 10.1016/j.bbrc.2024.151056
|
| 732 |
Feng Leng, Jiajia Huang, Liufeng Wu, Jianchao Zhang, Xinxin Lin, Ruhuan Deng, Jinhang Zhu, Zhen Li, Zhenghao Li, Yimeng Wang, Han Zhang, Desheng Lu, Thomas J. Kipps, Suping Zhang. Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma. iScience 2025; 28(1): 111589 doi: 10.1016/j.isci.2024.111589
|
| 733 |
Nancy M. Y. Teng, Christopher A. Price, Alastair M. McKee, Lindsay J. Hall, Stephen D. Robinson. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. International Journal of Cancer 2021; 149(3): 494 doi: 10.1002/ijc.33496
|
| 734 |
Jin Joo Kim, Jin You Kim, Lee Hwangbo, Hojun Lee. Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores. Clinical Breast Cancer 2025; doi: 10.1016/j.clbc.2025.04.014
|
| 735 |
Veronica Giusti, Francesca Ruzzi, Lorena Landuzzi, Marianna L. Ianzano, Roberta Laranga, Elena Nironi, Laura Scalambra, Giordano Nicoletti, Carla De Giovanni, Martina Olivero, Maddalena Arigoni, Raffaele Calogero, Patrizia Nanni, Arianna Palladini, Pier-Luigi Lollini. Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression. Oncogenesis 2021; 10(11) doi: 10.1038/s41389-021-00360-9
|
| 736 |
Kefang Chen, Xiaojin Xue, Weimin Yi, Liang Ai, Changzhi Yu, Jianjun Li, Qihui Huang, Linhui Cao. Construction of a cancer-associated fibroblast-related lncRNA signature for forecasting the prognosis, immune infiltration and drug response of breast cancer. Journal of Radiation Research and Applied Sciences 2025; 18(3): 101685 doi: 10.1016/j.jrras.2025.101685
|
| 737 |
Peilin Jia, Guangsheng Pei, Zhongming Zhao, Jonathan Wren. CNet: a multi-omics approach to detecting clinically associated, combinatory genomic signatures. Bioinformatics 2019; 35(24): 5207 doi: 10.1093/bioinformatics/btz441
|
| 738 |
Bassma El Sabaa, Haytham Fayed. Molecular subtypes of breast cancer, do they differ in different age groups among Egyptian female individuals? (retrospective study). Egyptian Journal of Pathology 2017; 37(1): 160 doi: 10.1097/01.XEJ.0000520762.56197.60
|
| 739 |
Bhawna Goel, Tarun Virmani, Vikas Jain, Girish Kumar, Ashwani Sharma, Abdullah Al Noman, Li Wu Zheng. Unveiling the Link Between Breast Cancer Treatment and Osteoporosis: Implications for Anticancer Therapy and Bone Health. BioMed Research International 2024; 2024(1) doi: 10.1155/2024/5594542
|
| 740 |
Federica Brugnoli, Silvia Grassilli, Yasamin Al‐Qassab, Silvano Capitani, Valeria Bertagnolo. PLC‐β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia‐related malignant potential. Molecular Carcinogenesis 2016; 55(12): 2210 doi: 10.1002/mc.22462
|
| 741 |
Wafaa K. Teleb, Mohamed A. Tantawy, Xueqing Xu, Aida A. Hussein, Mohamed A. Abdel-Rahman. Cytotoxicity and Molecular Alterations Induced by Scorpion Venom Antimicrobial Peptide Smp43 in Breast Cancer Cell Lines MDA-MB-231 and MCF-7. International Journal of Peptide Research and Therapeutics 2022; 29(1) doi: 10.1007/s10989-022-10474-2
|
| 742 |
Tamkin Ahmadzada, Glen Reid, David R. McKenzie. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophysical Reviews 2018; 10(1): 69 doi: 10.1007/s12551-017-0392-1
|
| 743 |
Sohini Roy, Sudeshna Rakshit, Geetha Shanmugam, Koustav Sarkar. Participation of Brahmi (Bacopa monnieri L.) plant in regulation of cancer. South African Journal of Botany 2024; 168: 236 doi: 10.1016/j.sajb.2024.03.017
|
| 744 |
Reiko Mitsueda, Hiroko Toda, Yoshiaki Shinden, Kosuke Fukuda, Ryutaro Yasudome, Mayuko Kato, Naoko Kikkawa, Takao Ohtsuka, Akihiro Nakajo, Naohiko Seki. Oncogenic Targets Regulated by Tumor-Suppressive miR-30c-1-3p and miR-30c-2-3p: TRIP13 Facilitates Cancer Cell Aggressiveness in Breast Cancer. Cancers 2023; 15(16): 4189 doi: 10.3390/cancers15164189
|
| 745 |
Adrivanio Baranoski, Simone Cristine Semprebon, Bruna Isabela Biazi, Thalita Alves Zanetti, Amanda Cristina Corveloni, Lilian Areal Marques, Sandra R. Lepri, Giuliana Castello Coatti, Mário Sérgio Mantovani. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines. Journal of Toxicology and Environmental Health, Part A 2024; 87(7): 294 doi: 10.1080/15287394.2024.2308801
|
| 746 |
Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, Matthew N. Bainbridge, Matthew J. Ellis, Svasti Haricharan. Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers. Clinical Cancer Research 2018; 24(19): 4887 doi: 10.1158/1078-0432.CCR-17-3702
|
| 747 |
Yajie Wang, Hua Sun, Zhiyan Xiao, Gang Zhang, Dan Zhang, Xiuqi Bao, Fangfang Li, Shaoyu Wu, Yuanchao Gao, Ning Wei. DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer. Cell Communication and Signaling 2018; 16(1) doi: 10.1186/s12964-018-0263-9
|
| 748 |
Ka Lun Leung, Devika Verma, Younus Jamal Azam, Emyr Bakker. The use of multi-omics data and approaches in breast cancer immunotherapy: a review. Future Oncology 2020; 16(27): 2101 doi: 10.2217/fon-2020-0143
|
| 749 |
Barbara Ruszkowska-Ciastek, Kornel Bielawski, Elżbieta Zarychta, Piotr Rhone. Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study. Journal of Clinical Medicine 2021; 10(10): 2184 doi: 10.3390/jcm10102184
|
| 750 |
Nicolas Alcaraz, Markus List, Richa Batra, Fabio Vandin, Henrik J. Ditzel, Jan Baumbach. De novo pathway-based biomarker identification. Nucleic Acids Research 2017; 45(16): e151 doi: 10.1093/nar/gkx642
|
| 751 |
Daniela Furrer, Claudie Paquet, Simon Jacob, Caroline Diorio. Cancer Prognosis. 2018; doi: 10.5772/intechopen.78271
|
| 752 |
Sayem Miah, Charles A. S. Banks, Mark K. Adams, Laurence Florens, Kiven E. Lukong, Michael P. Washburn. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. Molecular BioSystems 2017; 13(1): 42 doi: 10.1039/C6MB00639F
|
| 753 |
Mobina Jalalvand, Farzaneh Darbeheshti, Nima Rezaei. Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer. Immunotherapy 2021; 13(7): 587 doi: 10.2217/imt-2020-0283
|
| 754 |
Danilo Giffoni de Mello Morais Mata, Rossanna C. Pezo, Kelvin K. W. Chan, Ines Menjak, Andrea Eisen, Maureen Trudeau. A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. Current Oncology 2024; 32(1): 6 doi: 10.3390/curroncol32010006
|
| 755 |
Saeideh Jafarinejad-Farsangi, Maryam Moazzam-Jazi, Zari Naderi Ghale-noie, Nahid Askari, Zahra Miri Karam, Samaneh Mollazadeh, Morteza Hadizadeh. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis. Gene 2022; 821: 146328 doi: 10.1016/j.gene.2022.146328
|
| 756 |
Yoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, Akiko Shida, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takeo Sato, Norihiko Sengoku, Hirokazu Tanino, Keishi Yamashita, Masahiko Watanabe. Lymph node metastasis and high serum CEA are�important prognostic factors in hormone receptor positive and HER2 negative breast cancer. Molecular and Clinical Oncology 2018; doi: 10.3892/mco.2018.1716
|
| 757 |
Lin Qi, Wei Wang, Tan Wu, Lina Zhu, Lingli He, Xin Wang. Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.607817
|
| 758 |
Aby Cheruvathoor Poulose, Srivani Veeranarayanan, M. Sheikh Mohamed, Rebeca Romero Aburto, Trevor Mitcham, Richard R. Bouchard, Pulickel M. Ajayan, Yasushi Sakamoto, Toru Maekawa, D. Sakthi Kumar. Multifunctional Cu2−xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453. Scientific Reports 2016; 6(1) doi: 10.1038/srep35961
|
| 759 |
Dara Brena, Ming-Bo Huang, Vincent Bond. Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis. Translational Oncology 2022; 15(1): 101286 doi: 10.1016/j.tranon.2021.101286
|
| 760 |
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar, Sandeep Kumar Dash. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. Current Research in Pharmacology and Drug Discovery 2022; 3: 100131 doi: 10.1016/j.crphar.2022.100131
|
| 761 |
Arthur Xuan Wang, Xiao Jing Ong, Criselle D’Souza, Paul J. Neeson, Joe Jiang Zhu. Combining chemotherapy with CAR-T cell therapy in treating solid tumors. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1140541
|
| 762 |
Ted Laderas, Guanming Wu, Shannon Mcweeney. Between Pathways and Networks Lies Context: Implications for Precision Medicine. Science Progress 2015; 98(3): 253 doi: 10.3184/003685015X14368898634462
|
| 763 |
Mayram Amiri-Shoar, Masoumeh Hosseini, Mitra Arianmanesh, Reza Eghdam-Zamiri, Shahrokh Attarian, Ali Awsat Mellati. Comparative Proteomic Analysis of Breast Cancer Tissue and the Adjacent Normal Tissue in Iranian Patients with HER2 Negative Ductal Carcinoma of Breast. International Journal of Cancer Management 2017; 10(5) doi: 10.5812/ijcm.6019
|
| 764 |
Anjugam Paramanantham, Eun Jung, Hye Kim, Bae Jeong, Jin-Myung Jung, Gon Kim, Soon Hong, Won Sup Lee. Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling. International Journal of Molecular Sciences 2021; 22(22): 12438 doi: 10.3390/ijms222212438
|
| 765 |
Megan L. Kruse, Mona Patel, Jeffrey McManus, Yoon-Mi Chung, Xiuxiu Li, Wei Wei, Peter S. Bazeley, Fumihiko Nakamura, Aimalie Hardaway, Erinn Downs, Sarat Chandarlapaty, Mathew Thomas, Halle C.F. Moore, George T. Budd, W.H. Wilson Tang, Stanley L. Hazen, Aaron Bernstein, Serena Nik-Zainal, Jame Abraham, Nima Sharifi. Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer. JCI Insight 2021; 6(20) doi: 10.1172/jci.insight.150403
|
| 766 |
Marilina García-Aranda, Maximino Redondo. Immunotherapy: A Challenge of Breast Cancer Treatment. Cancers 2019; 11(12): 1822 doi: 10.3390/cancers11121822
|
| 767 |
Yassire Oubaddou, Mohamed Oukabli, Salma Fenniche, Abderrahim Elktaibi, Mohamed Reda Elochi, Abderrahmane Al Bouzidi, Zineb Qmichou, Nadia Dakka, Caroline Diorio, Antje Richter, Youssef Bakri, Rabii Ameziane El Hassani. BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach. Genes 2023; 14(9): 1680 doi: 10.3390/genes14091680
|
| 768 |
Ayat Gamal Lashen, Michael S Toss, Suzan Fathy Ghannam, Shorouk Makhlouf, Andrew Green, Nigel P Mongan, Emad Rakha. Expression, assessment and significance of Ki67 expression in breast cancer: an update. Journal of Clinical Pathology 2023; 76(6): 357 doi: 10.1136/jcp-2022-208731
|
| 769 |
Ana Cernea, Juan Luis Fernández-Martínez, Enrique J. deAndrés-Galiana, Enrique J. deAndrés-Galiana, José A. Galván, Carmen García Pravia, Jinxin Zhang. Analysis of Clinical Prognostic Variables for Triple Negative Breast Cancer Histological Grading and Lymph Node Metastasis. Journal of Medical Informatics and Decision Making 2018; 1(1): 14 doi: 10.14302/issn.2641-5526.jmid-18-2488
|
| 770 |
Jiayu Zhang, Jie Xiong, Min Wang, Bin Wu, Chunyin Zhang. Comparison of the diagnostic value of 68Ga-FAPI and 18F-FDG PET/CT in breast cancer: a systematic review. Clinical and Translational Imaging 2024; 12(6): 787 doi: 10.1007/s40336-024-00656-x
|